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This work first describes an enantioselective Zn-catalyzed [4+2] cycloaddition of 1-
azadienes and nitro-alkenes for the synthesis of medicinally valuable piperidines. The detrimental 
coordination of 1-azadienes to the Zn catalysts undermines the stereochemical control of the 
reaction. Fortunately, a novel bisoxazoline ligand limits this undesired coordination and delivers 
high stereoselectivity. Mechanistic studies suggest the reaction proceeds via a stepwise 
mechanism in which aza-Michael addition is followed by cyclization. This proposed mechanism 
also explains the successful cycloaddition between two electron-deficient reaction partners.  
Secondly, amide-directed carbon-carbon bond formation at unactivated sp3 C-H bonds 
has been achieved using photoredox catalysis. The reaction features a hydrogen atom 
abstraction from the C-H bond to a nitrogen radical generated from the amidyl N-H bond, leading 
to the formation of a carbon-centered radical. Trapping of the resulting alkyl radical with an 
electrophilic alkene gives the desired C-C bond formation. Experimental evidence supports the 
generation of the nitrogen radical through a stepwise deprotonation/oxidation event in a closed 
catalytic cycle. The potential to incorporate other functionalities in the C-H bonds, as well as  
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CHAPTER ONE: ASYMMETRIC SYNTHESIS OF PIPERIDINES BY ZINC-CATALYZED 
[4+2] CYCLOADDITION of 1-AZADIENES and NITRO-ALKENES 
1.1 Introduction 
1.1.1 Nitrogen-Heterocycles in Pharmaceuticals 
 
Figure 1.1.1: Examples of Nitrogen-Containing Drug Molecules 
The overwhelming presence of nitrogen in pharmaceuticals underscores the need for 
efficient synthesis of nitrogen-containing molecules. Among all small-molecule drugs approved 
by the Food and Drug Administration through 2012, 84% contain at least one nitrogen atom 
(Figure 1.1.1).1 There are two main impacts nitrogen atoms have on the pharmaceutical 
properties of a molecule. First, the presence of a nitrogen atom provides many potential 
pathways for the molecule to interact with a biological target. An N-H bond and a lone pair of 
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nitrogen can serve as a hydrogen bond donor or acceptor respectively. An ionic interaction with 
anions is possible upon acquiring a position charged through protonation or alkylation of the 
nitrogen. Secondly, the nitrogen can adjust the bioavailability of the molecule due to the 
itroge ’s apa it  to for  h drogen bonding and the potential to acquire a charge, as well as 
the increased polarity of the molecule. 
 
Figure 1.1.2: Examples of Nitrogen-Heterocycle-Containing Drug Molecules 
In pharmaceuticals, 59% of small-molecule-drugs contain at least one nitrogen-
heterocycle (Figure 1.1.2).1 The rationale behind the abundance of nitrogen heterocycles is that 
the nitrogen atom is configurationally locked in the ring. As a consequence, the entropy cost 
associated with the binding is smaller compared to their acyclic counterparts. Efficient syntheses 
of nitrogen heterocycles can streamline studies of medicinal chemistry on structural-activity 




Figure 1.1.3: Distribution of Nitrogen-heterocycles in Drug Molecules  
The Njardarson group has summarized the distribution of different nitrogen-heterocycles 
among small-molecule drugs approved by the FDA (Figure 1.1.3).1 Five- and six-membered are 
the most common nitrogen-heterocycles found. A deeper analysis further reveals that 
piperidines and pyridines are the most common motif.  
1.1.2 Aza-[4+2] Cycloaddition and Its Challenges 
 
Figure 1.1.4: Diels-Alder Cycloaddition and Aza-[4+2] Cycloaddition 
The Diels-Alder reaction of dienes and dienophiles is arguably the most common strategy 
for the assembly of cyclohexane rings.2 Similarly, 6-membered nitrogen-heterocycles, piperidine 
derivatives, can also be accessed via aza-[4+2] cycloaddition (Figure 1.1.4).3 However, several 
aspects of aza-[4+2] cycloaddition have hindered its development. First, the presence of a basic 
nitrogen atom in the starting materials and the products can coordinate to a transition-metal 
complex or a Lewis acid strongly or irreversibly, preventing the transition metal complex or the 
Lewis acid from promoting the reaction. This undesired coordination becomes a serious issue 
especially in the context of catalysis since the transition metal complex or the Lewis acid is only 
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present in a catalytic amount. In addition, the starting materials and products are either imines 
or enamines which are prone to decomposition under the reaction conditions or during 
purification. 
 
Figure 1.1.5: Consideration of Bond Energy in aza-[4+2] Cycloaddition 
Simple imines, 1-azadienes and 2-azadienes are three different classes of competent 
partners for aza-[4+2] cycloaddition.4 The reaction of simple imines in catalytic enantioselective 
[4+2] cycloaddition is largely limited to the use of highly electron-rich dienes such as 
Da ishefsk ’s die es as the rea tio  part ers. This has been reviewed by Jorgensen and will not 
be discussed here.5 The use of 2-azadienes is more investigated than 1-azadienes, as exemplified 
by the Povarov reaction, a formal cycloaddition between aniline-derived imines and electron-rich 
alkenes for the construction of tetrahydroquinolines.6 Although 1-azadienes can be readily 
accessed through amines and enals/enones, their use in aza-[4+2] cycloaddition represents a 
challenge,7 which is unsurprising when the bond strengths of the forming and breaking bonds are 
considered (Figure 1.1.5). In the event of an aza-[4+2] cycloaddition with 2-azadienes, two C-C  
bonds (83 kcal/mol) are formed at the expense of two C-C  bonds (63 kcal/mol). The estimated 
enthalpy change is calculated to be 40 kcal/mol.  On the other hand, for the use of 1-azadienes, 
one C-N  bond (73 kcal/mol) and one C-C  bond (83 kcal/mol) are formed while one C-N  bond 
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(74 kcal/mol) and one C-C  bond (63 kcal/mol) are broken. The net enthalpy is estimated to be 
19 kcal/mol, approximately 20 kcal/mol less in thermodynamic driving force than in the case of 
2-azadienes, because of the weaker forming C-N  bond and the stronger breaking C-N  bond. 
Similar to the all-carbon [4+2] cycloaddition, aza-[4+2] cycloadditions can potentially 
proceed through concerted and stepwise mechanisms. Frontier molecular orbital theory can be 
applied for the analysis of a concerted cycloaddition (Figure 1.1.6).8 For 1-azadienes, the 
presence of the electronegative nitrogen decreases the electron density of the dienes and thus 
lowers the energy of its highest-occupied-molecular-orbital (HOMO). Compared to the all-carbon 
analogue of a concerted [4+2] cycloaddition, the lower energy level of the HOMO of the dienes 
disfavors the interaction with the lowest-unoccupied-molecular-orbital (LUMO) of the 
dienophiles. This unfavorable HOMO-LUMO interaction renders a concerted normal-electron-
demand Diels-Alder reaction kinetically slow. In contrast, a concerted inverse-electron-demand 
Diels-Alder cycloaddition is more feasible because the lower energy level of the LUMO of the 
dienes will lead to a favorable interaction with the HOMO of the dienophiles, especially when the 
dienophiles are made electron rich by conjugation with a heteroatom.  In addition, because of 
the electron-withdrawing nature of the nitrogen, the dienes are polarizable. This would render 
the transition-state of the [4+2] cycloaddition asynchronous in the case of a concerted 
mechanism. A stepwise mechanism is the extreme case of a highly asynchronous transition state 
where the extent of bond-forming at the two ends of the dienes differs infinitely. The mechanism 
of a particular aza-[4+2] cycloaddition is likely contingent on the electronics of the dienes and the 
alkenes, and therefore should be determined on a case-by-case basis. Although efforts have been 
devoted to develop new aza-[4+2] cycloadditions to streamline the synthesis of piperidines, the 
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mechanistic aspects are often neglected. Mechanisms are proposed without any experimental 
evidence, and in most cases, no mechanism is proposed. 
 
Figure 1.1.6: Frontier Molecular Orbital Analysis of [4+2] Cycloaddition 
1.1.3 Asymmetric Aza-[4+2] Cycloaddition with 1-Azadienes 
 
Scheme 1.1.1: Use of Chiral Auxiliary in [4+2] Cycloaddition with Electron Rich Alkenes 
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Examples of asymmetric aza-[4+2] cycloaddition with 1-azadienes and electron-rich 
alkenes are limited. Boger developed a highly diastereoselective aza-[4+2] cycloaddition with N-
sulfonyl-1-azadienes 1 and homochiral enols 2 (Scheme 1.1.1).9 A single example of a 
moderately selective [4+2] cycloaddition of N-aryl-1-azadiene 4 with enantiomerically-enriched 
enamine 5 is reported by Palacios.10 In addition to the use of chiral auxiliaries, a few methods 
based on asymmetric catalysis can be found (Scheme 1.1.2). A chiral phosphoric acid catalyzed 
asymmetric cycloaddition of N-aryl-1-azadienes 7 and enecarbamates 8 was disclosed by 
Masson and co-workers.11 Arrayas and Carretero reported a Ni-catalyzed enantioselective 
inverse-electron-demand Diels Alder reaction with N-sulfonyl-1-azadienes 11 and enol ethers 
12.12 The Wang group applied a thiourea/primary amine bifunctional catalyst 18 for the [4+2] 
cycloaddition of sodium enolates 15 and 1-azadienes 16.13 The thiourea is believed to activate 
the 1-azadienes through hydrogen bonding while the condensation of the primary amine on the 
carbonyl group in the sodium enolates to form an iminium is proposed to be important for 
achieving high enantioselectivity. 
In addition, various groups have demonstrated the in-situ generation of an electron rich 
alkene with a chiral catalyst and the subsequent stereoselective [4+2] cycloaddition with electron 
poor N-sulfonyl 1-azadienes (Scheme 1.1.3). The Bode,14 Rovis15 and Ye16 groups generated the 
electron-rich alkenes, azolium enolates, from aldehydes or ketenes with nucleophilic heterocycle 
carbene catalysts 21, 26 and 30. As demonstrated by Smith group, the same kind of electron-rich 
alkene intermediates can also be generated from activated carboxylic acids and isothiourea 
catalyst 37.17  The Chen group condensed proline-derived secondary amine catalyst 36 onto a 




Scheme 1.1.2: Catalytic Enantioselective aza-[4+2] Cycloaddition with Electron-rich Alkenes 
Considering the electron-deficiency of the 1-azadienes, the use of an electron-poor 
alkene is considered to be more challenging with a concerted pericyclic mechanism. Indeed, 
there is only one report on catalytic enantioselective [4+2] cycloaddition of 1-azadienes with 
electron poor alkenes (Scheme 1.1.4). In this example, the electronic requirement for a concerted 
mechanism is obviated by a stepwise aza-Rauhut-Currier pathway. Other asymmetric 
cycloadditions of 1-azadienes with electron poor alkenes rely on the application of chiral 
auxiliaries. Ghosez demonstrated the diastereoselective aza-cycloaddition of 1-azadiene 42 and 
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maleic anhydride 43.19 There is also a single example of successful aza-cycloaddition of 1-
azadienes with chiral tungsten alkynylcarbene 47, as demonstrated by the Barluenga group.20 
 1.1.4 [4+2] Cycloaddition of 1-Azadienes and Nitro-alkenes 
A former co-worker in the Rovis group, Dr. Derek Dalton, discovered that 3-
nitropiperidines can be assembled by the aza-[4+2] cycloaddition of 1-azadienes and nitro-
alkenes (Scheme 1.1.5).21 The cycloadducts can be derivatized to 3-aminopiperidines, a 
medicinally valuable motif (Figure 1.1.7). Examples of drug molecules containing this motif 
include Tofacitinib,22 Alogliptin,23 Palonosetron,24 Lenalidomide25 and Maropitant.26 
The aza-[4+2] reaction developed by Dr. Dalton requires an earth-abundant Zn catalyst 
and different substitution patterns on both reaction partners are tolerated (Scheme 1.1.5). Nitro-
alkenes with small or relatively bulky substituents (49, 50, 51 and 53) on the -carbon are 
competent reaction partners. Other functionalities, such as protected alcohol (52), also do not 
affect the outcome of the reaction. For the 4-substituents on 1-azadienes, electron-rich, electron-
neutral and electron-poor aromatic rings (49, 54 and 55) are tolerated. Good yield of the 
cycloadducts can also be obtained with hetereoaryl furan (56) or even alkyl group (57). 
 








Scheme 1.1.4: Asymmetric aza-[4+2] Cycloaddition of 1-azadienes with Electron-poor Alkenes 
 




Scheme 1.1.6: Catalytic Enantioselective Synthesis of 3-nitropiperidines 
After extensive optimization with high throughout experimentation, the highest ee 
obtained for the [4+2] cycloaddition was 47% with Prophenol 60 (Scheme 1.1.6).27 During the 
course of this work, Sun and Lin reported catalytic enantioselective synthesis of 3-
nitropiperidines 64b with different substitution.28 
1.2 Results 
1.2.1 Initial Screening of Ligands 
Considering the medicinal relevance of 3-aminopiperidines, an asymmetric variant of the 
aza-[4+2] cycloaddition of 1-azadienes and nitro-alkenes is highly desired. Building off the work 
from Dr. Dalton, the objective of our work was to develop a catalytic enantioselective aza-[4+2] 
cycloaddition of 1-azadienes and nitro-alkenes. Initial efforts focused on the application of 
bisoxazoline ligands, the most common class of ligands for asymmetric Zn-catalyzed 
transformations (Scheme 1.2.1). Since the product from the aza-[4+2] cycloaddition contains an 
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enamine that is prone to hydrolysis during purification, a reductive workup protocol with ZnCl2, 
NaCNBH3 in MeOH was adopted to reduce the cycloadduct to stable piperidine 68. The result 
shows the commercial bisoxazolines L1, L2, L3 and L4 give apparently no stereochemical control 
for the [4+2] cycloaddition. Therefore, we explored other bisoxazoline ligands.29The biphenyl-
derived bisoxazoline L5 gives modest enantioselectivity. The axially chiral bisoxazoline L6 gives a 
moderate enantiomeric excess of 34%. Efforts to improve the selectivity by the installation of 
chiral elements at the oxazolines are not fruitful. In the mismatched case in ligand L7, almost all 
stereochemical control is lost. When both chiral elements from the binapthyl and the oxazolines 
in L8 favor the formation of the same stereoisomer, only a moderate ee (52%) is obtained. 
 




Scheme 1.2.2: Screening of BOPA Ligands Derived from Different Amino-alcohols 
 I spired  Du’s ork o  ) -catalyzed enantioselective Michael addition with nitro-
alkenes and indoles,30 we investigated the use of BOPA (bis(oxazolinylphenyl)amide) ligands. 
Ligand L9 gives an enantioselectivity (47% ee) similar to that obtained with L8. Considering its 
ease of modification, we focused on the use of BOPA ligands for subsequent studies. Screening 
with BOPA ligands derived from commercial chiral amino alcohols or those derived from amino 
acids was undertaken (Scheme 1.2.2). Changing the syn-relation of the two phenyl groups in L9 
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to anti in L10 leads to a slight increase in enantioselectivity. L11, which bears one phenyl group 
at each oxazoline, gives the same enantio-control as L9.  Different substituents at the oxazolines 
have a significant impact on the outcome of the reaction. With bisoxazolines L12 and L13, derived 
from valine or tert-leucine respectively, a decrease in stereoselectivity was found. The use of 
phenylalanine-derived ligand L14 gives essentially the same selectivity as ligand L10 with a much 
higher conversion. This higher catalytic efficiency allows the reaction to be conducted at rt and 
leads to an improvement in enantiomeric excess (71%). However, attempts to further lower the 
temperature result in poor conversion (<5%). L15, despite having extended benzyloxy groups at 
the para positions compared to ligand L14, does not lead to any improvement of stereochemical 
control. With ligand L14, extensive optimization with Zn(II) sources, solvents, concentration, 
metal/ligand ratio were undertaken, but no improvement in stereoselectivity was achieved. 
1.2.2 Structural and Selectivity Relationship of BOPA Ligand 
Seeking new directions to improve the catalyst, we turned our attention toward 
u dersta di g ho  the liga d’s stru ture i pa ts e a tiosele ti it . To this end, we synthesized 
the sulfur- and oxygen-analogues of BOPA ligands L16 and L17. A significant reduction in 
enantioselectivity with the sulfur analogue L16 is observed while the oxygen analogue L17 gives 
the opposite enantiomer in moderate selectivity (Scheme 1.2.3). Considering the similar bond 
length and bond angle an oxygen atom and a nitrogen atom can adopt, we attributed the 
different behavior with ligands L14 and L17 to the presence of the N-H bond in ligand L14. This is 
confirmed with ligand L18, which gives no apparent stereochemical control for the [4+2] 
cycloaddition. Although the significance of the N-H bond in the BOPA ligands remained unclear, 
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this observation is consistent with previously published Zn-catalyzed enantioselective Michael 
additions with this class of ligands.31 
 
Scheme 1.2.3: Significance of N-H Bond in BOPA Ligands 
In addition to the N-H bond, the role of the bisoxazolines were also studied. Ligand L19, 
bearing one oxazoline unit and a methyl ester was synthesized. This ligand lacking the C2 
symmetry in the BOPA ligand resulted in product formation with reversal of enantioselectivity 
and little stereochemical control (Scheme 1.2.4). The result suggests that both oxazolines are 
necessary for the enantioselectivity observed with ligand L14. 
1.2.3 Electronic Effects of BOPA Ligands 
After demonstrating the importance of both the N-H bond and the presence of both 
oxazoline units on the ligand, we became curious how the electronics of the BOPA ligands could 
affect enantioselectivity. Little effort has been devoted to study the electronic effects of BOPA 
ligands on metal-catalyzed reactions. The Du group reported the synthesis of BOPA ligands L20 
and L21 and their use in a Zn-catalyzed Michael addition reaction of indole 69 to nitro-styrene 
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70.32 Their results show that the electronics of the BOPA ligands have essentially no impact on 
both the stereochemical outcome and the catalytic efficiency of the reaction (Scheme 1.2.5). 
 
Scheme 1.2.4: Significance of Bisoxazolines in BOPA Ligands 
 
Scheme 1.2.5: Lack of Electronic Effect of Ligands for Zn-catalyzed Michael Addition 
 
Scheme 1.2.6: Intriguing Electronic Effect of Ligands on Enantioselectivity 
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I  o trast to Du’s ork, our reaction is highly sensitive to the electronic properties of the 
BOPA ligands (Scheme 1.2.6). The enantioselectivity decreases when the electron density of the 
BOPA ligands decreases. With novel ligand L23, a slight drop of enantioselectivity was observed. 
The use of more electron-deficient ligand L24 results in a larger decrease in selectivity. 
Intriguingly, with the BOPA ligand L25, the opposite enantiomer is formed in moderate 
enantiomeric excess. The reversal of enantioselectivity is also observed with novel ligand L26. 
Since the m-nitro and p-nitro benzoic acid have almost the same pka,33 the electronics of the 
bisoxazoline units in ligands L25 and L26 should be similar. On the other hand, due to 
delocalization of the lone pair of nitrogen to the nitro group in L26, the N-H bond in ligand L25 
should be significantly less acidic.34 Therefore, the similar stereochemical control observed with 
L25 and L26 suggests that the reversal of enantioselectivity observed is due to the change in the 
electronics of the bisoxazoline units, rather than the acidity of the N-H bond. 
We applied  values, which were first used to describe the electronic effects of different 
substituents on the aromatic rings on the acidity of benzoic acids, to quantify the electronic effect 
of the bisoxazoline units on the enantioselectivity.35 A Hammett plot indicates that such 
relationship is linear (Figure 1.2.1). The y-axis is log(k1/k2), where k1 and k2 are the rates of the 
formation of the two enantiomers, and k1/k2 is thus the enantiomeric ratio of the reaction.   
Although the origin of the electronic effects was unclear at this point, we reasoned that 
4-methoxy groups would increase the electron-density of the bisoxazoline and L27 would confer 
excellent enantioselectivity, as guided by the Hammett plot. Disappointingly, novel ligand L27 
gives an even lower enantio-control than the electron-neutral BOPA ligand L14 (Scheme 1.2.7). 
The puzzling behavior of this ligand could be explained by the previously reported crystal 
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structure of a Zn complex bearing a thio-linker analogue of BOPA (Figure 1.2.2).36 The crystal 
structure showed that the phenyl rings and the oxazolines are nearly perpendicular to each other. 
Therefore, there is a minimal overlap between the p-orbitals of the oxygen in OMe groups and 
the  orbitals of the oxazolines. Thus, the delocalization of the lone pair of oxygen to the 
oxazolines is minimized. The  electron-withdrawing nature of the oxygen becomes dominant 
and renders the 4-OMe groups in ligand L27 electron-withdrawing. A similar scenario is observed 
in m-OMe benzoic acid where the m-OMe group behaves as a mild electron-withdrawing group 
and increases the acidity of the benzoic acid.33 We are aware that the aromatic backbone and 
the bisoxazoline unit are only slightly out of plane in the crystal structure of a Ca-BOPA complex.37 
However, in this case, the N-H bond is deprotonated by a strong base and the resulting negative 
charge on nitrogen might require the backbone and the bisoxazoline to be in plane for 
stabilization by delocalization.  
 




Scheme 1.2.7: [4+2] Cycloaddition with BOPA Ligand Bearing p-OMe Groups  
 
Figure 1.2.2: Crystal Structure of a thio-analogue of BOPA Ligand 
An alternative strategy to harness the observed electronic effect was to render the 
bisoxazolines highly electron deficient to favor the formation of the opposite enantiomer. To this 
end, ortho-nitro bisoxazolines L28 was synthesized (Scheme 1.2.8). Disappointingly, the use of 
ligand L28 provides no stereochemical control. We reasoned that the oxazolines might not be 
electron-rich enough to coordinate to Zn and thus fluorinated BOPA ligand L29 was synthesized. 
Surprisingly, this ligand gave the same level of enantiomeric induction as the parent 
unsubstituted ligand. More synthesis and screening of more ligands revealed that the electronic 
effect disappeared in the presence of ortho substituents to the oxazolines. F-, Cl-, OMe- and Me- 
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bearing BOPA ligands (L29, L30, L31 and L32) give no apparent difference in the enantiomeric 
excess of the product. 
 
Scheme 1.2.8: Disappearing Electronic Effects of ortho-substituted Bisoxazoline 
1.2.4 Mechanism, Origin of Electronic Effect and Implications 
 
Figure 1.2.3: Concerted and Stepwise Mechanisms for aza-[4+2] Cycloaddition 
We strived to gain insight into the mechanism in order to understand the origin of the 
electronic effects. The cycloaddition can potentially proceed through a concerted (aza-Diels Alder 
cycloaddition) or a stepwise (aza-Michael addition followed by cyclization) mechanism (Figure 
1.2.3). It is tempting to believe a concerted mechanism is operative because the high 
diastereoselectivity can be easily explained by an endo-transition state, as in many cases of the 
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all-carbon [4+2] Diels-Alder reaction. In addition, the nitrogen atom has the highest coefficient in 
the HOMO of the 1-azadienes and the  carbon has the highest coefficient in the LUMO of the 
nitro-alkene. The favorable interaction between the nitrogen of the 1-azadiene and the -carbon 
of the nitro-alkene can explain the high regioselectivity of the cycloaddition if a concerted 
normal-electron-demand aza-Diels Alder cycloaddition is invoked. On the other hand, 
considering the high electron-deficiency of both reaction partners, the overlap between the 
HOMO of the 1-azadiene and the LUMO of the nitro-alkene would not be effective. This 
prompted us to design control experiments to differentiate the two mechanisms. 
First, the feasibility of a concerted mechanism was probed. 1,4-diphenyldiene and nitro-
alkene were subject to the reaction conditions, compared to 1-azadiene, the more electron rich 
nature of 72 should favor the [4+2] cycloaddition if a concerted mechanism is operative. However, 
no cyclohexene 73 is formed under the reaction conditions (Scheme 1.2.9). In addition, the role 
of the Zn catalyst is difficult to explain in the concerted mechanism. The Lewis acidity of the Zn 
catalyst would increase the electron-deficiency of the 1-azadiene and/or the nitro-alkene and 
should disfavor the required HOMO/LUMO interaction for a concerted cycloaddition. 
  
Scheme 1.2.9: No Cycloaddition with 1,4-diphenylbutadiene 
We then investigated the viability of a stepwise mechanism. Jorgensen previously 
reported a thiourea- catalyzed aza-Michael addition reaction of imine 74 with nitro-alkene 75 
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(Scheme 1.2.10).38 Thiourea catalyst 76 was proposed to activate nitro-alkene 75 through 
hydrogen bonding and increases its electrophilicity to allow for the nucleophilic attack of the 
imine 74. When the same conditions were applied to 1-azadiene 58, instead of imine 74, the aza-
[4+2] cycloadduct 68 was formed, indicating the feasibility of the stepwise aza-Michael 
addition/cyclization pathway. Similarly, when imine 75 was treated with nitro-alkene 75 in the 
presence of Zn(II)-catalyst, the formation of aza-Michael adduct 77 implicates a stepwise aza-
Michael addition/cyclization pathway in our aza-[4+2] chemistry. 
  
Scheme 1.2.10: Feasibility of Stepwise aza-Michael/Cyclization Pathway 
Thirdly, secondary kinetic isotope studies39 were undertaken (Scheme 1.2.11). An inverse 
secondary kinetic isotope effect was observed with nitro-alkene 67 but not 1-azadiene 78. This 
result is consistent with a change of hybridization state of sp2 to sp3 of the  carbon of the nitro-
24 
 
alkene but not the 1-azadiene. This implicates a stepwise mechanism with the aza-Michael 
addition as the turnover-limiting and the enantio-determining step. Overall, all our experimental 
results support a stepwise mechanism. 
 
Scheme 1.2.11: Secondary Kinetic Isotope Studies 
 
Scheme 1.2.12: Reversal of Enantioselectivity due to Structural Change of Catalysts 
With a better understanding of the mechanism of the reaction, we were poised to probe 
the origin of the electronic effects of the BOPA ligands in the aza-[4+2] cycloaddition. Hayashi has 
recently reviewed the reversal of enantioselectivity with catalysts of the same chiral sources.40 
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The phenomenon of the reversal of enantioselectivity are mostly explained by three factors, a 
structural change of the catalysts, the presence/absence of hydrogen bonding and a change in 
the mechanism. These were the three hypotheses that we initially formulated to explain the 
electronic effect. 
Concerning the structural change of catalysts, RajanBaBu reported that in the event of 
Pd-catalyzed allylation of diethyl malonate 80, different absolute stereochemistry of product 84 
can be obtained with the same chiral source when the R group on the axially-chiral phosphine 
ligands changes from phenyl to cyclohexyl ring (Scheme 1.2.12).41 Supported by the drastically 
different NMR spectra of the two Pd catalysts formed by the two ligands 82 and 83, it is proposed 
that the structural differences of the Pd catalysts upon switching ligands leads to the formation 
of different enantiomers in the reaction. We speculated that different coordination 
environments of Zn with BOPA ligands of different electronics would contribute to the observed 
trend in enantioselectivity in our aza-[4+2] cycloaddition. However, no electronic effect of the 
ligand was observed with the previously- reported Zn-catalyzed Michael addition of indoles to 
nitro-alkenes using the same class of ligands (Scheme 1.2.5).32 Not only was there no reversal of 
enantioselectivity, the application of BOPA ligands of different electronics gave essentially the 
same level of enantiomeric excess of the Michael adduct and an insignificant change in catalytic 
efficiency. This observation suggests a structural change of the Zn complex as the origin of the 
electronic effect is not likely. 
To explain the reversal of enantioselectivity obtained with bisoxazolines 86 and 87/88 for 
the same transformations, Ait-Haddou and Balavoine propose the presence of a hydrogen bond 
between the hydroxyl group in 86 and the nucleophile, the sodium salt of dimethyl malonate 
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(Scheme 1.2.13).42 While a structural difference between Pd complexes ligated by 86 and 88 is 
disproved by X-ray crystallography, the proposal for the hydrogen bonding is supported by the 
lack of the reversal of enantioselectivity with dimethyl malonate-derived silyl enol ether, which 
does not possess a negative charge on oxygen for hydrogen bonding interaction, as the 
nucleophile. 
 
Scheme 1.2.13: Reversal of Enantioselectivity due to Hydrogen-bonding 
Since the N-H bond is significant in achieving the observed enantioselectivity in our aza-
[4+2] cycloaddition, the change in the strength of a putative hydrogen bond appeared to us a 
plausible origin of the electronic effects of the BOPA ligands. In this case, drastically different 
stereoselectivity would be expected for L25/L26 or L23/L27 because there is a significant 
difference in the acidity of the N-H bond. The essentially equal enantioselectivity obtained with 
these two sets of ligands strongly implies that the change in hydrogen-bonding strength or the 
acidity of the N-H bonds is not the origin of the electronic effect (Scheme 1.2.14). 
Sawamura and Ito put forward two competitive pathways to explain the different 
absolute stereochemistry of the hydrogenation product 93 catalyzed by Rh(I) ligated by different 
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TRAP ligands 91 and 92 at different pressure of hydrogen gas (Scheme 1.2.15). Casey reported a 
stereo-divergent formation of 96 from Pt-catalyzed hydroformylation of styrene 94 at different 
temperatures. It is proposed that the enantio-determining step changes from platinum hydride 
addition at high temperature to partially reversible alkyl migration to CO and hydrogenolysis at 
low temperature. 
 
Scheme 1.2.14: Counter-evidence for Hydrogen Bond as Origin of Electronic Effects 
We were curious whether a change in the reaction mechanism attributed to the observed 
electronic effect of the BOPA ligands on stereoselectivity in the aza-[4+2] Cycloaddition. When 
the BOPA ligand becomes less electron rich, the increased Lewis acidity of the Zn complex would 
accelerate the aza-Michael step. On the other hand, the Zn nitronate intermediate is more 
stabilized and the cyclization step would become slower. This change in the relative rate of the 
two steps could potentially lead to a switch in the enantio-determining step from the aza-Michael 
addition step to the cyclization step. In this case, if the chiral element of the Zn complex favored 
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the formation of different enantiomers in the Michael and cyclization step, a reversal of 
enantioselectivity could be obtained. To test this hypothesis, secondary kinetic isotope effects 
with ligands of different electronics were investigated (Scheme 1.2.16). The same inverse 
secondary kinetic isotope effect from L14, L29 and L26 contradicts the hypothesis and suggests 
that the aza-Michael addition step remains the turnover-limiting step and enantio-determining 
step with all ligands. 
 
Scheme 1.2.15: Reversal of Enantioselectivity due to Change of Reaction Mechanism 
Further evidence that supports the aza-Michael addition is the enantio-determining step 
with ligands of different electronics is established with the use of -methyl nitro-ethylene 97 
(Scheme 1.2.17). With 97, no stereogenic center is formed in the first aza-Michael addition step. 
Therefore, opposite enantiomers would still be expected with ligands L14 and L26 if the 
secondary cyclization step was enantio-determining for these ligands. In the cycloaddition of 97 
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and 78, the same enantiomer is obtained with both ligands L14 and L26. This observation is 
consistent with the establishment of the absolute stereochemistry in the first aza-Michael 
addition step with both ligands in the case of nitro-alkene 67. 
 
Scheme 1.2.16: Secondary Kinetic Isotope Effects with Different Ligands 
 
Scheme 1.2.17: Formation of Same Enantiomer with -methyl Nitro-ethylene 
While studying the impact of the substituents of nitrogen in 1-azadienes, we observed a 
trend that could shed light on the origin of the electronic effect. The enantioselectivity of the 
reaction increases with the electron density of the 1-azadienes but the exceptionally rich 1-
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azadiene 101 gives the same selectivity as 58 (Scheme 1.2.18). To explain this observation, we 
hypothesized that 1-azadiene 101 can deleteriously coordinate to the Zn catalyst, forming a 
distorted Zn complex that gives rise to the formation of the opposite enantiomer (Figure 1.2.3). 
Such distorted Zn complex was only formed when the 1-azadiene is highly electron-rich. 
 
Scheme 1.2.18: Electronic Effect of 1-azadienes on Enantioselectivity 
 
Figure 1.2.3: Origin of Electronic Effect 
To test this hypothesis, electron-rich imine 102 was added for the [4+2] cycloaddition of 
58 and 67 with ligand L14 (Scheme 1.2.19). The observed drop in enantioselectivity is consistent 
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with the formation of a Zn complex that gives a lower level of enantio-control through the 
coordination of iminyl nitrogen in 102 to Zn. 
 
Scheme 1.2.19: Drop in Enantioselectivity in the Presence of Imine Additive 
To explain the electronic effect of the ligands, we hypothesized that Zn catalysts with less 
electron rich bisoxazolines are more susceptible to the coordination of the 1-azadienes and 
would thus exhibit a larger drop in enantioselectivity or a reversal of enantioselectivity. 
 
Scheme 1.2.20: Evidence for Undesired Coordination of 1-azadiene as Origin of Electronic Effect 
We verified the hypothesis with an established Michael addition of indole 69 and nitro-
styrene 70 catalyzed by Zn(BOPA) catalysts.32 In the absence of 1-azadiene, the same enantiomer 
32 
 
of 71 is obtained with the same yield and same level of stereochemical control, regardless of the 
electronic properties of the BOPA ligands on Zn (Scheme 1.2.20). On the other hand, the same 
electronic effect on enantioselectivity of the BOPA ligands as in our [4+2] cycloaddition was 
observed in the presence of 1-azadiene 58. The opposite enantiomer is formed with highly 
electron deficient bisoxazoline L26 and the electronic effect is minimized with bisoxazolines 
bearing ortho-substituent L29. Therefore, we believe the undesired coordination of 1-azadiene 
to the Zn catalysts is the origin of the electronic effect on the stereochemical outcome of the 
[4+2] cycloaddition. This coordination is disfavored when the bisoxazolines bear ortho-
substitution because of sterics, explaining the disappearing electronic effects with this class of 
BOPA ligand. 
 
Scheme 1.2.21: Consistency of Absolute Stereochemistry  
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The absolute stereochemistry of the aza-[4+2] cycloaddition was also established for the 
comparison of that obtained with the aza-Michael addition catalyzed by Zn-BOPA complexes 
(Scheme 1.2.21). 3-methyl-substituted 1-azadiene 103 was subject to the reaction conditions to 
give enantiomerically-enriched cycloadduct 104, which was previously synthesized and 
characterized.28 Through the measurement of the optical activity, the absolute stereochemistry 
of 104 was determined (Scheme 1.2.21). This stereochemical outcome is consistent with that 
obtained from enantioselective Michael additions of other nucleophiles to nitro-alkenes 
catalyzed by Zn-BOPA complexes with L10 and L9, which have the same configuration at the 
bisoxazolines.30,43 
In addition to the enantioselectivity, we observed that the yield of the model aza-Michael 
addition reaction is also impacted by the electronics of the BOPA ligands (Scheme 1.2.20). A lower 
conversion to 71 is obtained with more electron deficient BOPA ligand L26 while this decrease in 
conversion is recovered when using ortho-substituted bisoxazoline ligand L29 that minimize 
undesired coordination of 1-azadiene to the Zn catalysts. Therefore, the deleterious coordination 
of 1-azadiene does not only impact the stereochemical outcome, but also the catalytic efficiency. 
This implication regarding the catalytic efficiency should be put into serious consideration at 
lower reaction temperature because the coordination of the 1-azadiene has a lower entropy cost. 
While the use of L14 in our [4+2] cycloaddition leads to poor conversion (<5%) at 0oC, we 
proposed that this poor conversion at low temperature can be overcome by the higher catalytic 
efficiency with the ortho-substituted BOPA ligands and the low reaction temperature would serve 




Scheme 1.2.22: Optimization with ortho-substituted BOPA ligand 
Due to solubility issues, N-(4-phenoxyphenyl)-1-azadiene 78 was used to investigate the 
temperature effect (Scheme 1.2.22). We were delighted to find that the [4+2] cycloaddition with 
L29 proceeds smoothly at 3 oC with a slight increase in enantioselectivity, consistent with our 
proposal. The reaction temperature can be further adjusted to 18 oC with increased reaction 
time. In this case, the ee increases slightly to 78%. In order to improve the stereoselectivity, we 
further lowered the temperature to 38 oC and high enantiomeric excess (89%) was obtained, 
albeit with a longer reaction time (4 days). We were able to shorten the reaction time to 1 day 
by increasing the catalytic loading, the amount of nitro-alkene and the concentration. The desired 
3-nitro piperidine product was isolated in 82% yield and 89% ee with 20 mol % Zn catalyst at 0.18 
M. 
1.2.5 Reaction Scope under Optimized Conditions 
With the optimized conditions, the scope of the reaction was investigated (Scheme 
1.2.23). Due to differences in solubility, the reaction time did not reflect the intrinsic reactivity of 
the 1-azadiene and different concentrations were applied. Regardless of the electronic nature of 
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the aromatic ring on nitrogen in the 1-azadiene, excellent yields of the cycloadducts (79, 68 and 
109) can be obtained. Compared to 79, the enantioselectivity of 109 drops as the aromatic ring 
becomes less electron rich. The more electron rich 4-methoxyphenyl cycloadduct 68 also gives a 
lower ee than 79. Given that an opposite trend is obtained at rt, this observation is consistent 
with a lower entropy cost for the undesired coordination of the 1-azadiene to the Zn catalyst at 
lower temperatures. 
  
Scheme 1.2.23: The Scope of 1-Azadienes 
36 
 
To study the effect of the 4-substituents of 1-azadiene, different protecting groups on nitrogen 
are used and the one with a higher solubility is always used (Scheme 1.2.23). The yield does not 
vary with the electron density of the 4-substituent in the 1-azadiene. Cycloadducts 110, 111 and 
112 are all obtained in excellent yield. On the other hand, the enantioselectivity decreases when 
the substituents become more electron rich. This trend is again consistent with the proposed 
undesired coordination of 1-azadienes to Zn. The ortho substitution has a large impact on the 
yield and the cycloadduct 113 is obtained in moderate yield with a slight decrease of 
enantioselectivity. The reaction with the furan-substituted 1-azadiene is sluggish and affords 114 
in moderate yield and ee. With a 1-azadiene derived from an aliphatic enal, the yield and the 
enantioselectivity of 115 are modest. The reaction of more conjugated azatriene does not go to 
completion, even in the presence of a large excess of the nitro-alkene and a higher catalyst 
loading and the cycloadduct 116 is obtained in moderate enantioselectivity. Excellent yield of 
cycloadduct 117 can be obtained from chalcone-derived 1-azadiene with a moderate level of 
stereochemical control. 
For the scope of the nitro-alkenes, as the nitro-alkenes become more sterically bulky, the 
reaction gives the cycloadducts (79 vs 118 and 119) in lower enantioselectivity and requires a 
longer reaction time and/or a higher catalyst loading (Scheme 1.2.24). With even more bulky 
isopropyl nitro-alkene, an even bigger drop in enantiomeric excess in cycloadduct 120 is observed. 
Protected alcohol in the nitro-alkene is tolerated. This opens the possibility of further 
manipulation of piperidine 121 after the aza-[4+2] cycloaddition. The cycloaddition with nitro-
ethylene proceeds to give the product 122. However, its instability hinders the determination of 
enantioselectivity. -methyl nitro-ethylene is not a competent reaction partner and its use gives 
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123 in both moderate yield and ee. The use of nitro-styrene or more conjugated nitro-alkenes 
results in no conversion and the formation of 124 and 125 is not observed. 
 
Scheme 1.2.24: The Scope of Nitro-alkene 
1.2.6 Derivatization of Cycloadducts 
 
Scheme 1.2.25: Derivatization of Aza-[4+2] Cycloadducts 
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The protecting groups, 4-OMeC6H4 and 4-PhOC6H4 groups, on the nitrogen in 
cycloadducts 68 and 79 can be removed easily with cerium ammonium nitrate (CAN) to give free 
secondary amine 126 in satisfactory yield (Scheme 1.2.25). The resulting free N-H bond allows 
further manipulation for accessing structurally-diverse piperidines. Because 3-aminopepridine 
represents an important motif in medicinal chemistry, we investigated the reduction of the nitro-
group of 68 to primary amine 127. We found that reduction can be achieved by a NiCl2/NaBH4 
system, which is believed to generate nickel boride in-situ.44 
1.3 Summary 
The Zn-catalyzed asymmetric synthesis of piperidines was described, and represents a 
rare example of a catalytic enantioselective [4+2] cycloaddition reaction with 1-azadienes and 
electron-poor alkenes. Key to the success of this reaction is the use of a novel F-BOPA ligand, 
which disfavors the undesired coordination of 1-azadiene to the Zn catalyst. Experimental results 
support a stepwise aza-Michael/cyclization mechanism that explains the obviation of the 
electronic requirement of the two reaction partners inherent to a concerted mechanism. The 
product 3-nitropiperidines can be reduced to afford 3-aminopiperidine, an important structural 
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CHAPTER TWO: BACKGROUND ON DIRECTED FUNCTIONALIZATION OF SP3 C-H 
BONDS 
2.1 General Aspects of C-H Functionalization 
C-H functionalization is a powerful tool to derivatize organic molecules.1 Unlike most 
established transformations, no pre-existing functional group is required at the reactive site. The 
potential for new and diverse bond disconnections arising from the ability to discretely 
functionalize a specific C-H bond represents a valuable opportunity. Theoretically, such a strategy 
can be applied to the derivatization of any molecule to access a large array of derivatives, and is 
particularly appealing in late stage modification.2 
 
Figure 2.1.1: Challenges of C-H functionalization 
The major challenges associated with C-H functionalization are related to the reactivity 
and ubiquity of C-H bonds (Figure 2.1.1). There is a high activation barrier due to the high bond 
strength of C-H bonds. This reactivity issue can be addressed through the use of a directing group 
to provide a lower-energy pathway for the cleavage of the C-H bonds or the generation of a high-
energy reactive species such as highly unstable radicals, carbenes and nitrenes. The application 
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of a directing group is the major way to address the selectivity issue, with few exceptions where 
the bias for a particular C-H bond derives from its electronic and steric properties. For instance, 
the most acidic C-H bonds  to electron-withdrawing group can be deprotonated by a strong 
base, and terminal C-H bonds are the most sterically accessible and can be functionalized with 
emerging transition metal catalysis.3 
This chapter focuses on the directed functionalization of unactivated sp3 C-H bonds, 
where unactivated sp3 C-H bonds are defined as those are not allylic/benzylic/ to heteroatoms 
and do not include cyclopropyl or cyclobutyl C-H bonds. The three major strategies for the 
functionalization of these C-H bonds are transition-metal-catalyzed C-H activation, hydrogen 
atom transfer (HAT) to reactive radicals and the chemistry of metal carbenoids/nitrenoids. The 
transformations that can be accomplished with each strategy will be emphasized to show its 
strengths and limitations.  
2.2 Transition-Metal Catalyzed C-H Activation 
2.2.1 Introduction 
 
Figure 2.2.1: Transition-Metal Catalyzed C-H Activation 
Transition-metal catalyzed C-H activation has received tremendous attention in the past 
decade (Figure 2.2.1).4 The directing group brings the transition metal into close proximity to a 
particular C-H bond and facilitates its cleavage. Activation of a sp3 C-H bond might seem less 
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challenging due to the fact that sp3 C-H bonds (97-105 kcal/mol) are weaker than sp2 C-H bonds 
(113 kcal/mol) (Figure 2.2.2).5 However, transition-metal catalyzed activation of sp2 C-H bond is 
far more explored and well developed. This surprising fact could be explained by the 
consideration of the relative bond strength of metal-carbon bonds. As demonstrated by the Ir(III) 
and Rh(III) complexes in Figure 2.2.2, metal-sp3 carbon bonds are significantly weaker than metal-
sp2 carbon bonds.6 Therefore, the formation of an alkyl metal species is much more difficult than 
that of an aryl metal species.  Furthermore, the ubiquity of sp3 C-H bonds in most organic 
frameworks poses a greater challenge for regioselectivity. Early development of transition-metal 
catalyzed directed activation of inert sp3 C-H bonds was inspired by established works on either sp2 C-H 
bonds or undirected systems. The following is a brief review on the seminal reports and 
representative examples, and is not an exhaustive list of published works in this area. 
 
Figure 2.2.2: Consideration of Bond Energies for Transition-Metal Catalyzed C-H Activation 
2.2.2 Catalysis with Noble Metals (Pt, Pd, Ir, Rh and Ru) 
Based o  Shilo ’s s ste 7 and its catalytic variant8 for the hydroxylation of hydrocarbons with 
PtCl42-, Sames demonstrated that aliphatic amines and carboxylic acids can act as a directing group to 
install a hydroxyl group at either the  or  positions although both the yield and the selectivity of the 
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reactions is moderate (Scheme 2.2.1).9 Proline does not show any reactivity under the reaction conditions, 
supporting the role of carboxylic acid as a directing group in the latter case. A potential mechanism 
includes electrophilic C-H activation with Pt(II), subsequent oxidation of Pt(II) to Pt(IV) and final reductive 
elimination to furnish the C-O bond.  
 
Scheme 2.2.1: Pt-Catalyzed sp3 C-H Activation 
Despite Sa es’ o tri utio , it as ot u til the reports fro  the Sa ford a d Yu groups 
on Pd catalysis that transition-metal catalyzed sp3 C-H activation garnered tremendous attention. 
Based on their previous work on nitrogen-directed acetoxylation of sp2 C-H bonds and benzylic 
sp3 C-H bonds with catalytic Pd(OAc)2 and oxidant PhI(OAc)2, the Sanford group developed an 
oxime-directed acetoxylation of primary C-H bonds (Scheme 2.2.2).10 The reaction features the 
formation of a Pd(II) alkyl species and the subsequent oxidation of Pd(II) to Pd(IV) by PhI(OAc)2 
to drive reductive elimination to form a C-O bond. Soon after this report, Yu demonstrated the 
iodination of primary C-H bonds in 14 with oxazolines as the directing group.11 Similar to 




Scheme 2.2.2: Initial Reports on Pd-Catalyzed Activation of sp3 C-H Bonds 
Since the initial reports, various groups have developed different transformations 
featuring the activation of inert sp3 C-H bonds with Pd catalysis (Scheme 2.2.3). Yu reports the 
incorporation of different functionalities such as aryl, alkyne, fluorine and carbonyl groups at the 
 C-H bond of carbonyl groups. The success of these transformations is the use of a highly 
electron-deficient amide as a directing group.12 Trifluoromethanesulfonyl group can also be used 
as a directing group to activate the C-H bond  to the nitrogen. The resulting palladacycle can 
undergo a heck reaction and cyclization to yield pyrrolidines such as 21.13 Another remarkable 
example is the contributions from the Dong group that allows  oxygenation of alcohol and amine 
derivatives such as 23.14 A Pd(II)/Pd(IV) is believed to be operative to drive the reductive 
elimination of the C-O bond. Sanford developed a protocol for C-H arylation of medicinally 
valuable alicyclic amines such as 25.15 This represents the first report on transition-metal 
catalyzed transannular C-H activation. The Gaunt group also reported a synthesis of strained 
nitrogen-heterocycles like 29 featuring a 4-membered cyclopalladation of sp3 C-H bond in which 
unprotected secondary amines serve as a directing group.16 The palladacycle intermediate can 
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undergo carbonylation and reductive elimination to form -lactams. Although the rationale for 
the change in regioselectivity is unclear, 5-membered palladacycles can be formed from a sp3 C-
H bond  to sterically hindered amino-alcohols 30.17 
 
Scheme 2.2.3: Pd-Catalyzed sp3 C-H Activation 
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Asymmetric Pd-catalysis allows the establishment of the absolute stereochemistry during 
the C-H functionalization step (Scheme 2.2.4). Yu reported that with the use of amino acid 
derivatives as chiral ligands, desymmetrization of prochiral methyl groups in 32 can be achieved 
in moderate enantioselectivity.18 Yu also developed a protocol for highly enantioselective 
arylation of  methylene C-H bonds of carbonyl compounds.19 
    
Scheme 2.2.4: Asymmetric Pd-Catalyzed sp3 C-H Activation 
In addition to Pd, other noble transition metals have also shown to be competent 
catalysts for sp3 C-H activation (Scheme 2.2.5). Hartwig reported a low-valent Ir-catalyzed alcohol 
directed silylation of primary C-H bonds in a 3-step sequence.20  With Ir(III) catalysis, Chang 
successfully developed a protocol for -amination of oximes 42.21 Pyridine-directed amination 
and arylation of primary C-H bonds in 45 and 48 can be accomplished with cationic Rh(III) pre-
catalysts, as demonstrated by You22 and Glorius.23  A-Ru-catalyzed synthesis of succinimides 52 




2.2.3 Catalysis with Earth-Abundant Metals (Ni, Fe, Co and Cu) 
     
Scheme 2.2.5: Catalytic sp3 C-H Activation with Other Noble-Metals 
Efforts have been devoted to replace these precious metals by less expensive first row 
earth abundant metals such as nickel, cobalt and iron (Scheme 2.2.6). Unsurprisingly, nickel, 
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which is in the same group as Pd, is the initial focus.  Hiyama first employed a low valent Ni(0) 
pre-catalyst and an AlCl3 co-catalyst for the dehydrogenative [4+2] cycloaddition of formamide 
53 and alkyne 54 for the synthesis of piperidine  55.25 The research with Ni(II) pre-catalysts has 
been inspired by a bidentate 8-aminoquinoline directing group introduced to Pd-catalyzed sp3 C-
H activation by Daugulis.26 For instance, Chatani27 and Ge28 reported Ni-catalyzed -arylation and 
alkylation of carbonyl compounds respectively with this directing group. 
  
Scheme 2.2.6: Ni-Catalyzed sp3 C-H Activation 
For other first row-metals, 8-aminoquinoline is uniformly applied as the directing group 
(Scheme 2.2.7). With iron catalysis, Nakamura achieved  arylation of carbonyl groups with 
Grignard and diaryl zinc reagents.29 As demonstrated by Zhang, cobalt is also a competent 
catalyst for -functionalization of carbonyl groups.  Concomitant alkynylation and cyclization is 
accomplished to assemble pyrrolidine derivatives 67. More recently, -lactams 68 can be 
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synthesized through the cobalt-catalyzed activation of the  C-H bonds of carbonyl groups, a 
contribution from Ge.30 CuCl is also a competent catalyst for the same transformation.31  
 
Scheme 2.2.7: Fe-, Co- and Cu-Catalyzed C-H Activation 
The implication drawn from these representative examples is that the C-H activation 
reactions with first row transition metals require harsh conditions. The scope of the 
transformation is limited and only  functionalization of carbonyl compounds can be achieved. 
2.2.4 Applications in Natural Product Synthesis 
Even before Sames, Sa ford a d Yu’s i itial reports o  atal sis, the po er of sp3 C-H 
activation with a stoichiometric amount of transition metals, such as Pd,32 Pt,33 and Cu34 was 




Scheme 2.2.8: Applications of Transition-Metal Catalyzed C-H Activation 
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Baudoin applied an aryl bromide as a directing group in 69 to activate the homobenzylic 
sp3 C-H bond for the synthesis of cyclobutane 70 (Scheme 2.2.8).35 The cyclobutane can be 
fragmented with a tandem Curtius rearrangement, electrocyclic ring opening and 6 
electrocyclization reaction generate the isoqunoline framework of coralydine. Additionally, two 
sp3 C-H activation strategic steps are applied for the synthesis of aeruginosin B. The first step 
features the formation of a vinyl Pd intermediate from vinyl bromide 73 that activates a C-H bond 
 to nitrogen for the assembly of the bicyclic framework of 74. Another Pd-catalyzed reaction for 
-arylation delivers -hydroxy--aryl amide 77 that is present in the natural product.  Chen also 
demonstrates the power of -functionalization of carbonyl groups in natural product synthesis. 
For instance, a Pd-catalyzed  arylation of amide 78 is utilized for the installation of the indole in 
the synthesis of Celogentin C.36 A late-stage oxime-directed acetoxylation is used to install an 
alcohol functionality to yield 82 for the synthesis of the lactone in Jiadifenolide by Sorensen.37 
2.2.5 Strengths and Limitations 
Currently, transition-metal catalyzed sp3 C-H activation is the most powerful tool to 
functionalize primary C-H bonds. Various C-X bond formation is possible when switching the 
coupling partner. On the other hand, the shortcomings lie in the functionalization of unactivated 
methylene and tertiary C-H bonds. Despite the weaker bond strength of methylene and tertiary 
C-H bonds, the corresponding transition metal species are less stable than their primary 
counterparts. This is supported by the observations made on these alkyl Pd species which are 
equilibrating by -H elimination and re-insertion (Figure 2.2.3). Primary Pd alkyl is the 
thermodynamic sink and tertiary Pd alkyl is the least stable.38  This relative stability is parallel to 
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the ease of the activation of these C-H o ds ith tra sitio  etal, as e e plified  Hart ig’s 
Ir-catalyzed silylation of C-H bonds in which the primary C-H bonds are approximately 80 times 
more reactive than the secondary C-H bonds (Scheme 2.2.9). Therefore, the activation of 
secondary C-H bonds requires harsh conditions, as in the recent contributions from Yu19 and 
Sanford.15 The activation of tertiary C-H bonds with remains a formidable difficulty. 
  
Scheme 2.2.9: Limitations for Activation of Methylene C-H bonds 
 
Figure 2.2.3: Relative Energies of Different Alkyl Metal Species 
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2.3 Hydrogen Atom Transfer to Reactive Radicals  
2.3.1 Introduction 
 
Figure 2.3.1: Cleavage of C-H Bonds with Unstable Radicals 
 
Scheme 2.3.1: 1,4 HAT to Cleave Unactivated C-H Bonds 
In addition to transition-metal-catalyzed C-H activation, a C-H bond can also be cleaved 
by hydrogen atom transfer to a highly unstable radical species (vinyl, aryl, oxygen and nitrogen 
radicals) (Figure 2.3.1).39 The driving force for this process is the stronger bond strength of the 
formed X-H bond than that of the broken C-H bond. The resulting alkyl radical can be intercepted 
with a radical coupling partner to furnish a new bond. An intermolecular hydrogen atom transfer 
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event is less favorable than an intramolecular one due to higher entropy cost. Therefore, there 
are only a few examples of synthetically useful transformations with intermolecular hydrogen 
abstract from inert C-H bonds. Our discussion focuses on intramolecular HAT, where the initial 
radical can be viewed as a directing group.  
2.3.2 Selectivity of Intramolecular Hydrogen Atom Transfer 
For intramolecular hydrogen atom transfer (HAT) events, the site-selectivity is mainly 
determined by the geometry of the substrate. 1,4 HAT is uncommon and is mostly for the 
cleavage of activated C-H bonds (e.g. allylic, benzylic, or  to an electron-withdrawing group or 
donating groups).  An exception is a Norrish-type-I reaction of 88 reported by Vandewalle 
(Scheme 2.3.1).40 A hydrogen atom from an unactivated sp3 C-H bond is transferred to a carbonyl 
radical. On the other hand, the C-H being cleaved in this case is weakened by the presence of the 
radical  to it. Strictly speaking, it cannot be regarded as an unactivated sp3 C-H bond. Despite 
observations in spectroscopic studies,41 the use of 1,4 HAT to functionalize unactivated sp3 C-H 
bonds remains to be developed.  
1,5 HAT is the most common observed pathway due to a relatively low energy 6-
membered chair-like transition state (Scheme 2.3.2).42 As a representative example with alkoxy-
radicals, 1,5 HAT is favored over 1,6 HAT. Mihailovic observed that in acyclic substrates such as 
92, the ratio of 1,5 to 1,6 HAT is about 11:1 to 12:1.43 This ratio can be adjusted with the geometry 
of the substrate. As demonstrated by Wille, the vinyl radical generated by the addition of nitrate 
radical to cyclooctyne 95 gives rise to [5.2.0]-bicyclo and [4.4.0]-bicyclodecane 98 and 100 
respectively, which reflects a 3:1 ratio of 1,5 HAT to 1,6 HAT.44  
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There are limited examples of synthetically useful reactions with 1,6 HAT. Baran reports 
the synthesis of 1,3 diols featuring 1,6 HAT (Scheme 2.3.3).45 The three sp2 hybridized atoms in 
101 are believed to change the relative energy of the transition states for 1,5 and 1,6 HAT. A 
control experiment reveals that the selectivity for 1,6 HAT over 1,5 HAT is also explained by the 
weaker bond strength of tertiary C-H bonds and secondary C-H bonds since 105 and 106 are 
obtained in equal amount with 104. When there are no  C-H bonds available for 1,5 HAT, 
exclusive 1,6 HAT can operate. Penenory demonstrates that the aryl group in 107 can be 
transferred to the methyl group through 1,6 HAT (Scheme 2.3.3).46 
Scheme 2.3.2: Predominance of 1,5 HAT over 1,6 
For long-range 1,n HAT (n >6), the transition state would be a medium-size ring and the 
enthalpy/entropy penalty associated with the HAT would be high.47 Therefore, for successful 
applications of long-range HAT, conformational constraint on the substrates is required to 
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minimize the cost of enthalpy/entropy needed to reach the transition state. Related to the 
functionalization of unactivated sp3 C-H bonds is an example from Nishio, who demonstrated the 
synthesis of a polycyclic nitrogen heterocycle 113 through 1,8 HAT with a Norrish-type II reaction 
of 112 (Scheme 2.3.4).48 In this case, there is a strong conformational bias to drive the HAT. 
Overall, long-range HAT has not found general applications to functionalize unactivated sp3 C-H 
bonds.   
 
Scheme 2.3.3: Dependence of Selectivity of 1,5 vs. 1,6 HAT on Geometry  
  
Scheme 2.3.4: Long-Range Hydrogen Atom Transfer 
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2.3.3 Use of Nitrogen Radicals 
2.3.3.1 Generation and Transformations 
The first class of radicals capable of engaging in 1,5 HAT are nitrogen radicals. An N-H 
bond of a neutral organic amine has a bond energy of approximately 93-95 kcal/mol, comparable 
to unactivated sp3 C-H bonds.49 There lacks an appreciable driving force for 1,5 HAT with the use 
of nitrogen radicals. Therefore, a nitrogen radical is made more electron deficient by protonation. 
This increased electron deficiency of the nitrogen radicals strengthens the potential N-H bond 
and provides a thermodynamic driving force for abstraction of a hydrogen atom from an inert C-
H bond. 
 
Scheme 2.3.5: Nitrogen Radicals for Intramolecular HAT 
The first successful reaction for harnessing a nitrogen radical for functionalizing sp3 C-H 
bonds is the Hoffman-Loffler-Freytag reaction (HLF reaction), a serendipitous discovery made by 
Hoffman (Scheme 2.3.5).50 In the HLF reaction of 116, a nitrogen radical is generated through the 
light- or heat-induced homolytic cleavage of a nitrogen-halogen bond. The protonated nitrogen 
radical 117 abstract a hydrogen atom of a C-H bond that is  to the nitrogen. The resulting alkyl 
radical 118 can then combine with the halogen radical formed from the first step. This results in 
the formation of a carbon-halogen bond. A subsequent workup with base effects a SN2 cyclization 
event to yield pyrrolidine 120.  
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With the Suarez modification, the electron-deficiency of the nitrogen radical is increased 
by installing an electron-withdrawing group, such as a sulfonyl or carbonyl group, on the nitrogen 
which allows the reaction to be carried out under neutral conditions (Scheme 2.3.6).51 The in situ-
formed nitrogen-halogen bond from a strong oxidant and a halogen can be cleaved homolytically 
to generate a nitrogen radical that can effect the HLF reaction. 
 
Scheme 2.3.6: Suarez Modification for HLF Reactions 
There are other reports on the use of an N-H bond as a nitrogen radical precursor. The 
success of the majority of these protocols is the in-situ generation of a nitrogen-halogen bond. 
Muniz, Gonzalez and Herrera developed an iodine-catalyzed/mediated HLF reaction of 
sulfonamides 123 or 126 in the presence of a stoichiometric amount of hypervalent iodine 
reagent (Scheme 2.3.7). The key to the success is the in situ generation of a nitrogen-iodine bond 
for the generation of the nitrogen radical, as in the Suarez modifications. As a consequence, the 
scope for the use of a nitrogen radical has not received a significant attention and is mainly 
restricted to the formation of a carbon-halogen bond at the  position and the synthesis of 
pyrrolidines via subsequently SN2 reaction. A noteworthy exception is a report from Yu, who 
shows that the formation of pyrrolidine 130 is accompanied by the iodination of a  C-H bond 
(Scheme 2.3.7). 52 To account for the reactivity at the  C-H bond, the authors propose a hydrogen 
atom abstraction from the C-H bond in 131 from an azide radical generated in situ although the 
61 
 
more reasonable explanation by an E2 mechanism to eliminate an amidyl anion remains a 
possibility. 
 
Scheme 2.3.7: In-situ Generation of Nitrogen-Halogen Bonds 
In addition, an N-H bond can be oxidized with a strong oxidant to provide a nitrogen 
radical, obviating the need of a nitrogen-halogen bond. Nikishin reports the HLF reaction of 
sulfonamide 134 in the presence of a strong oxidant, K2S2O8 (Scheme 2.3.8).53 A nitrogen radical 
is a potential intermediate and can abstract a hydrogen atom from the  C-H bond. The resulting 
alkyl radical is oxidized to form a carbocation to allow cyclization to occur. Another HLF reaction 
that potentially proceeds with the same mechanism is the silver-catalyzed intramolecular C-H 
amination of trifluoromethanesulfonamide 137 reported by Shi (Scheme 2.3.8).54 The authors 
propose the formation of an Ag-alkyl intermediate through sulfonamide-directed concerted 
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metalation/deprotonation at the metal center. On the other hand, a nitrogen radical 
intermediate is proposed by the authors to account for another transformation under essentially 
the same reaction conditions.55 As demonstrated by Chiba, the N-H bond in amidine 140 can also 
be oxidized in the presence of a copper catalyst and molecular oxygen, resulting in the formation 
of an alkyl radical at the  C-H bond after 1,5 HAT.56 The alkyl radical can be trapped by oxygen 
and thus oxygenation of the C-H bond is realized.    
 
Scheme 2.3.8: Generation of Nitrogen Radicals by Oxidation 
With a relatively weak N-H bond, the homolytic cleavage of the N-H bond is another way 
to generate a nitrogen radical. Chiba shows that the hydrogen atom in the N-H bond in 143 can 
be transferred to TEMPO (Scheme 2.3.9).57 Since the nitrogen radical is stabilized by the iminyl 
nitrogen, an equilibrium exists between the nitrogen radical and the alkyl radical by 1,5 HAT, 
favoring the nitrogen radical. Despite its low concentration, the alkyl radical can be trapped by 




Scheme 2.3.9: Homolytic Cleavage of N-H Bonds for Nitrogen Radical Generation 
 
Scheme 2.3.10: Generation of Nitrogen Radicals by Reducing Agents 
The reduction of nitrogen functionality at high oxidation level is an alternative way to 
generate nitrogen radicals. Kim reported the generation of N-tributyltin substituted aminyl 
radicals from organic azides 148 and Bu3SnH or Bu3SnD (Scheme 2.3.10).58 Such tin-substituted 
nitrogen radicals can abstract a hydrogen atom from activated C-H bonds but not inert sp3 C-H 
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bonds. Generation of nitrogen radicals by the decomposition of organic azides with other 
reducing agents suffer the same limitation.59 Amidoxime 151 can be reduced by a copper catalyst 
to afford an amidinyl radical that is capable of abstracting a hydrogen atom from tertiary C-H 
bonds.60 Subsequently oxidation of the radical to a carbocation allows cyclization to yield 
dihydroimidazole 152. Similarly, Bower demonstrated that iminyl radical can be generated 
through a single-electron reduction of a N-O bond in oxime-ester 155. The resulting neutral iminyl 
radical is responsible for the cleavage of the activated tertiary allylic C-H bond.61 With photoredox 
catalysis, the N-Cl bond in 159 can be reduced to form a nitrogen radical that abstracts a 
hydrogen atom from the  C-H bond.62  The resulting alkyl radical is oxidized by the photocatalyst 
to complete the catalytic cycle. Cyclization to form HLF product 160 follows.  
2.3.3.2 Applications and Limitations 
Nitrogen radicals have been used to generate pyrrolidines or to realize C-H halogenation 
in the context of natural product synthesis. Corey reported the use of a HLF reaction of 161 to 
furnish the pyrrolidine ring in the synthesis of dihydroconessine (Scheme 2.3.11).63 Williams 
accessed pyrrolidine 164, which can be functionalized to VM55599, by a HLF reaction.64 For the 
synthesis of ()-isoatisine, a Suarez-modified HLF reaction featuring a 1,6 HAT is employed by 
Baran to incorporate a iodine functionality in the C-H bond of a methyl group in 166.65 In this 
case, the diaxial relationship of the nitrogen and the methyl groups in the cyclohexane puts them 
in proximity, leading to a favorable 1,6 HAT event. Building off his previous work on hydroxyl-
directed C-H bromination, Baran utilized a Suarez-modified HLF reaction of 167 to install the 1,3 
diol motif in the syntheses of eudesmane terpenes, a class of natural products that comprise 




Scheme 2.3.11: Applications of Nitrogen Radicals for Intramolecular HAT 
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The limitation of the use of nitrogen radicals in C-H functionalization stems from the use 
of a nitrogen-halogen bond as the nitrogen-radical precursor. The concomitant formation of the 
halogen radical through homolysis leads to the inevitable formation of a carbon-halogen bond. 
This greatly limits the versatility of the alkyl radical formed by 1,5 HAT. As discussed earlier, 
efforts have been devoted to utilize a nitrogen-hydrogen bond as a nitrogen radical precursor.  
While this strategy addresses the synthetic efforts required to access the HLF substrates, the 
incorporation of non-halogen functionalities still represents a challenge. The only example in this 
regard is the C-H oxygenation reaction developed by Chiba.56 
2.3.4 Oxygen Radical 
2.3.4.1 Generation and Transformations 
 
Scheme 2.3.12: Reactions of Oxygen Radicals 
Oxygen radicals are more electrophilic than neutral nitrogen radicals due to the higher 
electronegativity of oxygen. Therefore, oxygen radicals are more reactive than neutral nitrogen 
radicals and the high O-H bond energy (105 kcal/mol)Error! Bookmark not defined. provides 
enough driving force for the abstraction of a hydrogen atom from inert C-H bonds without the 
need of the protonation of the oxygen atom. On the other hand, because of the strong bond 
strength of C=O bonds, an oxygen radical can lead to the cleavage of the C-C bond with the 
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simultaneous formation of a carbonyl group and a more stable alkyl radical. This  scission 
process is sometimes a competitive pathway with 1,5 HAT (Scheme 2.3.12). 
 
Scheme 2.3.13: C-X Bond Formation at C-H Bonds with O-X Bond as Radical Precursors 
One of the most common precursors to oxygen radicals is an oxygen-heteroatom bond. 
The functionalities that can be incorporated depends on the identity of the heteroatom in the 
oxygen-heteroatom bond. For instance, in the well-known Barton reaction, an alcohol 
functionality is first converted to nitrile ester 170 (Scheme 2.3.13).67 The N-O is then cleaved in 
the presence of a light source to yield an oxygen radical 172. A hydrogen atom from the  C-H 
bond is transferred to the oxygen radical and therefore the radical is transposed to the carbon. 
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The alkyl radical 173 combines with the nitrosyl radical to give the oxime product 171 after 
tautomerization. With the O-Cl bond68 and O-S bond69 in 175 and 177, a C-Cl bond and a C-S bond 
can be formed respectively. 
In some cases, the functionality incorporated into the C-H bonds depend on the 
conditions applied, instead of the identity of the oxygen radical precursor. As demonstrated by 
Cekovic, when the reaction with 179 proceeds in the presence of Bu3SnH, the alkyl radical can be 
trapped with an electrophilic alkene, resulting in the alkylation of the inert C-H bonds (Scheme 
2.3.14).70 He also shows that when a peroxy group in 182 is used to generate an oxygen radical 
in the presence of FeSO4 and a Cu(II) salt, various C-X bond can be formed at the inert C-H bonds, 
depending on the identity of the counter ion of the Cu(II) salts.71 
 
Scheme 2.3.14: Trapping of Alkyl Radicals with Other Reagents  
An oxygen-centered radical can also be formed from free alcohol with a strong oxidant. 
Pb(OAc)4 is one of the most commonly employed reagents (Scheme 2.3.15).42 It is proposed that 
Pb alkoxide intermediate 185 formed by ligand exchange between the alcohol and one of the 
acetates can undergo homolysis to give oxygen-centered radical 186 and Pb(III) species 187. The 
alkyl radical 188 formed from 1,5 HAT can be intercepted by the Pb(III) species. The 
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intramolecular nucleophilic attack by the oxygen at the carbon-lead bond furnishes furan 189. 
Other oxidizing agents, such as PhI(OAc)2, HgO or Ag2O, can be used in conjunction with 
elemental halogens to generate an oxygen-halogen bond in-situ.42 The weak oxygen-halogen 
bond is unstable and will break homolytically to give an oxygen radical and a halogen radical. The 
alkyl radical formed from HAT can capture the halogen radical and a subsequent SN2 reaction 
ield a fura  ri g, as e e plified  Suarez’s o ditio s ith al ohol 190.  It should be noted that 
with free alcohols as the oxygen radical precursor, the reactions invariably give furans as the final 
product, except in cases where a high pressure of CO is applied and a lactone can be obtained, a 
discovery made by Ryu.72   
 
Scheme 2.3.15: Furan or Lactone Formation with Free Alcohols as Oxygen Radical Precursors 
An alternative way to generate an oxygen radical is the illumination of UV light on a 
carbonyl group (Scheme 2.3.16). An electron is excited from the n orbital of the C-O bond to the 
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*antibonding orbital of the same bond resulting in the formation of a diradical species, where 
the radicals reside on both the carbonyl oxygen and carbon. The oxygen-centered radical can 
then undergo 1,5 hydrogen atom transfer and dislocate the radical to the carbon atom  to the 
oxygen. In the Norrish-Yang cyclization of 196, the newly formed carbon radical can combine to 
the carbonyl carbon radical to form alkoxy-cyclobutane 199.73  
 
Scheme 2.3.16: Norrish-Yang Cyclization 
 




Breslow demonstrated that this way of generating oxygen radicals can be harnessed for 
remote functionalization of unactivated C-H bonds (Scheme 2.3.17). For 200, the long 
hydrogencarbon chain tethered to a benzoquinone through an ester linkage can be selectively 
oxidized for carbon-carbon bond formation at the terminal methylene groups.74 This strategy has 
been extended to selective oxidation for complex steroid molecules such as 203.75  
 
Scheme 2.3.18: Generation of Oxygen Radicals by Cleavage of Epoxides 
The homolytic cleavage of a C-O bond of epoxides represents another way to generate an 
oxygen-centered radical. As demonstrated by Barton and Motherwell, the formation of a carbon 
radical  to the epoxide from 205 would lead to the homolytic cleavage of the C-O bond to form 
oxygen-centered radical 208 due to the ring strain of the epoxide (Scheme 2.3.18).76 Rawal77 and 
Kim78 took the advantage of this way to generate an oxygen radical for inert sp3 C-H bond 
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functionalization. The alkyl radical formed by 1,5 HAT can cyclize onto the alkene to from a 
cyclopentane (Scheme 2.3.18). Cyclopentanes 210 and 214 are synthesized in this way.  
Recently, Chiba shows that a hydrogen atom in oxime 217 can be transferred to TEMPO 
to give oxygen radical 219 (Scheme 2.3.19).57 The alkyl radical generated by 1,5 HAT can be 
trapped by TEMPO. After elimination and cyclization, isoxazole 218 is formed as the final product. 
The overall transformation is the oxidation of the C-H bond. 
 
Scheme 2.3.19: Transfer of Hydrogen from Oxime to TEMPO for Oxygen Radical Generation 
2.3.4.2 Applications and Limitations 
Oxygen radicals are also often used in natural product syntheses (Scheme 2.3.20). Burke 
reported the oxidation of 220 to furan 221, which is later oxidized to a -lactone for the synthesis 
of Nagilactone F.79 In the total synthesis of punctatin A by Paquette, cyclobutane 222 is 
assembled by a Norrish-Yang cyclization of ketone 223.80 Baran uses an alcohol as a directing 
group in 224 to install functionalities in a remote methyl group, allowing the formation of 
cycloheptane in cortistatin A.  Again by Baran, a Norrish-Yang cyclization of 226 is applied as the 
key step in the synthesis of ouabagenin to access cyclobutane 227, which fragments to yield a 
primary alcohol.81 The use of oxygen radicals for C-H functionalization shows a higher versatility 
than nitrogen radicals. If the OH bond is pre-activated to be a C-X bond, difficult functionalities 
can be incorporated. However, this pre-activation step is non-trivial and shows poor functional 
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group compatibility due to the strongly oxidizing conditions. In addition, the O-X bond is highly 
unstable and difficult to handle. This limits the utility of oxygen radicals. As demonstrated by the 
representative examples in natural product synthesis, an oxygen radical is mainly used for the 
formation of carbon-halogen bonds and Norrish-Yang cyclization. In these cases, a free O-H bond 
and a carbonyl group can be used to generate the oxygen radicals respectively. 
 
Scheme 2.3.20: Applications of Oxygen Radicals for Intramolecular HAT 
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2.3.5 Vinyl and Aryl Radicals 
2.3.5.1 Generation and Transformations 
The last class of high-energy radicals that can abstract a hydrogen atom form sp3 C-H 
bonds are vinyl or aryl radicals. The higher bond strength of sp2 C-H bonds (113 kcal/mol) than 
sp3 C-H bonds (<100 kcal/mol) renders the HAT feasible. 
 
Scheme 2.3.21: Generation of Vinyl and Aryl Radicals by Reduction of Carbon-Halide Bonds 
Generally, a vinyl or aryl radical is generated from the respective vinyl aryl halide in the 
presence of Bu3SnH or other hydride sources and a radical initiator under thermal or 
photochemical conditions (Scheme 2.3.21). The reaction between the radical formed the initiator 
and the Sn hydride generates a Sn radical that can abstract the halogen atom from a carbon-
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halogen bond to give the vinyl or aryl radical. If the vinyl halide is used, the alkyl radical formed 
by intramolecular HAT would be in the perfect position to cyclize on the vinyl group to from 
cyclopentanes, as demonstrated in the seminar report on the synthesis of 229 from 228 by 
Parsons.82 Curran was the first to use this way of generating vinyl radicals for functionalizing 
unactivated sp3 C-H bonds.83 In these examples, a catalytic amount of Bu3SnH is generated from 
Bu3SnCl and NaCNBH3.84 This method of generating Sn-H is important to keep the concentration 
of Sn-H low and to minimize the reduction of the vinyl radical, a competitive pathway with 1,5 
HAT.  
  
Scheme 2.3.22: Generation of Vinyl Radicals by Radical Addition to Alkynes 
A vinyl radical can also be formed from radical addition to alkynes. Stork reported the 
addition of Sn(IV) radical 238 to alkyne 236 to form vinyl radical 239 (Scheme 2.3.22).85 Malacria 
showed that linear triquinane 242 can be synthesized from acyclic 241 with a radical 
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cyclization/1,5 HAT/elimination cascade in which the alkyl radical in 243 adds to the alkyne to 
generate vinyl radical 244.86  
Furthermore, as demonstrated by Weinreb, aryl radicals can be generated from primary 
anilines with NaNO3 under acidic conditions (Scheme 2.3.23).87 The NH2 group in 245 is converted 
into diazonium 247 whose decomposition is mediated by a copper salt to form aryl radical 248. 
After 1,5 HAT and oxidation, -oxygenated product 246 is formed. This method to generate aryl 
radicals for 1,5 HAT has been used to oxidize C-H bonds  to nitrogen, but not unactivated sp3 C-
H bonds. 
 
Scheme 2.3.23: Generation of Aryl Radicals with Diazonium Salts 
2.3.5.2 Applications and Limitations 
1,5 hydrogen atom transfer by vinyl or aryl radicals has been used for the functionalization 
of sp3 C-H bonds in natural product synthesis. However, in all cases, the sp3 C-H bonds are 
activated by a functional group such as a nitrogen atom. For instance, for the assembly of the 
[3.2.1] bicycloheptane framework of epibatidine, an aminyl radical is formed by the cleavage of 
a C-H bond  to nitrogen with an aryl radical (Scheme 2.3.24). 88 In the synthesis of phyllanthine 
and norsecurinine, Weinreb generates an aryl radical through copper-mediated decomposition 
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of an aryl diazonium species.89 A 1,5 HAT event gives the aminyl radical that is subsequently 
oxidized for the formation of a C-Cl or C-O bond. 
 
Scheme 2.3.24: Use of Aryl Radicals for Functionalization of C-H Bonds 
Regarding the application of vinyl radicals to functionalize C-H bonds, Beaudry reported 
the formation of indole 255 through a radical translocation strategy that features a hydrogen 
atom transfer from a C-H  to nitrogen to an aryl radical in the synthesis of goniomitine (Scheme 
2.3.25).90   
 




Scheme 2.3.26: Intramolecular Trapping of Alkyl Radicals with Tethered Alkenes 
The functionalities that can be incorporated into an unactivated sp3 C-H with the use of 
aryl or vinyl radicals are very limited. The hydride sources required to generate the vinyl/aryl 
radical can act as a hydrogen atom donor to the aryl radical before 1,5 HAT can take place or to 
the alkyl radical formed from 1,5 HAT. The overall transformation would be the net reduction of 
the vinyl or aryl halide while the alkyl C-H bond appears intact. Therefore, most of the successful 
reactions with this strategy have a tethered alkene or alkyne as the intramolecular radical trap 
to out-compete the side reaction between the alkyl radical and the hydride source. For instance, 
i  Curra ’s proto ol to fu tio alize the  C-H bond of alcohols, the alkyl radical is trapped by a 
tethered alkene to give cyclopentane 257 (Scheme 2.3.26).91 The diastereoselective synthesis of 
cyclopentane 260 developed by Malacria also includes the addition of an alkyl radical formed 
from 1,5 HAT to a tethered alkene.92 Alternatively, the nucleophilicity of the alkyl group is 
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enhanced by a heteroatom. Along with the use of a large excess of an electrophilic alkene (15 
equiv.), the rate for the trapping of the radical with an untethered alkene increases drastically, 
leading to a synthetically useful reaction.93 However, the C-H bonds applicable in this scenario 
are only limited to those  to oxygen or nitrogen and cannot be classified as inert C-H bonds. 
With the surge of photoredox catalysis, there appear novel ways to reduce an aryl halide to aryl 
radical with a photocatalyst but the use of the aryl intermediate for the functionalization of 
unactivated C-H bonds through intramolecular HAT remains to be explored.94 
2.4 Chemistry of Metal Carbenoids/Nitrenoids 
2.4.1 Reactivity 
 
Figure 2.4.1: Trivalent Carbon and Nitrogen 
Carbenes and Nitrenes are carbon and nitrogen with six electrons in the outermost shell. 
Because of the lack of an octet configuration, these species are highly unstable and can break 
even strong C-H bonds (Figure 2.4.1). On the other hand, the high reactivity also leads to 
selectivity issues and so in successful applications of carbenes and nitrenes in C-H 
functionalization, their reactivity is always modulated by stabilization by a transition metal 
catalyst, such as rhodium, copper or silver. With the resulting metal carbenoids and nitrenoids, 
the selectivity of a reaction can be tuned by the identity of the metals or the ligands on the metals. 
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The transition metal catalyst can also increase the ease of the formation of these species and 
allow reactions to be carried out under reasonably mild conditions. 
There are two major classes of reactions that a metal carbenoid can undergo: 
cyclopropanation, and X-H insertion (X= C, O, N and Si) (Figure 2.4.2). Related to our discussion 
about sp3 C-H functionalization is the C-H insertion reaction. The metal carbenoid, usually formed 
from the decomposition of -diazo compounds in the presence of a metal, can insert into a C-H 
bond to form a C-C bond.  
 
Figure 2.4.2: Reactivity of Metal Carbenoids 
2.4.2 Intramolecular C-H insertion 
Initial investigation of metal-mediated C-H insertion focused on the use of copper.95 
Teyssie first demonstrated the use of Rh carbenoids from diazo compounds with Rh(II) complexes 
for intermolecular O-H96 and C-H insertions97 (Scheme 2.4.1). Concurrently, Wenkert found that 
Rh(II) complexes are also competent catalysts for intramolecular allylic C-H insertion of 268.98 In 
the latter case, the excess of the substrates that bear the C-H bonds is not required and thus the 
reaction is synthetically useful. The focus here is the intramolecular C-H insertion in which the -
diazo o pou d a  e ie ed as a dire ti g group. Soo  after We kert’s report, Ta er 
demonstrated that unactivated sp3 C-H bonds in 270 can also undergo insertion for the synthesis 
of cyclopentanone 271.99 In the current state-of-the-art for intramolecular C-H insertion 




Scheme 2.4.1: Initial Reports on Rh(II)-Catalyzed C-H Insertion 
The first highly enantioselective intramolecular C-H insertion, albeit applicable only for C-
H bonds  to oxygen, was reported by Doyle (Scheme 2.4.2).100 Enantiomerically enriched  
lactone 273 can be assembled from acyclic substrate 272 through Rh(II)-catalyzed C-H insertion. 
The key to the success is the use of novel chiral Rh(II) carboxamide catalysts. The extension to 
asymmetric insertion into unactivated C-H bonds, also a contribution from Doyle, can be achieved 
with Rh(II) complexes derived from chiral oxazolidinones.101 Desymmetrization of prochiral alkyl 
groups in 276 can result in the generation of disubstituted  lactone 277.102 
An intramolecular C-H insertion is a directed sp3 C-H functionalization reaction, in which 
the geometry of the transition state plays the paramount role and favors the formation of 
cyclopentanes over cyclohexanes in acyclic substrates. Generally, Rh(II) catalyzed C-H insertion is 
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believed to be a single-step reaction with a concerted, yet asynchronous, transition state.103 As a 
positive charge is being developed in the transition state, more electron rich C-H bonds are more 
reactive towards C-H insertion chemistry (Scheme 2.4.3). 
  
Scheme 2.4.2: Asymmetric Intramolecular C-H Insertion 
2.4.3 Intramolecular C-H Amination 
Similar to metal carbenoids, reactions that are feasible with metal nitrenoids include 
aziridination and amination of sp3 C-H bonds. In regard to amination, Breslow first reported the 
tosylamidation of cyclohexane 282 with Mn or Fe catalysts ligated with tetraphenylporphyrin and 
(tosyliminoiodo)benzene 281 (Scheme 2.4.4).104 Che demonstrated that the iminoiodobenzene 




Scheme 2.4.3: Higher Reactivity with More Electron Rich C-H Bonds 
  
Scheme 2.4.4: Seminal Reports on Amination of Unactivated C-H Bonds 
The first intramolecular amination reaction with metal nitrenoid where the amine 
derivatives can be viewed as a directing group, is reported by Du Bois with Rh(II) catalysis 
(Scheme 2.4.5).106 The use of carbamate leads to selective formation of 5-membered pyrrolidines 
while 6-membered piperidines are the predominant product with sulfonamides and 
phosphoramidates. An alternative way to generate a metal nitrenoid is by the decomposition of 
organic azides. Betley reports that pyrrolidine 293 can be synthesized by the catalytic 
decomposition of organic azide 291 with a novel iron complex.107 
Since then, intramolecular catalytic enantioselective C-H amination has been developed 




Scheme 2.4.5: Intramolecular C-H Amination for Synthesis of Nitrogen Heterocycles 
The mechanism of C-H amination with metal nitrenoids is contingent on the identity of 
the metal catalysts. For Rh(II) catalyzed intramolecular C-H amination, experimental evidence 
and theoretical studies support a concerted asynchronous mechanism.109 On the other hand, a 
carbon radical formed from the abstraction of a hydrogen atom from the C-H bond by the metal 
nitrenoid is proposed for Ru, Mn or Fe catalysts ligated by porphyrins (Figure 2.4.3).110 The latter 
mechanism resembles a rebound mechanism that is believed to be responsible for the 
hydroxylation of C-H bonds by the cytochrome P450 class of enzymes.111 Sometimes, the 
e ha is  is less lear. Both e ha is s are elie ed to e feasi le for Betle ’s ase. 
  




Scheme 2.4.6: Asymmetric Intramolecular C-H Amination 
Brewlow demonstrated that selective oxidation of unactivated C-H bonds of steroid 
molecules can be accomplished by installation of sulfonic acid-containing-directing groups which 
have a strong affinity to the cyclodextrin on the Mn catalyst (Scheme 2.4.7).112 More recently, 
White reported a Fe-catalyzed directed hydroxylation of unactivated sp3 C-H bonds that features 
this rebound mechanism allowed by a high valent Fe-oxo catalytic species.113 For instance, 




2.4.4 Applications and Limitations 
The chemistry of metal carbenoids and nitrenoids has found countless applications, 
especially as a strategy for late-stage sp3 C-H functionalization in natural product synthesis. Early 
examples include contributions from Cane114 and Taber115, who independently synthesized the 
methyl ester of pentalenolactone E with Rh-catalyzed C-H insertion (Scheme 2.4.8). Cane 
assembles the six-membered lactone with the Rh carbenoid while one of the cyclopentanes is 
synthesized with the C-H i sertio  step i  Ta er’s s thesis. Additio all , Taber prepared heavily 
functionalized cyclopentane 311, which is elaborated into alkaloid 251F.116  
 




Scheme 2.4.8: Applications of C-H Insertion with Metal Carbenoids 
Stereoselectivity of the C-H insertion is sometimes an important issue in natural product 
synthesis. In these cases, the chiral ligands on the metal carbenoids play an important role in 
governing the stereochemical outcome of the reaction. In the synthesis of ()-astrogorgidiol by 
Taber, a diastereoselective C-H insertion reaction of 312 is used to construct cyclopentane 313 
(Scheme 2.4.9).117 While the use of non-chiral Rh catalysts gives almost no diastereoselectivity, 
the chiral catalyst derived from phenyl alanine favors the formation of the desired diastereomer. 
Doyle established the absolute stereochemistry of -lactone 315 through an enantioselective C-




Scheme 2.4.9: Chiral Ligands for Stereoselective C-H insertion in Natural Product Synthesis 
Regarding the use of metal nitrenoid in total synthesis, Du Bois reports a Rh(II)-catalyzed 
amination of a tertiary C-H bond as a key step in the synthesis of manzacidin A (Scheme 2.4.10).118 
For the synthesis of ()-tetrodotoxin, he applied a Rh(II)-catalyzed C-H amination of a sterically 
hindered tertiary C-H bond in structurally complex polycyclic intermediate 318.119 Garg’s 
synthesis of ()-N-methylwelwitindolinone features the amination of the unactivated tertiary C-
H bond of advanced intermediate 320 which bears multiple functionalities with a silver 
nitrenoid.120 The two latter examples underscore the utility of the chemistry with metal 
carbenoid/nitrenoid in late-stage functionalization of complex molecules. 
The power of C-H insertion and amination is demonstrated by the aforementioned 
examples in natural product synthesis. This kind of transformation is particularly useful for 
electron rich tertiary or secondary C-H bonds and is applicable even when the C-H bonds are in a 
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sterically encumbered environment. Despite its success, it does not provide a way to 
functionalize sp3 C-H bonds beyond C-C bond formation and amination. In an intramolecular 
event where the carbenoids and nitrenoids act as a directing group to control the site-selectivity, 
a carbo- or heterocycle is inevitably formed. This lack of versatility falls short of the expectation 
to meet the need to derivatize an organic molecule with minimal structural distortion, especially 
in the context of medicinal chemistry and chemical biology. 
 






The functionalization of unactivated sp3 C-H bonds has served as the strategic steps in the 
synthesis of many natural products and biologically active molecules. In many cases, the directing 
group is the key for addressing reactivity and selectivity issues. The three main approaches for 
realizing C-H functionalization are transition-metal catalyzed C-H activation, hydrogen atom 
transfer, and C-H insertion/amination with metal carbenoids/nitrenoids. To further broaden the 
versatility of each of these already powerful approaches, future research should be directed to 
address the limitations associated with the scope of functionalities that can be encoded into the 
C-H bonds, the choice of directing groups, the position of the C-H bonds relative to the directing 
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CHAPTER THREE: AMIDE-DIRECTED PHOTOREDOX-CATALYZED C-C BOND 
FORMATION AT UNACTIVATED SP3 C-H BONDS 
3.1 Introduction  
3.1.1 Research Design and Inspiration 
 
Scheme 3.1.1: Rh(III)-Catalyzed C-H Activation for Nitrogen-Heterocycles 
As described in Chapter 1, the Rovis group has had a long-standing interest in the 
synthesis of nitrogen-heterocycles. In 2010, Fagnou,1 Miura,2 and Rovis3 concurrently reported a 
Rh(III)-catalyzed 2-component synthesis of isoquinolines from benzamides and alkynes (Scheme 
3.1.1). The key feature of this reaction is the use of an amide to direct the Rh(III) catalyst to cleave 
the ortho sp2 C-H bond. This consequently generates a Rh-aryl intermediate that can insert into 
the alkyne. To enhance the power and versatility of Rh(III)-catalyzed C-H activation, we are 
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focusing our efforts towards the activation of sp3 C-H bonds.4  We developed a Rh(III)-catalyzed 
synthesis of azabicycles from the activation of allylic sp3 C-H bonds. Since piperidines are the 
most prevalent nitrogen-heterocycles in small-molecule drugs,5 our plan was to develop a Rh(III)-
catalyzed synthesis of piperidines (10). This was envisioned via a formal [4+2] cycloaddition with 
aliphatic amines (8) and unsaturated systems, such as diphenylacetylene 9. The key step would 
feature the activation of a sp3 C-H bond to form a Rh(III)-alkyl intermediate (Scheme 3.1.2). 
Unfortunately, our efforts in this direction proved fruitless. 
 
Scheme 3.1.2: Original Proposal on Rh(III)-Catalyzed sp3 C-H Activation 
 
Scheme 3.1.3: Hofmann-Loffler-Freytag Reaction  
While current research on functionalization of unactivated sp3 C-H bonds is dominated 
by transition-metal catalysis, 1,5 hydrogen atom transfer (HAT)6 appeared to us as an 
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alternative strategy to functionalize unactivated sp3 C-H bonds (See chapter 2 for details of 
HAT). As shown in the Hofmann-Loffler-Freytag (HLF) reaction, a protonated nitrogen radical 
can abstract a hydrogen atom from an unactivated sp3 C-H bond by 1,5 HAT (Scheme 3.1.3).7 In 
the Suarez modification, the nitrogen radical is made electrophilic with an electron withdrawing 
group, rather than protonation.8  
 
Scheme 3.1.4: Original Proposed Synthesis of Azepines with 1,5 HAT 
I spired  Bo er’s o tri utio s of tra sition-metal catalyzed reductions of N-O bonds 
en route to nitrogen radicals,9 we attempted to develop a transition-metal catalyzed synthesis of 
azepines (21) with oxime esters (19) and alkenes (20) (Scheme 3.1.4). In the proposed catalytic 
cycle, the low-valent metal catalyst (Mn+) reduces the nitrogen-oxygen bond generating a 
nitrogen radical. A subsequent 1,5 HAT leads to the formation of an alkyl radical, which can be 
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trapped by the alkene. The resulting radical can be oxidized by Mn+1 affording a cation that will 
effect cyclization. Alternatively, the radical and Mn+1 would react to form high valent Mn+2 species. 
Final reductive elimination will furnish the C-N bond to yield the desired azepine upon 
regeneration of the catalyst Mn+. 
 
Scheme 3.1.5: Generation of Nitrogen Radicals from N-H Bonds 
Despite failures to realize the proposed transformation, a report on a copper-mediated 
Hofmann-Loffler-Freytag reaction with 22 came to our attention (Scheme 3.1.5).10 Remarkably, 
the precursor to the nitrogen radical is an N-H bond. We reasoned that the use of an N-H bond 
would substantially enhance the versatility of nitrogen radical chemistry. Currently, the most 
common way to generate a nitrogen radical is via homolytic cleavage of a nitrogen-halogen 
bond.11 The halogen radical generated concomitantly combine with the alkyl radical from a 1,5 
HAT to form a carbon-halogen bond. This subsequently hinders the interception of the alkyl 
radical with other radical couples. On the other hand, Nikishin reports that CuCl2 and K2S2O8 are 
also capable of reacting with the alkyl radical, leading to the formation of pyrrolidines. Similarly, 
the Shi group generates a nitrogen radical from an N-H bond in 24 with Ag(I) and a hypervalent 
iodine reagent (Scheme 3.1.5).12 The use of stoichiometric amounts of strong oxidants to 
104 
 
generate the nitrogen radical eludes the trapping of the alkyl radical by radical couples. Our idea 
was to generate a nitrogen radical with an N-H bond in the absence of a transition metal or 
oxidants that can interfere with the alkyl radical. This would allow the trapping of the alkyl radical 
with various radical partners, resulting in the formation of various C-X bonds. 
 
Scheme 3.1.6: Generation of Oxygen Radicals from Carboxylates 
Recent reports from MacMillan and colleagues inspired us to incorporate photoredox 
catalysis in our research.13 As illustrated in Scheme 3.1.6, the photoredox-catalyzed 
decarboxylative coupling of carboxylic acid 26 and electrophilic alkene 27 is proposed through 
the oxidation of the carboxylate by the excited photocatalyst. This generates an oxygen radical 
intermediate, which undergoes decarboxylation. The resulting alkyl radical is trapped by the 
electron-poor alkene forming a C-C bond.  This reaction can be extended to decarboxylative 
fluorination, in which Selectfluor (30) is used as the radical partner with the alkyl radical (Scheme 
3.1.6). These two reports from MacMillan demonstrate the feasibility of generating oxygen 
radicals from negatively-charged oxygen with photoredox catalysis. 
3.2 Results  
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3.2.1 Reaction Discovery  
 
Scheme 3.2.1: Proposed Synthesis of Azocanes Featuring sp3 C-H Functionalization 
With the concept of generating a nitrogen radical from an N-H bond with photocatalysis, 
we proposed that a nitrogen radical can be generated from photoredox catalysis for the synthesis 
of 8-membered nitrogen heterocycles (34) (Scheme 3.2.1). An electron withdrawing group is 
installed on the nitrogen in 32 to facilitate deprotonation. This provides a driving force for 1,5 
HAT as described in the Suarez modification. In the envisioned catalytic cycle, the excited 
photocatalyst oxidizes a negatively charged nitrogen. The nitrogen radical IA undergoes 1,5 HAT 
to propagate the radical to the carbon. The resulting alkyl radical IIA would be trapped by 
106 
 
electrophilic alkene 33. Elimination of the sulfinate radical, which can be reduced by the 
photocatalyst to complete the catalytic cycle from IIIA, would install an electrophilic alkene at 
the amide (IVA). A subsequent intramolecular aza-Michael addition would realize cyclization, 
yielding the desired product 34.   
 
Scheme 3.2.2: Initial Results with Tf-Bearing Nitrogen 
We began our investigation with the use of a Tf group on nitrogen. The pKa of the N-H is 
, lose to that of ar o li  a ids i  Ma Milla ’s report. Interestingly, when employing Ir(dF-
(CF3)ppy)2(bpy)PF6 as the photocatalyst under basic conditions, the alkylation of 35 with alkene 
36 does not take place at the  position, but the  position to give 37 (Scheme 3.2.2). We propose 
that deprotonation at the  position after generation of the nitrogen radical (IB) results in the 
formation of a radical anion. This radical anion is represented by a hybrid of resonance structures 
(IIB and IIIB). The trapping of this intermediate with 36 would explain the formation of 37. To 
shut down this undesired pathway, sulfonamide 38 with full substitution at the  position was 
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investigated. Despite the failure to trap the putative alkyl radical with the electrophilic alkene 
(36), alkylation with methyl methacrylate (39) at the  position was achieved in moderate yield. 
No conversion is observed when the reaction is conducted in the absence of the base K2HPO4, 
the photocatalyst or the Blue LED light source.  
Although this transformation deviates from our original goal of accessing nitrogen-
heterocycles, amide-directing C-C bond formations represent a powerful tool for the 
functionalization of nitrogen-containing molecules. It is noteworthy that 84% of all FDA-approved 
small molecule drugs in 2012 contain at least one nitrogen atom (Figure 3.2.1).5 Considering their 
prevalence in pharmaceuticals, it is vital for synthetic chemists to develop efficient protocols for 
the functionalization of nitrogen-containing molecules to facilitate optimization of drug 
candidates. 
 
Figure 3.2.1: Examples of Nitrogen-Containing Small-Molecule Drugs 
Currently, there are only limited reports of nitrogen-directed functionalization of inert sp3 
C-H bonds from Gaunt,14 Daugulis,15 Chen16 and Yu.17 These Pd-catalyzed C-H activation reactions 
functionalize the  and  C-H bonds relative to the nitrogen (Scheme 3.2.3). Our approach 
functionalizes the  position and is complementary to the Pd-catalyzed C-H activation. 
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After initial investigations, we became aware that the Knowles group was working on the 
generation of nitrogen radicals via photoredox catalysis (Scheme 3.2.4).18 The mechanism for the 
generation of nitrogen radicals is different from our proposal. In their case, a proton-coupled 
electron transfer event (concerted deprotonation and oxidation) is proposed. In our proposal, 
deprotonation of the N-H bond must first take place to allow for oxidation. After communication 
with the Knowles group, we realized that they conceived the same idea for remote alkylation of 
C-H bonds with nitrogen radicals. Therefore, the work described in this chapter was conducted 
independently but published concurrently with the Knowles group. 
 
Scheme 3.2.3: Pd-Catalyzed  and  Activation of Amine Derivatives 
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While preparing our work for publication, the Chen group reported the generation of an 
oxygen radical from the reduction of an N-O bond for the remote alkylation of  C-H bonds 
through 1,5 HAT (Scheme 3.2.5).19 Mechanistically, the catalytic cycle begins with the reduction 
of the N-O bond and ends with oxidation. In contrast, the photocatalyst oxidizes the amidyl anion 
and gets regenerated upon reduction. In addition, the protocol from Chen allows for access to 
functionalized alcohols with an activated N-O bond. Our chemistry, on the other hand, benefits 
the derivatization of nitrogen-containing molecules from an N-H bond. 
 
Scheme 3.2.4: Generation of Nitrogen Radical through PCET 
3.2.2 Optimization of Reaction Conditions 
Next, we focused on reaction optimization. The challenge was to shut down the undesired 
-aminyl radical anion pathway. We reasoned that a weaker electron-withdrawing group on the 
nitrogen disfavors the deprotonation event after the formation of the nitrogen radical. This 
would prevent the formation of the undesired -radical anion. Although strong base is needed, 
we found that a better yield of the C-H functionalized product (60) is obtained when the Tf 
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group is replaced by a less electron-withdrawing trifluoroacetyl (tfa) group (59) (Scheme 3.2.6). 
Consistent with our proposal, the desired  C-H functionalized product was obtained in 
moderated yield with trifluoroacetamide 62 bearing no -substitution. On the other hand, a tosyl 
group on the nitrogen leads to only slight decomposition. No conversion is observed with all 
other amides bearing less acidic N-H bonds in the forms of dilfuoroacetamide, 
pentafluorobenzamide and benzamide. These results are consistent with our proposal in which 
the deprotonated amidyl anion is required for the generation of nitrogen radicals. 
 
Scheme 3.2.5: Generation of Oxygen Radical from N-O Bond for C-H Alkylation through 1,5 HAT 
 
Scheme 3.2.6: Remote Alkylation with Trifluoroacetamides 
In the optimization studies with trifluoroacetamide 61, while most available 
photocatalysts do not afford any product, the reaction is highly sensitive to solvent (Scheme 
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3.2.7). In general, polar aprotic solvents (DMF, DMSO, MeCN and acetone) give satisfactory yields. 
Undesired Michael addition between polar protic solvents (e.g. MeOH and EtOH) and the alkene 
prevents their use. The use of solvents that bear C-H bonds activated by oxygen results in a messy 
reaction. This is presumably due to hydrogen transfer between the nitrogen radical and the 
solvents. PhCF3 is identified to be the most optimal solvent. Any base weaker than K3PO4, such 
as K2CO3, K2HPO4, KH2PO4, or KOAc, does not result in any conversion (Scheme 3.2.7). This 
observation is consistent with our proposal that deprotonation of the N-H bond is required. The 
use of a stronger base in NaOH leads to decomposition of the alkene. This was evident by the 
observed color change of the reaction mixture upon addition of NaOH in the absence of a 
photocatalyst. Efforts to improve the yield by altering concentration were successful. The yield 
improves with a higher concentration at 0.03 M to 0.2 M (Scheme 3.2.7). No further increase in 
yield is observed when concentration reaches 0.2 M. With PhCF3 as solvent and K3PO4 as base at 
a concentration of 0.4 M, the desired C-H functionalization product can be isolated in 75% yield. 
 




3.2.3 Reaction Scope 
 
Scheme 3.2.8: Alkene Scope 
For the alkene scope, the use of ethyl and tert-butyl acrylates shows that -substitution 
on the electrophilic alkene is not required for reactivity as 66 and 67 are obtained in good yields 
(Scheme 3.2.8). The presence of highly activated benzylic C-H bonds are tolerated as alkylation 
with benzyl acrylate gives 68 in 69% yield. Less reactive N,N dimethyl acrylamide provides the 
desired C-H functionalization product 69 in satisfactory yield. A higher catalyst loading and less 
equivalents of methyl vinyl ketone were required in order to obtain a good yield of 70. Altering 
the reaction conditions for this particular entry is necessary to favor the oxidation of the amidyl 
anion by the excited photocatalyst over aza-Michael addition. -substituted enones, regardless 
of the alkene geometry, are competent coupling partners at higher catalyst loadings and alkene 
equivalents as 71 and 72 were provided in 51% and 59% yields, respectively.  73 can be obtained 
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with dimethyl maleate albeit in moderate yield. In contrast to the traditional Hoffmann-Loffler-
Freytag reaction, an array of products can be accessed by switching the alkene reaction partner. 
 
Scheme 3.2.9: Amide Scope 
A variety of amides were also tolerated (Scheme 3.2.9). Substrates bearing more hindered 
tertiary C-H bonds were converted to their corresponding alkylated products (74 and 75) in 
modest to good yield. There is no diastereo control in the latter case. Incorporation of 
enantiomerically enriched substrates results in complete racemization as observed in the 
formation of product 76. This stereochemical outcome is consistent with the proposed radical 
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mechanism. -Substituted amides are competent substrates when a more polar solvent is used. 
Thus, amides 77 and 60 are obtained in excellent yields with DMF. Poor conversion is observed 
with PhCF3. It is believed that the decreased acidity of the amide is accounted for through the 
use of a more polar solvent. For β-substituted amides, PhCF3/tert-Amyl alcohol and higher 
catalyst loadings are needed. Protected alcohols are tolerated as 78 is obtained in good yield. 
The less acidic N-H bond of the carbamate in amide 79 does not alter the outcome of the reaction. 
This compatibility opens up the possibility of having multiple amine functionalities in the 
molecule of interest. With high catalyst loadings and equivalents of alkene, substrates with more 
electron-rich tertiary C-H bonds can be activated in order to promote alkylation. This is reflected 
through the acquisition of amides 80 and 81. A limitation of the method, however, is mitigated 
reactivity with secondary C-H bonds. Alkylation with tert-butyl acrylate proceeds in moderate 
yield to give 82a. A higher yield of 82b can be obtained with a -substituted enone. Nevertheless, 
the two methyl groups at the -position to the amide are important for the reactivity as 83 is 
formed in a lower yield than 82b. 
We were also interested in the functionalization of amides that possess multiple reactive 
C-H bond sites (tertiary C-H bonds or those activated by heteroatoms). Excellent selectivity for 
the tertiary C-H bond  to the nitrogen was observed with amide 84 (Scheme 3.2.10). The remote 
tertiary C-H bond in 86 remains intact. This indicates that an intramolecular HAT is responsible 
for the generation of the alkyl radical. With reactive C-H bonds at both the  and  positions, 
there is potential competition between 1,5 and 1,6 HAT. For amide 87, the  position can be 
selectively alkylated to yield 88 in 54% yield. 26% of the starting material is also recovered. This 
poor conversion could be attributed to the electron-withdrawing oxygen. This oxygen can slow 
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down the HAT or the trapping of the alkyl radical by rendering it less nucleophilic. When the 
reaction is carried out to full conversion with amide 89, a mixture of mono- and dialkylated 
products are obtained. On other hand, when the reaction is stopped at ~50% conversion, selective 
alkylation at the  position affords 90.  After isolation, 90 can be re-subjected with another alkene 
to yield -alkylated product 91. Although the yields for this sequential 1,5- 1,6 HAT are moderate, 
there are currently no methods that incorporate two different alkenes into two inert C-H bonds 
at different positions of the molecule. 
 
Scheme 3.2.10: Functionalization of Amides with Multiple C-H Bonds 
3.2.4 Application to Medicinally-Relevant Molecules 
After studying the scope of the reaction, this method was applied to the derivatization of 
medicinally relevant molecules (Scheme 3.2.11). An analogue of Pregabalin, a drug used to 
combat nerve and muscle pain,20 can be successfully obtained via alkylation at the C-H bond  to 
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the nitrogen in 92. Steroid 94, which bears 7 tertiary C-H bonds, can be alkylated at the  position 
to give compound 95 while other C-H bonds remain intact. 
 
Scheme 3.2.11: Functionalization of Medicinally-Relevant Molecules 
3.3 Mechanistic Studies 
3.3.1 Chain Propagation vs. Closed Catalytic Cycle 
The reaction can proceed through a closed catalytic cycle or a chain propagation pathway. 
In a closed catalytic cycle, the photocatalyst is involved in the formation of each molecule of the 
C-H functionalization product (Figure 3.3.1). The catalytic cycle begins with the oxidation of the 
N-H bond of amide IC by the photocatalyst. A 1,5 hydrogen atom transfer forms the alkyl radical 
IIIC that is trapped by an electrophilic alkene. The cycle is then closed upon reduction of the final 
radical intermediate IVC. As for the chain propagation mechanism, the intermediate nitrogen 
radical IIC can be formed without the participation of the photocatalyst. For instance, the final 
radical intermediate IVC can translocate the radical to substrate IC by abstracting a hydrogen 
atom or by taking an electron (Figure 3.3.1). The resulting nitrogen radical can lead to the 
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functionalization of the C-H bond. This obviates the involvement of the photocatalyst in the 
formation of each molecule of the product. 
 
Figure 3.3.1: Catalytic Cycle vs. Chain Propagation 
To differentiate a closed catalytic cycle versus a chain propagation mechanism, the 
quantum yield of the reaction was measured and determined to be 0.11 (Scheme 3.3.1). After 
the absorption of a photon, the photocatalyst can undergo relaxation and other unproductive 
pathways. Therefore, a quantum yield of less than 1 does not necessarily lead to the conclusion 
that a closed catalytic cycle is operative.  To seek more evidence for a closed catalytic cycle, 
ON/OFF responses to light were studied (Figure 3.3.2). In the event of chain propagation, light is 
only required to initiate the formation of the first nitrogen radical. Thus, the reaction 
theoretically still proceeds when light is removed. Our result shows that the reaction occurred 
only in the presence of light. No conversion is observed in the dark. The reactivity is recovered 
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once the reaction is exposed to light. This ON/OFF response is consistent with a closed catalytic 
cycle. 
 
Scheme 3.3.1: Quantum Yield for Amide-Directed C-H Functionalization  
 
Figure 3.3.2: On/Off Response to Light 
It is also believed that chain propagation is unlikely if the bond strengths a d pKa’s of 
potential intermediates is considered (Scheme 3.3.2). The first possibility of chain propagation 
involves a direct electron transfer to the final -radical intermediate ID from amidyl anion IID. 
This is unlikely as the C-H bond  to an ester (95 kcal/mol)21 is 15 kcal/mol weaker than an amidyl 
N-H bond (110 kcal/mol).22 The resulting  anion (pKa= 29.5 in DMSO) is substantially less stable 
than the initial amidyl anion (pKa= 17.2 in DMSO)23. The second possibility is that -radical ID 
abstracts hydrogen from the N-H bond of the neutral amide (VD). This is unlikely since the -




































Consequently, the  C-H bond (95 kcal/mol) formed would be much weaker than the amidyl N-
H bond (110 kcal/mol) that is being broken. The last possibility is that -radical ID abstracts a 
hydrogen directly from the tertiary C-H bond  to the amide through intermolecular HAT. This is 
disproved because the remote tertiary C-H bond of 84 remains intact. This remote tertiary C-H 
bond is more electron-rich and should be cleaved in an intermolecular HAT. Therefore, our 
analysis, along with quantum yield and the response to light, suggests a closed catalytic cycle.   
 
Scheme 3.3.2: Evidence against Potential Chain Propagation Steps 
120 
 
3.3.2 Mechanism for the Generation of the Nitrogen Radical 
There are three possible mechanisms for the generation of the nitrogen radical (Figure 
3.3.3). The first one involves the stepwise oxidation of the neutral amide followed by 
deprotonation. The second proposed mechanism features a stepwise deprotonation followed by 
oxidation of the amidyl anion. The third mechanistic pathway involves a concerted deprotonation 
and oxidant event (i.e. proton-coupled electron transfer, PCET). 
 
Figure 3.3.3: Three Mechanisms for the Generation of Nitrogen Radicals 
 
Figure 3.3.4: No Quenching of Ir Photocatalyst by Neutral Amide 
Cyclic Voltammetry and Stern-Volmer studies25 were performed to probe the mechanism. 














Ir photocatalyst’s o idatio  pote tial (E1/2 = +1.21 V vs. SCE in MeCN)26. Stern-Volmer studies also 
indicate that the excited Ir photocatalyst cannot be quenched by neutral trifluoroacetamide 97 
(Figure 3.3.4). This rules out a stepwise oxidation/deprotonation event en route to the nitrogen 
radical. 
 
Figure 3.3.5: Quenching of Ir Photocatalyst with Amidyl Anion 
The potassium salt of the trifluoroacetamide (98) was prepared via deprotonation of 
trifluoroacetamide 97 with KH under anhydrous conditions. CV studies suggest that 98 (Ep = +0.77 
V vs. MeCN) can be oxidized by the excited Ir photocatalyst. The oxidation of 98 by the excited 
photocatalyst is supported by Stern-Volmer studies in which linearity between concentration and 
intensity is observed (Figure 3.3.5).  
The quenching of the excited state Ir photocatalyst suggests the possibility of a stepwise 
deprotonation/oxidation event. However, this does not rule out a concerted PCET mechanism. 
The Knowles group reasoned that large acidity differences between the amide and base (>20) 















and the short photocatalyst life-time favor the PCET over the stepwise deprotonation/ oxidation 
mechanisms in their hydroamination chemistry.18 I  our ase, si ilar pKa’s of the 
trifluoroacetamide (pKa: 13.8 in H2O)27 and K3PO4 (pKa: 12.3 in H2O) suggest that invoking a PCET 
mechanism is unnecessary but do not provide evidence to differentiate the two mechanisms. 
 
Figure 3.3.6: Consideration of Free Energy Change for Generation of Nitrogen Radical  
To gather more mechanistic insight, the free energy change (G) associated with the 
generation of nitrogen radicals from the amide is considered (Figure 3.3.6). This process can be 
broken down into several elementary steps: homolytic cleavage of the N-H bond, oxidation of a 
hydrogen atom to a proton, protonation of the base with H+, and the reduction of the excited Ir 
photocatalyst.  As a result, the G for the generation of the nitrogen radical can be predicted by 
the sum of these steps (G1+G2+G3+G4).  
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These bond dissociation free energies (BDFEs) have been successfully used to predict the 
feasibility of a proton-coupled electron-transfer process, as described by the Knowles group.18 
With the same photocatalyst and base, any change in G comes from the N-H bond strength, 
which varies with the identity of the amide. Weaker N-H bond strength associated with a weaker 
electron-withdrawing group on the nitrogen in the amide should theoretically lead to a less 
positive (or more negative) G. This, in turn, will make the generation of the nitrogen radical 
more favorable. However, our experimental results obtained when going from 
trifluoroacetamide 61 (pka of CF3CO2H=0.2)28 to difluoroacetamide 99 (pKa of CF2HCO2H=1.1)29 
and pentafluorobenzamide 101 (pKa of C6F5CO2H=1.7)30 contradict these predictions. The use of 
difluoroactamide  99 and pentafluorobenzamide 101 results in no remote alkylation, which can 
only be explained by a kinetic argument (Scheme 3.3.3). While it is not trivial to offer an 
explanation in the case of a PCET mechanism, the decrease in acidity of the N-H bond, while 
having no effect on overall G, could stop deprotonation. This would result in no generation of 
nitrogen radical in the stepwise deprotonation/oxidation mechanism, presenting a valid kinetic 
argument for the lack of reactivity with amides 99 and 101. 
 




Scheme 3.3.4: Studies of the Presence of Amidyl Anion under Reaction Conditions 
To probe whether there is an appreciable amount of the corresponding amidyl anions, 
difluoroactamide 99 and pentafluorobenzamide 101, were treated with methyl vinyl ketone 103 
and K3PO4 in wet PhCF3 (Scheme 3.3.4). There is no conversion of these amides to aza-Michael 
products, indicating that no significant amounts of amidyl anions are present. As discussed earlier, 
these two amides are not competent substrates for photocatalytic C-H functionalization. For 
trifluoroacetamide 61, the formation of the aza-Michael adduct (106) with methyl vinyl ketone 
(103) in the presence of no photocatalyst shows that there is an appreciable amount of the 
amidyl anion. Thus, there appears to be parallel reactivity between C-H functionalization and aza-
Michael addition. This parallel reactivity implicates that amidyl anions are needed for successful 
C-H functionalization. This also offers an explanation for the contradictory experimental 
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observations as well as the trends predicted from BDFEs. Therefore, we believe that a stepwise 
deprotonation/oxidation event is responsible for the generation of nitrogen radicals in our C-H 
functionalization chemistry.  
3.4 Future Directions  
3.4.1 Extension to Formation of Various C-X Bonds 
Scheme 3.4.1: Various C-X Bond Formation at Inert C-H Bonds 
A unified protocol combining 1,5 HAT with photoredox catalysis to functionalize the  C-
H bond amides will be pursued. The proposed mechanism for the aforementioned C-C bond 
formation implies that any reagent which reacts with an alkyl radical to generate a reducible 
intermediate can potentially be applied for a variety of C-X bond formations. We tested this 
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hypothesis and found out that alkynlyation with benziodoxolone (107),31 fluorination with NFSI 
(110), azidation with PhSO2N3 (113), aminomethylation with oxime (116), hydroxymethylation 
with paraformaldehyde (119)32 are possible. Scheme 3.4.1 shows the preliminary results for 
these transformations and their reducible intermediates. The optimization of these 
transformations are currently being pursued by Dr. Keith Barbato, a postdoctoral researcher in 
the Rovis Group.  
3.4.2 Functionalization of Other C-H Bonds Relative to Nitrogen 
 
Scheme 3.4.2: Limitation of -aminyl Radical from Primary Amines 
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We plan to develop a general protocol for the functionalization of C-H bonds α to aliphatic 
amines. The directing group on the nitrogen would determine the site-selectivity. The 
serendipitous discovery of -functionalization of primary amines bearing highly electron-
withdrawing groups provides a good starting point for these investigations (Scheme 3.2.2). While 
-aminyl radicals from secondary33 and tertiary amines34 can be generated via cleavage of a C-H 
bond, the current-state-of-the-art approach for primary amines requires an activating group such 
as a carboxylic acid35 or halide36 (Scheme 3.4.2). These prerequisite groups greatly limit the 
reaction scope since they are not trivial to install.  
3.4.3  Functionalization of Carbonyl Compounds 
We also plan to extend the amide-directed remote alkylation with photoredox catalysis 
to functionalize the -position of carbonyl groups (Scheme 3.4.3). Currently, transition-metal 
catalyzed C-H activation approaches functionalize the -position of carbonyl groups.37 Only few 
examples of  C-H fu tio alizatio  ha e ee  reported. I  Core  a d Che ’s reports, the ulk  
NPhth group is required to favor the formation of the palladacycle from the  C-H bonds.38 The 
protocols developed by Yu are applicable only for carbonyl compounds without  C-H bonds.39 
We aim to advance this research field by providing a more general protocol, in order to broaden 
both substrate scope and functionalities that can be incorporated for -functionalization of 
carbonyl compounds with a 1,5 HAT as the key step. As exemplified the amide-directed C-H 
functionalization, various transformations, such as alkylation, fluorination, azidation and 





Scheme 3.4.3: Limited Examples of -Functionalization of Carbonyl Groups 
Our mechanistic studies indicate that the N-H bond has to be acidified by a strong 
electron-withdrawing group. This will provide access to the aminyl anion allowing for oxidation 
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to the nitrogen radical. We therefore began our investigation with amide 148, which bears an 
electron-withdrawing trifluoromethyl group. Unfortunately, no desired product (151) is obtained 
when subjected to standard reaction conditions (Scheme 3.4.4). It is speculated that the 
formation of a radical-anion may compete with 1,5 HAT due to the potential stabilization of IIIE 
by the captodative effect.40 We attempted to stop this putative pathway through increased 
sterics. Unfortunately, only decomposition of the amide (149) was observed. A control 
experiment with sulfonamides 154 and 156 shows that sterics has a minimal effect on the 
formation of the radical-anion. As a result, alkylated products 155 and 157 are formed in similar 
yield. Guided by this finding, we designed amide 150 in order to shut down the possibility of a 
radical-anion pathway. Indeed, the use of amide 150 results in the formation of the desired  
alkylated product 153 in minimal yield. 
The successful formation of C-H functionalization product from 150, but not 148 and 149, 
suggests the significance to have a specially-designed group on nitrogen that lacks  C-H bond to 
shut down the undesired formation of radical anion. To this end, we acidified the N-H bond with 
a sulfonyl group (Scheme 3.4.5). Unfortunately, the use of 158 results in no reaction. We 
attributed this lack of reactivity to decreased reducing power of the amidyl anion. Therefore, we 
investigated the use of amide 159, which bears a milder electron-withdrawing acetyl group on 
nitrogen. Gratifyingly, the remote alkylation between 39 and 160 is successful as product 161 is 
provided in moderate yield. Currently, Dr. Devin Chen, a postdoctoral researcher in the Rovis 




Scheme 3.4.4: Significance of the Lack of -CH Bonds to Nitrogen 
  
Scheme 3.4.5: Preliminary Results for -Functionalization of Carbonyl Groups 
3.5 Summary 
A photoredox-catalyzed protocol for nitrogen-directed C-C bond formations at inert C-H 
bonds is developed. The reaction features an N-H bond for the generation of the nitrogen radical 
and a subsequent 1,5 HAT for the generation of an alkyl radical. Preliminary results suggest that 
fluorination, azidation, hydroxymethylation, aminomethylation and alkynylation of inert C-H 
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bonds can also be achieved via 1,5 HAT. In addition, this strategy can also be extended to  
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APPENDIX ONE: CHAPTER 1 EXPERIMENTAL 
A.1.1 General Procedure 
All reactions were carried out under an atmosphere of argon in over-dried glassware. 
Dichloromethane, diethyl ether and toluene were degassed with argon and passed through a 
column of neutral alumina and a column of Q5 reactant. All other solvents were freshly distilled. 
Unless otherwise stated, flash column chromatography was performed on Silicycle Inc. silica gel 
60 (230-400 mesh). Florisil (<200 mesh, fine powder, activated magnesium silicate) was also used 
when the products were acid-sensitive. Thin layer chromatography was performed on Silicycle 
Inc. 0.25 mm silica gel 60-F plates. Visualization was accomplished with UV light (254 nm), 
anisaldehyde or potassium permanganate. 1H NMR and 13C NMR spectra were obtained in CDCl3 
at ambient temperature and chemical shifts are expressed in parts per illio  δ, pp . Mass 
spectra were obtained on an Agilent Technologies 6130 Quadropole Mass Spec (LRMS, ESI + APCI). 
Infrared spectra were collected on a Nicolet iS-50 FT-IR spectrometer. 
Ligands L9-141 and L162 were synthesized according to previously reported procedures. 
Other ligands are commercial. All nitro-alkenes3 are either known compounds or commercially 
available. 
A.1.2 Synthesis of 1-Azadienes and Imines 
Unless otherwise stated, all 1-azadienes and imines were synthesized with this procedure: 
A solution of enal or aldehyde (1 equiv.), aniline (1 equiv.) and anhydrous MgSO4 in Et2O or PhMe 
(2.5 mL per mmol of enal) was stirred at rt overnight. The mixture was filtered to remove MgSO4. 
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The solvent was removed under vacco to afford 1-azadiene (>90% yields in all cases) which could 
be used without further purification. 1-azadienes sometimes were purified by recrystallization 
from absolute EtOH or by flash chromatography on silica gel (EtOAc/hexane with 1% NEt3 as an 
additive). 
 
The spectral data is identical to those reported in the literature.4 
 
1H NMR (CDCl3, 400 MHz): 8.30 (dd, J=6.6, 1.6, 1H), 7.55 (d, J=7, 2H); 7.42-7.33 (m, 5H), 
7.21 (d, J=6.6, 2H), 7.14-7.09 (m, 3H), 7.05-7.02 (m, 4H); 13C NMR (CDCl3, 100 MHz): 160.7, 157.3, 
155.7, 147.0, 143.7, 135.6, 129.8, 129.5, 128.9, 128.6, 127.5, 123.3, 122.3, 119.5, 118.8; 
Molecular Weight [MH]: 300.1 (expected), 300.1 (found); IR (cm-1): 3058, 3038, 2979, 2946, 




1H NMR (CDCl3, 400 MHz): 8.24 (d, J= 8.6, 1H), 7.54 (d, J= 8.2, 2H), 7.49 (d, J= 8.6, 2H), 
7.43-7.35 (m, 3H), 7.18 (d, J= 16.0, 1H), 7.12-7.04 (m, 3H); 13C NMR (CDCl3, 100 MHz): 162.0, 150.7, 
144.7, 135.4, 132.2, 129.8, 129.0, 128.3, 127.6, 122.6, 110.5; Molecular Weight [MH]:286.02, 
288.02 (expected), 286.1, 288.1 (found); IR (cm-1): 3079, 3058, 3038, 3022, 2999, 2975, 2922, 
2875, 2850, 1625, 1602, 1591, 1572, 1483, 1448. 
 
The spectral data is identical to those reported in the literature.5 
 
1H NMR (CDCl3, 400 MHz): 8.32 (dd, J= 5.8, 2.7, 1H), 7.53 (d, J= 7.0, 2H), 7.41-7.32 (m, 3H), 
7.22 (d, J= 9.0, 2H), 7.12-7.11 (m, 2H), 6.93 (d, J= 9.0, 2H), 3.88-3.86 (m, 4H), 3.19-3.17 (m, 4H); 
13C NMR (CDCl3, 100 MHz): 158.8, 150.0, 143.7, 142.6, 135.9, 129.3, 128.94, 128.88, 127.3, 122.1, 
116.0, 66.9, 49.3; Molecular Weight [MH]: 293.2 (expected), 293.2 (found); IR (cm-1): 3026, 




1H NMR (CDCl3, 400 MHz): 8.50 (s, 1H), 7.92-7.87 (m, 2H), 7.49-7.44 (m, 3H), 7.26 (d, J= 
8.6, 2H), 6.95 (d, J= 9.0, 2H), 3.90-3.86 (m, 4H), 3.21-3.16 (m, 4H); 13C NMR (CDCl3, 100 MHz): 
157.8, 149.9, 144.1, 136.6, 130.9, 128.7, 128.5, 122.1, 116.1, 66.9, 49.4; Molecular Weight 
[MH]: 267.2 (expected), 267.2 (found); IR (cm-1): 3057, 3036, 2956, 2886, 2855, 2830, 1622, 
1601, 1588, 1571, 1507, 1447.  
 
1H NMR (CDCl3, 400 MHz): 8.33 (d, J=7.8, 1H), 8.25 (d, J=8.7, 2H), 7.67 (d, 9.0, 2H), 7.36 
(dd, J= 8.0, 8.0, 2H), 7.25-7.19 (m, 4H), 7.15-7.11 (m, 1H), 7.06-7.02 (m, 4H); 13C NMR (CDCl3, 100 
MHz): 159.1, 157.0, 156.5, 147.9, 146.3, 141.9, 140.1, 132.7, 129.8, 127.9, 124.3, 123.5, 122.5, 
119.4, 119.0; Molecular Weight [MH]: 345.12 (expected), 345.2 (found); IR (cm-1): 3097, 3069, 
3055, 3040, 2926.0, 2874, 1622, 1594.  
 
1H NMR (CDCl3, 400 MHz): 8.28 (dd, J= 6.9, 1.5, 1H), 7.53 (d, J= 8.6, 2H), 7.40-7.32 (m, 4H), 
7.20 (d, J= 6.6, 2H), 7.13-7.08 (m, 3H), 7.04-7.01 (m, 4H); 13C NMR (CDCl3, 100 MHz): 160.1, 157.2, 
155.9, 146.8, 142.1, 134.6, 132.1, 129.8, 129.3 128.8, 123.6, 123.3, 122.31, 119.5, 118.8; 
Molecular Weight [MH]: 378.05, 380.05 (expected), 378.1, 380.1 (found); IR (cm-1): 3058, 3038, 




The spectral data is identical to those reported in the literature.6 
 
1H NMR (CDCl3, 400 MHz): 8.31 (d, J=9.0, 1H); 7.58 (dd, J=7.9, 1.6, 1H), 7.48 (d, J= 16.0, 
1H); 7.32 (dd, J= 7.9,1.6, 1H), 7.22-7.14 (m, 3H); 6.98 (dd, J= 7.5,7.5, 1H); 6.94-6.90 (m, 3H), 3.90 
(s, 3H), 3.83 (s, 3H); 13C NMR (CDCl3, 100 MHz): 160.6, 158.2, 157.5, 144.8, 138.3, 130.6, 129.3, 
127.6, 124.7, 122.2, 120.9, 114.4, 111.1, 55.50, 55.47; Molecular Weight [MH]: 268.13 
(expected), 268.2 (found); IR (cm-1): 3036, 2999, 2943, 2906, 2835, 1620, 1607, 1502, 1386, 1464, 
1438.   
 
1H NMR (CDCl3, 400 MHz): 8.21 (d, J= 8.6, 1H), 7.48 (d, J= 1.6, 1H), 7.19 (d, J= 8.6, 2H), 6.98 
(dd, J= 15.7, 9.0, 1H), 6.93-6.86 (m, 3H), 6.54 (d, J= 3.5, 1H), 6.46 (dd, J= 3.6, 1.5, 1H); 3.82 (s, 3H); 
158.9, 158.3, 152.1, 144.7, 144.0, 129.4, 126.9, 122.2, 114.4, 112.16, 112.16, 55.5; Molecular 
Weight [MH]: 228.1 (expected), 228.1 (found); IR (cm-1): 3039, 2999, 2946, 2906, 2859, 2835, 




Although the imine obtained was not pure, it could not be purified due to its instability. 
1H NMR (CDCl3, 400 MHz): 8.07 (d, J= 7.4, 1H); 7.11 (d, J= 8.6, 2H), 6.88 (d, J= 8.6, 2H), 3.79 (s, 
3H), 2.53 (sep, J= 6.6, 1H), 1.10(d, J= 6.6, 6H); 13C NMR (CDCl3, 100 MHz): 160.5, 158.0, 154.2, 
144.8, 128.5, 122.0, 114.3, 55.4, 31.4, 21.6; Molecular Weight [MH]: 204.1 (expected), 204.1 
(found); IR (cm-1): 3035, 2958, 2931, 2906, 2858, 2834, 1642. 1608, 1577.    
 
1H NMR (CDCl3, 400 MHz): 8.21 (d, J= 9.4, 1H), 7.48 (d, J= 7.5, 2H), 7.36 (dd, J= 7.2, 7.2, 
2H), 7.31-7.27 (m, 1H), 7.19 (d, J= 8.6, 2H), 7.03-6.89 (m, 4H), 6.80 (d, J=14.5, 1H), 6.65 (dd, J= 
14.5, 9, 1H), 3.82 (s, 3H); 13C NMR (CDCl3, 100 MHz): 159.3, 158.4, 144.7, 143.0, 137.4, 136.5, 
132.5, 128.8, 128.6, 127.8, 127.0, 122.2, 114.4, 55.5; Molecular Weight [MH]: 264.14 
(expected), 264.2 (found); IR (cm-1): 3055, 3032, 3023, 3001, 2955, 936, 2909, 2835, 1613, 1597, 
1575, 1565, 1502, 1487, 1466, 1441. 
 
Aniline (0.465 g, 5.0 mmol, 1 equiv.) and chalcone (1.04 g, 5.0 mmol, 1 equiv.) was 
dissolved in DCM (15 mL). NEt3 (1.39 mL, 10 mmol, 2 equiv.) was added. At 0 oC, TiCl4 (0.55 mL, 
5.0 mmol, 1 equiv.) was added dropwise. The mixture was allowed to warm to rt and stirred for 
142 
 
16 h. The reaction was quenched with H2O. The aqueous layer was extracted with DCM three 
times. The combined organic layer was washed with brine, dried over Na2SO4 and filtered. 
Solvent was removed under vacco. The crude product was purified by flash column 
chromatography (6%-17% EtOAc/hex). Recrystallization from hexane afforded pure N,1,3-
triphenylprop-2-en-1-imine (0.570 g, 40%) as a mixture of geometric isomers.  
1H NMR: all the peaks appear in the aromatic region and cannot be assigned; 13C NMR 
(CDCl3, 100 MHz): 167.1, 150.9, 141.6, 139.4, 135.7, 131.7, 129.9, 129.3 128.9, 128.8, 128.3, 127.5, 
123.9, 121.9, 120.8; Molecular Weight [MH]284.1 (expected), 284.1 (found); IR (cm-1): 3057, 
3025, 1621, 1585, 1574, 1493, 1481, 1448.    
 
1H NMR (CDCl3, 400 MHz): 8.25 (dd, J=6.1, 2.2, 1H), 7.43-7.41 (m, 2H), 7.34-7.32 (m,2H), 
7.19-7.17(m, 2H), 7.05-7.03 (m, 2H), 6.91-6.89 (m, 2H), 3.80(s, 3H); 13C NMR (CDCl3, 100 MHz): 
159.0, 158.5, 144.4, 141.3, 135.1, 134.2, 129.3, 129.1, 128.5, 122.2, 114.4, 77.3, 77.0, 76.7, 55.5; 
Molecular Weight [MH]272.1 (expected), 272.1 (found); IR (cm-1): 3091, 3051, 3008, 2961, 




1H NMR (CDCl3, 400 MHz): 8.21 (s, 1H), 7.48 (d, J= 7.5, 2H), 7.42 (t, J= 7.7, 2H), 7.32 (t, J= 
7.3, 1H), 7.18 (d, J= 8.6, 2H), 6.97 (s, 1H), 6.93 (d, J= 9.0, 2H), 3.83 (s, 3H), 2.30 (s, 3H); 13C NMR 
(CDCl3, 100 MHz): 163.6, 158.0, 145.2, 140.8, 137.6, 136.6, 129.5, 128.4, 127.9, 122.1, 114.3, 55.5, 
13.2; Molecular Weight [MH]252.14 (expected), 252.2 (found); IR (cm-1): 3162, 3052, 3032, 
2998, 2953, 2910, 2866, 2835, 1609, 1502, 1465, 1442.  
A.1.3 Procedure for Ligand Screening 
A solution of Zn(OTf)2 (0.015 mmol, 10 mol %), the ligand (0.015 mmol, 10 mol %) and MS 
4Å in PhMe (0.5 mL) in a vial was stirred at rt for 15 mins. A solution of nitro-alkene (0.225 mmol, 
1.5 equiv.) in PhMe (0.5 mL) in a vial was added to the zinc complex. The vial containing nitro-
alkene was rinsed with 0.5 mL and then 0.2 mL PhMe to ensure complete transfer of the nitro-
alkene. 1-Azadiene (0.15 mmol, 1 equiv.) was added. The vial was sealed with a cap. The mixture 
was stirred for 16 h at the temperature specified. MeOH (1 mL) was added at rt. NaCNBH3 (0.225 
mmol, 1.5 equiv.) and ZnCl2 (0.225 mmol, 1.5 equiv.) were added. The mixture was stirred until 
all [4+2] cycloadduct was consumed. The reaction was quenched with sat. NaHCO3. The aqueous 
and organic layers were separated. The aqueous layer was extracted with Et2O twice. The 
combined organic layer was dried over anhydrous Na2SO4 and filtered. The solvent was removed 
under vacco. The yield was determined by 1H NMR using 1,3,5-trimethoxybenzene as an internal 
standard.  
A.1.4 Mechanistic Experiments and Origin of Electronic Effect of Ligands 
Control Experiment with 1,4-diphenyldiene: A solution of Zn(OTf)2 (5.5 mg, 0.015 mmol, 
10 mol %), ligand L14 (7.4 mg, 0.015 mmol, 10 mol %) and MS 4Å in PhMe was stirred for 15 min. 
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A solution of 1,4-diphenylbutadiene 72 (30.9 mg, 0.15 mmol, 1 equiv.), nitroalkene 67 (29.4 mmol, 
0.225 mmol, 1.5 equiv.) in PhMe (1 mL) was added. The mixture was stirred at rt overnight. The 
mixture was filtered through florisil. The solvent was removed under vacco. TLC and NMR analysis 
indicated there was no reaction. 
  
Control Experiments with thiourea catalyst: To a solution of thiourea 767 (11.5 mg, 0.02 
mmol, 20 mol %) and MS 4Å in PhMe (0.5 mL), a solution of 1-azadiene 58 (23.7 mg, 0.1 mmol, 1 
equiv.) and nitroalkene 67 (19.4 mg, 0.15 mmol, 1.5 equiv.) in PhMe (0.5 mL) was added. The 
mixture was stirred at rt overnight. MeOH was added. NaCNBH3 and ZnCl2 were added. The 
mixture was stirred for 2 h. The reaction was quenched with sat. NaHCO3. The aqueous and 
organic layers were separated. The aqueous layer was extracted with Et2O twice. The combined 
organic layer was dried over anhydrous Na2SO4 and filtered. The yield of 68 was determined by 
NMR spectroscopy with 1,3,5-trimethoxy- benzene as an internal standard. 
 
A solution of Zn(OTf)2 (5.5 mg, 0.015 mmol, 10 mol %), L29 (7.7 mg, 0.015 mmol, 10 mol 
%) and MS 4Å in PhMe (0.5 mL) was stirred at rt for 15 min. A solution of diphenylmethanimine 
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74 (27.3 mg, 0.15 mmol, 1 equiv.) and nitroalkene 75 (29.3, mg, 0.23 mmol, 1.5 equiv.) in PhMe 
(0.5 mL). 0.5 mL of PhMe was used to rinse the remaining diphenylmethanimine 74 and 
nitroalkene 75 to the reaction mixture. The mixture was stirred at rt for 24 h. The mixture was 
filtered through florisil. Solvent was removed under vacco. N-(diphenylmethylene)-1-nitrohexan-
2-amine 77 was obtained in 90% yield by 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as 
an internal standard. 
 
Synthesis of Deuterated Nitro-alkene and 1-Azadiene: 
 
To a solution of LAD (1.29 g, 30.7 mmol, 1.9 equiv.) in Et2O (35 mL) was added ethyl 
pentenoate (2.4 mL, 16.1 mmol, 1 equiv.) dropwise. The reaction mixture was stirred at rt for 1h 
and then reflux for 1h. The mixture was cooled to rt. Sodium sulfate decahydrate was added 
slowly until no gas bubbles were observed. The mixture was filtered. Solvent was removed under 
vacco to give a mixture of deuterated pentan-1-ol and water. DCM was added. The mixture was 
dried over anhydrous Na2SO4 and filtered. Solvent was removed under vacco. The crude 
deuterated pentan-1-ol was used without further purification. To a solution of (COCl)2 (2.2 mL, 
26.0 mmol, 1.6 equiv.) in DCM (41.5 mL) was added DMSO (3.7 mL, 52.1 mmol 3.2 equiv.) 
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dropwise at –78oC. The mixture was stirred for 15 min. A solution of the crude pentan-1-ol 
described previously in DCM (6.2 mL) was added slowly. The mixture was stirred for 30 min. NEt3 
(7.25 mL, 52.1 mmol, 3.2 equiv.) was added slowly. The mixture was stirred for 2 h and then 
allowed to warm to rt. The mixture was quenched with sat. NH4Cl and extracted with DCM three 
times. The combined organic layer was washed with water twice and brine, dried over anhydrous 
Na2SO4 and filtered. Solvent was removed under vaccu. The crude pentanal was dissolved in THF 
(8 mL) and tBuOH (8 mL). Nitromethane (1.4 mL, 25.8 mmol, 1.6 equiv.) was added. At 0 oC, KtOBu 
(0.387 g, 3.45 mmol, 0.21 equiv.) was added. The mixture was stirred at rt overnight. The mixture 
was quenched with sat. NH4Cl. The organic layer and aqueous layer were separated. The aqueous 
layer was extracted with Et2O three times. The combined organic layer was washed with brine, 
dried over Na2SO4 and filtered. Solvent was removed under vacco. Flash column chromatography 
(10-18% EtOAc/hex) afforded pure deuterated 1-nitrohexan-2-ol (1.015g, 43% over 3 steps). 1H 
NMR (CDCl3, 300 MHz): 4.45-4.33 (m, 2H), 2.46 (br, 1H), 1.58-1.32 (m, 6H), 0.92 (t, J= 7.3, 3H). 
The 1H NMR spectrum has all the signals of non-deuterated 1-nitrohexan-2-ol8 except the peak 
at 4.35-4.27 ppm.  
 
To a solution of deuterated 1-nitrohexan-2-ol (901.3 mg, 6.08 mmol, 1 equiv.) was added 
TFAA (0.888 mL, 6.39 mmol, 1.05 equiv.) at 0 oC dropwise. NEt3 (1.865 mL, 13.4 mmol, 2.20 equiv.) 
was added dropwise at 0 oC. The mixture was allowed to stirred at the same temperature for 15 
min. At 0 oC, the mixture was quenched with sat. NH4Cl. The organic and aqueous layers were 
separated. The aqueous layer was extracted with DCM twice. The combined organic layer was 
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washed with NH4Cl three times, dried over Na2SO4, and filtered. Solvent was removed under 
vacco. Pure deuterated (E)-1-nitrohex-1-ene D-67 (366.4 mg, 41%) was obtained by flash 
chromatography (10% Et2O/hex) and then vacuum distillation. 1H NMR (CDCl3, 400 MHz): 6.98-
6.97 (m, 1H), 2.27 (t, J= 7.5, 2H), 1.54-1.47 (m, 2H), 1.43-1.33 (m, 2H), 0.94 (t, J= 7.3, 2H). The 1H 
NMR spectrum has all the signals of non-deuterated (E)-1-nitrohex-1-ene except the peak at 7.31-
7.22 ppm.  
 
To a solution of ethyl 2-(diethoxyphosphoryl)acetate (2.0125 g, 8.977 mmol, 1.05 equiv.) 
in THF (24 mL) was added NaH (0.384 g, 60% in mineral oil, 9.6 mmol, 1.1 equiv.) at 0 oC. The 
mixture was stirred for 10 min. Deuterated benzaldehyde (0.885 mL, 8.715 mmol, 1 equiv.) was 
added dropwise. The mixture was warm to rt and stirred overnight. The mixture was quenched 
with sat. NH4Cl. The mixture was extracted with Et2O three times. The combined organic layer 
was washed with sat. NaHCO3, brine,, dried over Na2SO4 and filtered. Solvent was removed under 
vacco. The crude ester was dissolved in DCM (38. 5mL). At –78 oC, DIBAL-H (20.1 mL, 1 M solution 
in hexane, 20.1 mmol, 2.31 equiv.) was added dropwise. The mixture was stirred at –40 oC for 2 
h. The mixture was diluted with Et2O. Ro elle’s salt as added. The i ture as stirred at rt 
overnight. The mixture was extracted with Et2O three times. The combined organic layer was 
washed with 1 M HCl, sat. NaHCO3 and brine, dried over Na2SO4 and filtered. Solvent was 
removed under vacco. The crude alcohol was dissolved in DCM (48 mL). MnO2 (6.005 g, 69.7 
mmol, 8.00 equiv.) was added. The mixture was stirred at rt overnight. Excess MnO2 was removed 
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by filtration. Solvent was removed under vacco. Flash column chromatography (5%-20% Et2O/hex) 
afforded pure deuterated cinnamaldehyde (881.3 mg, 76% over 3 steps). 1H NMR (CDCl3, 400 
MHz): 9.72 (d, J= 7.5, 1H), 7.59-7.56 (m, 2H), 7.45-7.42 (m, 3H), 6.73 (dt(1:1:1 t), 7.9, 2.4, 1H). The 
1H NMR spectrum has all the signals as non-deuterated cinnamaldehyde except the peak at 7.48 
ppm.  
 
To a solution of deuterated cinnamaldehyde (221.2 mg, 1.66 mmol, 1 equiv.) and MgSO4 
(0.1 g) in Et2O (4 mL) was added 4-phenoxyaniline (307.7 mg, 1.66 mmol, 1 equiv.) The mixture 
was stirred at rt overnight. MgSO4 was removed by filtration. Solvent was removed under vacco. 
The deuterated (E)-4-phenoxy-N-((E)-3- phenylallylidene)aniline (499.3 mg, 100%) D-78 obtained 
was pure by 1H NMR spectroscopy. 1H NMR (CDCl3, 400 MHz): 8.30 (d, J= 9.0, 1H), 7.56-7.53 (d, 
2H), 7.42-7.33 (m, 5H), 7.21 (dt, J= 8.6, 2.8, 2H), 7.13-7.09 (m, 2H), 7.05-7.01 (m, 4H). The 1H NMR 
spectrum has all the signals of non-deuterated (E)-4-phenoxy-N-((E)-3- phenylallylidene)aniline 
except the peak at 7.12 ppm. 
Studies on Kinetic Isotope Effects: 
Deuterated Nitro-alkene: A solution of Zn(OTf)2 (2.8 mg, 0.0077 mmol, 10 mol %), Ligand 
(0.0077 mmol, 10 mol %) and MS 4Å in PhMe (0.92 mL) was stirred for 15 min. A stock solution 
of 1:1 nitro-alkene: d1-nitroalkene was prepared by the addition of 2.7 mL PhMe to a mixture of 
129.9 mg nitro-alkene and 130.9 mg d1-nitro-alkene. 0.1 mL of this stock solution (0.0377 mmol 
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each, 0.5 equiv. each) was added. The mixture was stirred for 5 min. 1-azadiene 78 (11.3 mg, 
0.0377 mmol, 0.5 equiv.) was added. The mixture was stirred for the 16 h. A few drops of NEt3 
was added to prevent hydrolysis of the product. The mixture was filtered through florisil. Solvent 
was removed under vacco. Conversion was determined by 1H NMR spectroscopy. Pure product 
was obtained by flash chromatography (5-20% Et2O/hex, florisil as stationary phase). The ratio of 
D-product to H-product was determined by 1H NMR with d1=25 s, nt= 128. All experiments were 
repeated a d o siste t KIE’s were obtained. 
 
Deuterated 1-azadiene: Both the deuterated and non-deuterated aza-dienes were 
recrystallized with EtOH before use. A solution of Zn(OTf)2 (5.5 mg, 0.015 mmol, 20 mol %), Ligand 
(0.015 mmol, 20 mol %) and MS 4Å in PhMe (0.4 mL) was stirred for 15 min. A solution of nitro-
alkene 67 (4.9 mg, 0.038 mmol, 0.5 equiv.) in PhMe (0.25 mL) was added. The mixture was stirred 
for 5 min. A stock solution of 1:1 azadiene: d1-azadiene was prepared by the addition of 40.0 mL 
PhMe to a mixture of 499.5 mg azadiene and 501.2 mg d1-azadiene. 0.91 mL of this stock solution 
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(0.038 mmol each, 0.5 equiv. each) was added. The mixture was stirred for 16 h. The workup 
procedure was the same as described before. The ratio of D-product to H-product was 
determined by 1H NMR with d1=25 s, nt= 128. In all cases, an 1:1 ratio of the D-product to the H-
product was obtained. 
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Effect of 1-Azadiene on Zn-catalyzed Michael Addition: 
 
Without 1-azadiene 58: A solution of Zn(OTf)2 (2.8 mg, 0.0077 mmol, 5 mol %), Ligand 
(0.0077 mmol, 5 mol %) and MS 4Å in PhMe (0.92 mL) was stirred at rt for 15 min. Nitro-styrene 
70 (23.0 mg, 0.15 mmol, 1 equiv.) was added. The mixture was stirred for 5 min. Indole 69 (18.1 
mg, 0.15 mmol, 1 equiv.) was added. The mixture was stirred at rt for 18-20 h. Solvent was 
removed under vacco. The yield of 71 was determined by 1H NMR spectroscopy with 1,3,5-
methoxybenzene as an internal standard. The crude product was either purified by flash column 
chromatography (10-25% EtOAc/hex) or filtration through silica gel before HPLC analysis. The 
spectral data are identical to those previously reported.9 HPLC conditions: IB column, 70:30 Hex: 
IPA, 0.8 mL/min, t1=14.6 min (minor enantiomer), t2= 16.0 min (major enantiomer).  
With 1-azadiene 58: A solution of Zn(OTf)2 (2.8 mg, 0.0077 mmol, 5 mol %), Ligand (0.0077 
mmol, 5 mol %) and MS 4Å in PhMe (0.92 mL) was stirred at rt for 15 min. Nitro-styrene 70 (23.0 
mg, 0.15 mmol, 1 equiv.) and 1-azadiene 58 (36.6 mg, 0.15 mmol, 1 equiv.) was added. The 
mixture was stirred for 5 min. Indole 69 (18.1 mg, 0.15 mmol, 1 equiv.) was added. The mixture 
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was stirred at rt for 18-20 h. Solvent was removed under vacco. The yield of 71 was determined 
by 1H NMR spectroscopy with 1,3,5-methoxybenzene as an internal standard. The crude product 
was either purified by flash column chromatography (10-25% EtOAc/hex). Same HPLC conditions 
were applied as described above.  
A.1.5 Optimization of [4+2] Cycloaddition with Ligand L29 
A solution of Zn(OTf)2 (10 or 20 mol %), Ligand L29 (10 or 20 mol %) and MS 4Å in PhMe 
(0.4 or 0.8 mL) in a vial was stirred at rt for 15 mins. A solution of nitro-alkene 67 (1.5 or 3 equiv. 
in PhMe (0.15 or 0.3 mL) in a vial was added to the zinc complex. The vial containing nitro-alkene 
67 was rinsed with 0.15 or 0.3 mL twice to ensure complete transfer of the nitro-alkene 67. The 
mixture was cooled to the specified temperature. 1-Azadiene 78 (0.15 mmol, 1 equiv.) was added. 
The vial was sealed with a cap. The mixture was stirred at the specified temperature until no 1-
azadiene 78 was detected by TLC. The mixture was warmed to rt and MeOH (1 mL) was added. 
NaCNBH3 (0.60 mmol, 4 equiv.) and ZnCl2 (0.60 mmol, 4 equiv.) were added. The mixture was 
stirred until all [4+2] cycloadduct was consumed. The reaction was quenched with sat. NaHCO3. 
The aqueous and organic layers were separated. The aqueous layer was extracted with Et2O twice. 
The combined organic layer was dried over anhydrous Na2SO4 and filtered. The solvent was 
removed under vacco. The crude piperidine 79 was purified by flash column chromatography. 
A.1.6 Procedure for [4+2] Cycloaddition under Optimized Conditions 
A solution of Zn(OTf)2 (0.03 mmol, 20 mol %), Ligand R (0.03 mmol, 20 mol %) and MS 4Å 
in PhMe (0.4 mL) in a vial was stirred at rt for 15 mins. A solution of nitro-alkene (0.45 mmol, 3 
equiv.) in PhMe (0.15 mL) in a vial was added to the zinc complex. The vial containing nitro-alkene 
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was rinsed with 0.15 mL twice to ensure complete transfer of the nitro-alkene. The mixture was 
cooled to 78 oC. 1-Azadiene (0.15 mmol, 1 equiv.) was added. The vial was sealed with a cap and 
put into a freezer at 38 oC. The mixture was stirred until no 1-azadiene was detected by TLC. The 
mixture was warmed to rt and MeOH (1 mL) was added. NaCNBH3 (0.60 mmol, 4 equiv.) and ZnCl2 
(0.60 mmol, 4 equiv.) were added. The mixture was stirred until all [4+2] cycloadduct was 
consumed. The reaction was quenched with sat. NaHCO3. The aqueous and organic layers were 
separated. The aqueous layer was extracted with Et2O twice. The combined organic layer was 
dried over anhydrous Na2SO4 and filtered. The solvent was removed under vacco. The crude 
piperidine was purified by flash column chromatography.      
 
1H NMR (CDCl3, 400 MHz): 7.37-7.30 (m, 4H), 7.26 (t, J= 7.1, 1H), 6.85-6.80 (m, 4H), 4.94-
4.91 (m, 1H), 4.38 (dd, J= 7.3, 7.3, 1H), 3.77 (s, 3H), 3.52 (ddd, J= 12.5, 4.0, 1.6, 1H), 3.37-3.26 (m, 
2H), 2.94 (qd, J= 12.9, 5.1, 1H), 1.97-1.90 (m, 1H), 1.82-1.69 (m, 2H), 1.40-1.27 (m, 4H), 0.91-0.87 
(m, 3H); 13C NMR (CDCl3, 100 MHz): 153.5, 144.2, 139.8, 128.6, 127.4, 127.2, 119.0, 114.5, 87.9, 
62.9, 55.6, 42.4, 37.9, 29.0, 26.1, 24.1, 22.5, 13.9; Molecular Weight [MH]: 369.22 (expected); 
369.3 (found); IR (cm-1): 3028.5, 2955, 2930, 2859, 2832, 1546, 1510; []20D= 95.4o (c= 1.00, 
CHCl3); HPLC (IB column, gradient elution: 100% H2O at 0 min to 5% H2O in MeCN at 58 min, 1 




1H NMR (CDCl3, 400 MHz): 7.38-7.26 (m, 7H), 7.04 (dd, J= 7.4, 7.4, 1H), 6.97-6.93 (m, 4H), 
6.86 (d, J= 9.0, 2H), 4.95-4.91 (m, 1H), 4.48 (dd, J= 7.3, 7.3, 1H), 3.64 (dd, J= 12.6, 3.9, 1H), 3.40-
3.29 (m, 2H), 2.95 (qd, J= 12.5, 5.1, 1H), 1.98-1.91 (m, 1H), 1.84-1.87 (m, 2H), 1.40-1.32 (m, 4H), 
0.93-0.90 (m, 3H); 13C NMR (CDCl3, 100 MHz): 158.5, 149.4, 146.7, 139.6, 129.6, 128.6, 127.4, 
127.3, 122.3, 120.6, 118.3, 117.6, 87.9, 62.2, 42.0, 38.1, 29.0, 26.9, 23.9, 22.5, 13.9; Molecular 
Weight [MH]: 431.23 (expected), 431.3 (found); IR (cm-1): 3061, 3039, 2956, 2930, 2860, 1588, 
1546, 1488, 1467; []20D= 3.9o (c= 0.92, CHCl3); HPLC (IB column, gradient elution: 100% H2O at 
0 min to 5% H2O in MeCN at 28 min, 1 mL/min): 26.7 min, 27.5 min (major).  
 
1H NMR (CDCl3, 400 MHz): 7.38-7.22 (m, 7H), 6.88 (d, J= 8.2, 2H), 6.82 (t, J= 7.3, 1H), 4.98-
4.91 (m, 1H), 4.56 (dd, J=7.4, 7.4, 1H), 3.74 (dd, J= 12.9, 3.9, 1H), 3.39 (dt, J= 13.3, 4.2, 1H), 3.32 
(td, J= 12.7, 3.1, 1H), 2.95 (qd, J=12.9, 5.0, 1H), 1.97-1.90 (m, 1H), 1.84-1.79 (m, 2H), 1.41-1.33 
(m, 4H), 0.91 (t, J= 6.9, 3H); 13C NMR (CDCl3, 100 MHz): 150.2, 139.6, 129.2, 128.6, 127.4, 127.3, 
119.3, 116.6, 87.8, 61.4, 41.5, 38.3, 28.9, 27.3, 23.9, 22.5, 13.9; Molecular Weight [MH]: 339.21 
(expected), 339.3 (found); IR (cm-1): 3026, 2956, 2930, 1597, 1546, 1466; []20D= 23.4o (c= 1.00, 
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CHCl3); HPLC (IB column, gradient elution: 100% H2O at 0 min to 5% H2O in MeCN at 28 min): 25.0 
min, 26.3 min (major).  
 
1H NMR (CDCl3, 400 MHz): 8.22 (d, J= 9.0, 2H), 7.50 (d, J= 8.6, 2H), 7.32-7.27 ( m, 2H), 7.04 
(t, J= 7.4, 1H), 6.97-6.93 (m, 4H), 6.86 (dt, J= 6.7, 3.0, 2H), 4.95-4.91 (m, 1H), 4.56 (dd, J= 7.2, 7.2, 
1H), 3.62 (dd, J= 12.9, 3.9, 1H), 3.47 (dt, J= 13.3, 4.0, 1H), 3.35 (td, J= 12.6, 3.2, 1H), 2.91 (qd, 
J=13.0, 4.9, 1H), 2.05-1.98 (m, 1H), 1.88-1.74 (m, 2H), 1.43-1.30 (m, 4H), 0.93-0.89 (m, 3H); 13C 
NMR (CDCl3, 100 MHz): 158.3, 149.9, 147.4, 147.1, 146.3, 129.6, 128.3, 123.8, 122.5, 120.6, 118.7, 
117.7, 87.3, 62.4, 41.8, 37.9, 29.0, 26.7, 24.0, 22.5, 13.9; Molecular Weight [MH]: 476.22 
(expected), 476.3 (found); IR (cm-1): 3040, 2957, 2931, 2860, 1599, 1589, 1547, 1489; []20D= 





1H NMR (CDCl3, 400 MHz): 7.48 (d, J=8.2, 2H), 7.32-7.27 (m, 2H), 7.19 (d, J= 8.6, 2H), 7.04 
(dd, J= 7.4, 7.4, 1H), 6.97-6.92 (m, 4H), 6.85 (d, J= 6.6, 1H), 4.88-4.86 (m, 1H), 4.48 (dd, J= 7.5, 7.5, 
1H), 3.62 (dd, J=12.9, 4.3, 1H), 3.35-3.27 (m, 2H), 2.89 (qd, J= 12.9, 5.1, 1H), 1.94-1.88 (m, 1H), 
1.85-1.72 (m, 2H), 1.41-1.27 (m, 4H), 0.92-0.89 (m, 3H); 13C NMR (CDCl3, 100 MHz): 158.4, 149.6, 
146.5, 138.7, 131.7, 129.6, 129.1, 122.4, 121.2, 120.6, 118.4, 117.61, 87.6, 62.2, 41.9, 37.6, 29.0, 
26.9, 23.9, 22.5, 13.9; Molecular Weight [MH]: 509.1, 511.1 (expected), 509.2, 511.2 (found); 
IR (cm -1): 3040, 2956, 2929, 2869, 2860, 1606, 1589, 1546, 1488, 1467; []20D= 24.4o (c=1.00, 
CHCl3); HPLC (IB column, 95:5 hex: EtOAc, 1 mL/min): 9.8 min (major), 11.1 min.  
 
1H NMR (CDCl3, 400 MHz): 7.22 (d, J=8.8, 2H), 6.88 (d, J=8.8, 2H), 6.82-6.81 (m, 4H), 4.88-
4.85 (m, 1H), 4.34 (dd, 7.1, 7.1, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.52 (dd, 12.6, 3.6, 1H), 3.32-3.25 
(m, 2H), 2.90 (qd, J= 12.9, 5.1, 1H), 1.92-1.85 (m, 1H), 1.79-1.70 (m, 2H), 1.40-1.26 (m, 4H), 0.91-
0.86 (m, 3H); 13C NMR (CDCl3, 100 MHz): 158.6, 153.4, 144.3, 131.7, 128.4, 118.9, 114.5, 114.0, 
88.1, 62.8, 55.6, 55.3, 42.4, 37.4, 29.1, 26.2, 24.4, 22.5, 13.9; Molecular Weight [MH]: 399.23 
(expected), 399.3 (found); IR (cm-1): 3038, 2994, 2955, 2931, 2869, 2860, 1612, 1583, 1508, 1464; 
[]20D= 10.8o (c= 1.00, CHCl3); HPLC (IC column, 85:15 hex: EtOAc, 1 mL/min): 13.7 min (major), 




1H NMR (CDCl3, 400 MHz): 7.38 (d, J= 7.4, 1H), 7.25 (td, J= 7.3,1.6, 1H), 6.99 (t, J= 7.4, 1H), 
6.88-6.80 (m, 5H), 5.16 (m, 1H), 4.38 (ddd, J= 9.8, 4.7, 1.6, 1H), 3.86 (s, 3H), 3.77 (s, 3H), 3.71 (ddd, 
J= 13.3, 3.7, 3.7, 1H), 3.48 (ddd, J=12.1, 4.7, 1.6, 1H), 3.31 (ddd, J= 12.1, 12.1, 3.1, 1H), 2.93 (qd, 
J= 12.9, 5.5, 1H), 1.94-1.84 (m, 1H), 1.79-1.75 (m, 1H), 1.42-1.29 (m, 4H), 0.91 (t, J= 6.9, 3H); 13C 
NMR (CDCl3, 100 MHz): 156.4, 153.4, 144.4, 128.8, 128.1, 127.6, 120.8, 119.1, 114.4, 109.8, 85.1, 
63.1, 55.6, 55.2, 42.8, 32.0, 28.8, 25.4, 24.0, 22.5, 14.0; Molecular Weight [MH]: 399.22 
(expected), 399.3 (found); IR (cm-1): 3040, 2954, 2932, 2868, 2835, 1601, 1584, 1545, 1510, 1492, 
1464; []20D= 14,2o (c= 1.00, CHCl3); HPLC (IA column, 90:10 hex: EtOAc, 1 mL/min): 6.3 min, 7.5 
min (major).  
 
1H NMR (CDCl3, 400 MHz): 7.32 (d, J=1.6, 1H), 6.82-6.80 (m, 4H), 6.34 (dd, J=3.1, 1.9, 1H), 
6.18 (d, J= 3.1, 1H), 5.07-5.05 (m, 1H), 4.39 (ddd, J= 7.2, 7.2,1.9, 1H), 3.76 (s, 3H), 3.44-3.39 (m, 
2H), 3.27 (td, J= 12.1, 3.1, 1H), 2.66 (qd, J= 12.9, 5.5, 1H), 2.06-1.99 (m, 1H), 1.71-1.65 (m, 2H), 
1.35-1.23 (m, 4H), 0.87-0.84 (m, 3H); 13C NMR (CDCl3, 100 MHz):153.8, 153.7, 144.19, 144.20, 
119.3, 114.5, 110.6, 105.9, 84.4, 62.6, 55.6, 41.2, 32.9, 28.9, 25.9, 23.8, 22.4, 13.8; Molecular 
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Weight [MH]: 359.2 (expected), 359.2 (found); IR (cm-1): 3040, 2956, 2932, 2861, 2833, 1548, 
1509, 1465; []20D= 36.6o (c= 1.00, CHCl3); HPLC (IB column, gradient elution: 100% H2O at 0 min 
to 5% H2O in MeCN at 28 min, 1 mL/min): 23.4 min, 24.4 min (major).  
 
1H NMR (CDCl3, 400 MHz): 6.80-6.75 (m, 4H), 4.77-4.74 (m, 1H), 4.30 (ddd, J= 7.4, 7.4, 1.2, 
1H), 3.75 (s, 3H), 3.34 (dd, J= 12.6, 4.7, 1H), 3.10 (ddd, J= 12.6, 12.6, 3.6, 1H), 2.16 (qd, J= 12.9, 
5.5, 1H), 1.90-1.79 (m, 2H), 1.60-1.54 (m, 2H), 1.52-1.44 (m, 1H), 1.32-1.15 (m, 4H), 1.01 (d, J= 
6.7, 3H), 0.96 (d, J= 6.6, 3H), 0.85-0.82 (m, 3H); 13C NMR (CDCl3, 100 MHz): 153.2, 144.4, 118.7, 
114.4, 84.8, 62.9, 55.6, 42.2, 40.2, 29.1, 28.9, 25.8, 24.2, 22.4, 21.2, 20.5, 13.7; Molecular Weight 
[MH]: 335.23 (expected), 335.3 (found); IR (cm-1): 3039, 2958, 2933, 2870, 2833, 1545, 1509, 
1455, 1442; []20D= 35.2o (c= 1.00, CHCl3); HPLC (IA column, 95:5 hex: EtOAc, 1 mL/min): 5.0 
min, 5.4 min (major).  
 
1H NMR (CDCl3, 400 MHz): 7.38-7.23 (m, 5H), 6.84-6.80 (m, 4H), 6.55 (d, J= 16.0, 1H), 6.39 
(dd, J= 16.0, 7.4, 1H), 4.70-4.66 (m, 1H), 4.35 (td, J= 6.7, 1.6, 1H), 3.77 (s, 3H), 3.39-3.32 (m, 1H), 
3.20 (td, J=12.1, 3.1, 1H), 2.95-2.87 (m, 1H), 2.49 (qd, J= 12.4, 5.1, 1H), 1.84-1.76 (m, 1H), 1.68-
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1.63 (m, 2H), 1.35-1.22 (m, 4H), 0.85 (t, J= 6.9, 3H); 13C NMR (CDCl3, 100 MHz): 153.7, 144.3, 136.7, 
132.2, 129.2, 128.6, 127.7, 126.3, 119.5, 114.5, 87.4, 62.5, 55.6, 42.4, 36.9, 28.7, 26.2, 26.1, 22.5, 
13.9; Molecular Weight [MH]: 395.23 (expected), 395.3 (found); IR (cm-1): 3080, 3025, 2955, 
2930, 2859, 2832. 1544, 1509, 1464; []20D= 60.6.o (c= 1.00, CHCl3); HPLC (IC column, 95:5 hex: 
EtOAc, 1 mL/min): 12.4 min (major), 23.0 min (major).  
 
1H NMR (CDCl3, 400 MHz): 7.35-7.23 (m, 7H), 7.18 (t, J= 7.5, 2H), 7.12-7.05 (m, 3H), 6.85-
6.81 (m, 3H), 5.12-5.07 (m, 1H), 4.34 (dt, J= 9.4, 3.5, 1H), 4.65 (dd, J= 11.3, 3.9, 1H), 3.54 (dt, J= 
13.3, 3.9, 1H), 2.92 (q, J= 12.8, 1H), 2.21 (dt, J= 13.3, 4.0, 1H), 1.98-1.89 (m, 1H), 1.82-1.74 (m, 
1H), 1.38-1.19 (m, 4H), 0.86 (t, J= 6.5, 3H); 13C NMR (CDCl3, 100 MHz): 148.8, 144.0, 139.5, 128.6, 
128.3, 128.2, 127.3, 127.3, 127.2, 126.7, 125.3, 122.4, 87.9, 66.2, 57.7, 37.7, 35.3, 29.0, 24.7, 22.4, 
13.8; Molecular Weight [MH]: 415.24 (expected), 415.3 (found); IR (cm-1): 3086, 3061, 3027, 
3003, 2956, 2930, 2870, 1597, 1584, 1547, 1492, 1465, 1452; []20D= 81.8o (c= 1.00, CHCl3); 
HPLC (IB column, gradient elution: 100% H2O at 0 min to 5% H2O in MeCN at 58 min, 1 mL/min): 




1H NMR (CDCl3, 400 MHz): 7.36-7.25 (m, 8H), 7.23-7.17 (m, 4H), 7.05 (t, J= 7.3, 1H), 6.96 
(d, J= 7.8, 2H), 6.92 (d, J= 9.0, 2H), 6.78 (d, J= 9.0, 2H), 4.93-4.91 (m, 1H), 4.52 (t, J= 6.9, 1H), 3.68 
(dd, J= 12.5, 3.5, 1H), 3.38-3.31 (m, 2H), 2.95 (qd, J= 12.9, 5.1, 1H), 2.80-2.67 (m, 2H), 2.23-2.09 
(m, 2H), 1.97-1.91 (m, 1H);13C NMR (CDCl3, 100 MHz): 158.5, 149.5, 146.4, 140.5, 139.4, 129.6, 
128.8, 128.6, 128.4, 127.31, 127.28, 126.5, 122.4, 120.6, 118.3, 117.6; Molecular Weight [MH]: 
479.23 (expected), 479.3 (found); IR (cm-1): 3060, 3026, 2927, 2855, 1601, 1588, 1547, 1506, 1488; 
[]20D= 2.2o (c= 1.00, CHCl3); HPLC (IA column, 99:1 hex: EtOAc, 1 mL/min): 27.8 min, 32.6 min 
(major).  
  
1H NMR (CDCl3, 400 MHz): 7.38-7.27 (m, 7H), 7.05 (t, J= 7.5, 1H), 6.98-6.94 (m, 4H), 6.87 
(d, J= 9.0, 2H), 4.93-4.91 (m, 1H), 4.58-4.54 (m, 1H), 3.61 (dd, J= 12.5, 3.5, 1H), 3.41-3.28 (m, 2H), 
2.96 (qd, J= 12.9, 5.5, 1H), 1.99-1.92 (m, 1H), 1.73-1.60 (m, 3H), 0.97-0.96 (m, 6H); 13C NMR (CDCl3, 
100 MHz): 158.5, 149.5, 146.4, 139.6, 129.6, 128.6, 127.4, 127.3, 122.4, 120.6, 118.6, 117.6, 88.02, 
60.3, 42.1, 37.9, 35.9, 25.4, 24.0, 23.2, 22.0; Molecular Weight [MH]: 431.23 (expected), 431.3 
(found); []20D= 11.5o (c= 0.59, CHCl3); IR (cm-1): 3060, 3039, 2956, 2929, 2868, 1588, 1547, 1520, 
1488, 1468, 1451; HPLC (IB column, gradient elution: 100% H2O at 0 min to 5% H2O in MeCN at 




1H NMR (CDCl3, 400 MHz): 7.37-7.33 (m, 2H), 7.31-7.25 (m, 5H), 7.03 (dd, J= 7.5, 7.5, 1H), 
6.96-6.89 (m, 4H), 6.80 (d, J= 9.0, 2H), 5.09-5.07 (m, 1H), 4.18 (d, J= 11.0, 1H), 3.87 (dd, J=13.7, 
5.1, 1H), 3.42-3.34 (m, 2H), 2.98 (qd, J= 12.9, 5.1, 1H), 2.55-2.42 (m, 1H), 1.90-1.83 (m, 1H), 1.21 
(d, J= 6.7, 3H), 0.96 (d, J= 6.6, 3H); 13C (CDCl3, 100 MHz): 158.7, 148.2, 147.7, 139.7, 129.5, 128.7, 
127.4, 127.3, 122.1, 120.8, 117.4, 116.4, 86.5 67.7, 41.8, 38.7, 28.4, 23.2, 20.7, 20.6; Molecular 
Weight [MH]: 417.22 (expected), 417.3 (found); IR (cm-1): 3060, 3040, 2962, 2928, 2870, 1588, 
1546, 1488; []20D= 42.6o (c= 1.00, CHCl3); HPLC (IB column, gradient elution: 100% H2O at 0 min 
to 5% H2O in MeCN at 28 min, 1 mL/min): 26.13 min, 26.8 min (major).  
 
1H NMR (CDCl3, 400 MHz): 7.38-7.27 (m, 7H), 7.04 (t, J= 7.5, 1H), 6.98-6.89 (m, 5H), 5.39-
5.36 (m, 1H), 4.57 (dd, J= 8.9, 5.0, 1H), 4.07 (dd, J= 10.0, 10.0, 1H), 3.88 (dd, J= 10.2, 5.1, 1H), 3.69 
(ddd, J= 12.5, 4.7, 1.6, 1H), 3.48 (dt, J= 13.3, 5.5, 1H), 3.34 (td, J= 12.3, 3.1, 1H), 2.93 (qd, J= 13.1, 
5.1, 1H), 1.98 (dd, J= 12.5, 2.3, 1H), 1.11-1.04 (m, 15H); 13C NMR (CDCl3, 100 MHz): 158.5, 149.5, 
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146.1, 139.6, 129.6, 128.7, 127.29, 127.25, 122.3, 120.8, 117.9, 117.5, 85.6, 62.5, 58.8, 43.6, 38.4, 
23.8, 18.00, 17.98, 11.8; []20D= 7.8o (c= 1.00, CHCl3); HPLC (IC column, 88:12 hex: EtOAc, 1 
mL/min): 5.5 min (major), 5.8 min.  
 
51 is unstable to be purified. Reductive workup with ZnCl2, NaCNBH3 and MeOH leads to 
decomposition. 
 
1H NMR (C6D6, 400 MHz): 7.22 (d, J= 7.0, 2H), 7.15-7.12 (m, 2H), 7.08-7.04 (m, 3H), 6.99 
(d, J= 7.8, 2H), 6.92 (d, J= 9.0, 2H), 6.83 (t, J= 7.3, 2H), 6.66 (d, J= 9.0, 2H), 3.88 (dd, J= 12.9, 1.5, 
1H), 3.15-3.11 (m, 1H), 2.66 (qd, J= 12.7, 4.7, 1H), 2.27-2.21 (m, 3H), 1.41 (dq, J= 13.3, 3.2, 1H), 
1.08 (s, 3H); 13C NMR (C6D6, 100 MHz): 158.8, 150.8, 147.4, 138.5, 130.2, 129.6, 127.3, 122.3, 
120.52, 120.51, 119.3, 117.7, 88.0, 62.4, 49.89, 49.88, 27.7, 23.6; Molecular Weight [MH]: 
389.2 (expected), 389.2 (found); IR (cm-1): 3060, 3029, 2930, 2868, 1588, 1538, 1505, 1487, 1463, 
1451; []20D= 19.8o (c= 0.96, CHCl3); HPLC (IB column, 98:2 hex: EtOAc, 1 mL/min): 13.3 min, 




A.1.7 Functionalization of Cycloadducts 
 
Removal of PG in 68: To a solution of (2R,3S,4R)-2-butyl-1-(4-methoxyphenyl) -3-nitro-4-
phenylpiperidine 68 (13.8 mg, 0.0375 mmol) in MeCN/H2O (4:1, 0.95 mL) was added CAN (125.8 
mg, 0.229 mmol, 6 equiv.) at 0 oC. The mixture was stirred at 0 oC for 3 h. The mixture was diluted 
with Et2O and H2O, and basified with solid K2CO3. The organic and aqueous layers were separated. 
The aqueous layer was extracted with EtOAc twice. The combined organic layer was dried over 
Na2SO4 and filtered. The solvent was removed under vacco. Flash chromatography (1:5:95 to 
1:70:30 NEt3:EtOAc:hexane) afforded (2R,3S,4R)-2-butyl-3-nitro-4-phenylpiperidine 126 (8.6 mg, 
88%) as a yellow solid. 1H NMR (CDCl3, 400 MHz): 7.35-7.31 (m, 2H), 7.28-7.24 (m, 1H), 7.19 (d, 
J= 7.1, 2H), 4.69 (dd, J= 4.3, 0.8, 1H), 3.35-3.28 (m, 2H), 3.14 (ddd, J= 14.5, 4.7, 2.4, 1H), 2.96-2.89 
(m, 1H), 2.49 (qd, J= 12.8, 4.7, 1H), 1.90-1.81 (m, 2H), 1.68 (dq, J= 13.3, 3.4, 1H), 1.64-1.52 (m, 
2H), 1.45-1.36 (m, 3H), 0.96 (t, J= 7.1, 3H); 13C NMR (CDCl3, 100 MHz): 139.7, 128.8, 127.5, 127.3, 
89.2, 56.2, 39.9, 39.4, 30.5, 29.0, 25.0, 22.5, 14.0; Molecular Weight [MH]: 263.2 (expected), 
263.2 (found); IR (cm-1): 3086, 3061, 3028, 2954, 2931, 2869, 1541, 1495, 1465, 1452. 
Removal of PG in 79: To a solution of (2R,3S,4R)-2-butyl-3-nitro-1-(4-phenoxyphenyl) -4-
phenylpiperidine 79 (19.2 mg, 0.0446 mmol) in MeCN/H2O (4:1, 1.10 mL) was added CAN (146.7 
mg, 0.2676 mmol, 6 equiv.) at 0 oC. The mixture was stirred at 0 oC for 2 h. The mixture was 
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diluted with Et2O and H2O, and basified with solid K2CO3. The organic and aqueous layers were 
separated. The aqueous layer was extracted with EtOAc twice. The combined organic layer was 
dried over Na2SO4 and filtered. The solvent was removed under vacco. Flash chromatography 
(1:5:95 to 1:50:50 NEt3:EtOAc:hexane) afforded (2R,3S,4R)-2-butyl-3-nitro-4-phenylpiperidine 
126 (5.7 mg, 49%) as a yellow solid.  
Reduction of Nitro Group: To a solution of (2R,3S,4R)-2-butyl-1-(4-methoxyphenyl) -3-
nitro-4-phenylpiperidine 68 (21.1 mg, 0.0573 mmol) in MeOH (1.35 mL) was added nickel(II) 
chloride hexahydrate (32.3 mg, 0.143 mmol, 2.5 equiv.) at 0 oC. NaBH4 (33.9 mg, 0.946 mmol, 
16.5 equiv.) was added in portions. The mixture was stirred at 0 oC for 60 mins. The mixture was 
quenched with H2O and then 10% HCl. The mixture was neutralized with 2M NaOH. The aqueous 
layer was saturated with solid NaCl and extracted with EtOAc fourteen times. The combined 
organic layer was dried over Na2SO4 and filtered. The solvent was removed under vacco. Flash 
chromatography (1:5:95 to 1:50:50 NEt3:EtOAc:hexane) afforded (2R,3S,4R)-2-butyl-1-(4-
methoxyphenyl)-4-phenyl- piperidin-3-amine 127 (17.4 mg, 90%) as a yellow solid. 
1H NMR (CDCl3, 400 MHz): 7.39-7.35 (d, 2H), 7.29-7.23 (m, 5H), 3.77 (s, 3H), 3.39-3.29 (m, 
1H), 3.22-3.09 (m, 2H), 2.25 (qd, J= 12.8, 4.4, 1H), 1.82-1.70 (m, 2H), 1.65-1.50 (m, 2H), 1.35-1.20 
(m, 4H), 0.85 (t, J= 6.8, 3H); 13C NMR (CDCl3, 100 MHz): 152.9, 145.7, 143.2, 128.6, 127.7, 126.4, 
118.7, 114.4, 64.5, 55.6, 53.2, 42.7, 40.0, 29.4, 25.3, 23.2, 22.8, 14.0; Molecular Weight [MH]: 





A.1.8 Synthesis of New Ligands 
General Procedure A for Sandmeyer reaction: 
Anthranilic acid (1 equiv.) was dissolved in AcOH (0.6 mL per mmol of anthranilic acid), 
HBr (48% in H2O, 0.4 mL per mmol of anthranilic acid ) and H2O (0.4 mL per mmol of anthranilic 
acid. The mixture was cooled with ice-water bath saturated with NaCl. NaNO2 (1 equiv.) in H2O 
(0.2 mL per mmol of NaNO2) was added dropwise while cooling. After addition, the mixture was 
stirred at 0 oC for 2.5-3 h. While the resulting diazonium salt was still at 0 oC, it was added to CuBr 
(1 equiv.) in HBr (48% in H2O, 0.5 mL per mmol of CuBr) at rt. The mixture was stirred at 65 oC for 
2.5-3 h. The mixture was diluted with H2O and extracted with EtOAc three times. The organic 
layer was washed with H2O several times until no more precipitate was formed when H2O was 
added. The organic layer was washed with brine, dried over Na2SO4, filtered. The solvent was 
removed under vacco. 2-bromobenzoic acid was obtained as a white or pale yellow solid. The 
product was analytically pure and used without further purification. 
General Procedure B for Ullmann Coupling: 
2-bromobenzoic acid (1 equiv.), anthranilic acid (1.1 equiv.), copper powder (0.2 equiv.), 
Cu2O (0.1 equiv.), K2CO3 (3 equiv.) in DMF (1.50 mL per mmol of 2-bromobenzoic acid) was 
refluxed overnight. The reaction mixture was cool to rt. H2O was added to dissolve the product. 
Copper powder and copper salt were removed by filtration through celite. The filtrate was 
acidified by conc. HCl until pH <3. The mixture was filtered and the solid was collected and dried 
under vacuum. The product obtained was usually pure and used without further purification. 
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General Procedure C1 for the Formation of Bis(hydroxy-amide): 
Dibenzoic acid (1 equiv.) in SOCl2 (1.48 mL per mmol of dibenzoic acid) was refluxed for 
3-5 h. The excess SOCl2 was removed under vacco. The resulting di(acid chloride) was dissolved 
in DCM (8.7 mL per mmol of dibenzoic acid). (If the di(acid) was not completely dissolved, more 
DCM was added.) This solution was added to a solution of amino alcohol (2-2.2 equiv.), NEt3 (2 
equiv.) in DCM (1.4mL per mmol of amino alcohol) at 0 0C. The reaction mixture was stirred at rt 
overnight. Sat. NH4Cl solution was added. The organic layer was washed with 1M HCl, sat. 
NaHCO3, H2O and brine. The organic layer was dried over Na2SO4 and filtered. The solvent was 
removed under vacco. Bis(hydroxy-amide) was obtained was a solid. 
General Procedure C2 for the Formation of Bis(hydroxy-amide): 
To a solution of amino alcohol (2.2 equiv.), EDCl hydrochloride salt (2.3 equiv.), HOBt (2.3 
equiv.) in DCM (23 mL per mmol of dibenzoic acid) was added dibenzoic acid (1 equiv.). The 
reaction mixture was stirred at rt for 2 overnights. The reaction mixture was quenched with H2O. 
The organic layer was washed with 1M NaOH and brine. The organic layer was dried over Na2SO4 
and filtered. The solvent was removed under vacco. Flash chromatography afforded bis(hydroxy-
amide) as a while or yellow solid.   
General Procedure D for the Formation of Bisoxazolines: 
To a solution of hydroxy-amide (1 equiv.), NEt3 (8 equiv.), either DMAP or 4-
pyrrolidinopyridine (10 mol %) in DCM (13.9 mL per mmol of bis(hydroxy-amide)) was added a 
solution of TsCl (2-2.2 equiv.) in DCM (2.3 mL per mmol of TsCl) at 0 oC. The reaction mixture was 
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stirred at rt for at least two overnights. The reaction was quenched with sat. NH4Cl. The organic 
layer was washed with H2O and brine, and was dried over Na2SO4 and filtered. The solvent was 
removed under vacco. Flash chromatography afforded bisoxazoline as a while or yellow solid. 
General Procedure E for Esterification of Dibenzoic acids: 
To a solution of dibenzoic acid in MeOH (2.65 mL per mmol of dibenzoic acid) was added 
conc. H2SO4 (0.265 mL per mmol of dibenzoic acid) dropwise. The reaction mixture was reflux 
overnight. The solvent was removed under vacco. H2O was added. Solid Na2CO3 was added until 
no more gas bubbles were observed. The mixture was extracted with EtOAc three times. The 
organic layer was washed with brine, dried over Na2SO4 and filtered. The solvent was removed 
under vacco to afford diester as a solid. The product was analytically pure and used without 
further purification. 
Synthesis of Ligand L15:  
 
General Procedure C1: 2,2'-azanediyldibenzoic acid (0.75 g) afforded 2,2'-azanediylbis(N-
((S)-1-(4-(benzyloxy)phenyl)-3-hydroxypropan-2-yl)benzamide) (2.20 g) in 100% yield. It was 




General Procedure D with 4-pyrrolidinopyridine: 2,2'-azanediylbis(N-((S)-1-(4- 
(benzyloxy)phenyl)-3-hydroxypropan-2-yl)benzamide) (150.0 mg) afforded bis(2-((S)-4-(4-
(benzyloxy)benzyl)-4,5-dihydrooxazol-2-yl) phenyl)amine L15 (86.4 mg, 61%). Flash 
chromatography: 1:20:80- 1:80:20 NEt3: EtOAc: hexane. 1H NMR (CDCl3, 400 MHz): 10.98 (br, 1H), 
7.82 (dd, J= 7.9, 1.6, 2H), 7.48 (d, J= 8.6, 2H), 7.42-7.28 (m, 12H), 7.09 (d, J= 8.2, 4H), 6.90 (t, J= 
7.5, 2H), 6.81 (d, J= 8.2, 4H), 4.99 (s, 4H), 4.45-4.37 (m, 2H), 4.23 (t, J= 8.6, 2H), 3.96 (t, J= 7.9, 2H), 
3.05 (dd, J= 13.7, 5.9, 2H), 2.68 (dd, J= 13.7, 7.8, 2H); 13C NMR (CDCl3, 100 MHz): 162.9, 157.4, 
143.2, 137.1, 131.3, 130.5, 130.4, 130.3, 128.5, 127.9, 127.5, 119.7, 118.1, 115.7, 114.7, 110.0, 
70.6, 69.9, 68.3, 40.9; Molecular Weight [MH]: 700.3 (expected), 700.4 (found); IR (cm-1): 3028, 
2892, 1640, 1608, 1580, 1510, 1457; []20D= 14.4o (c= 0.25, CHCl3). 




General Procedure C1: 2,2'-oxydibenzoic acid10 (1.08 g) afforded 2,2'-oxybis(N-((S)-1-
hydroxy-3-phenylpropan-2-yl)benzamide) (2.03 g) in 93% yield. It was used without further 
purification.  
 
General Procedure D with DMAP: 2,2'-oxybis(N-((S)-1-hydroxy-3-phenylpropan-2- 
yl)benzamide) (1.70 g) afforded (4S,4'S)-2,2'-(oxybis(2,1-phenylene))bis(4-benzyl- 4,5-
dihydrooxazole) L17 (1.46 g, 92%). Flash chromatography: 1:30:70- 1:70:30 NEt3: EtOAc: hexane. 
1H NMR (CDCl3, 400 MHz): 7.85 (dd, J= 7.8, 1.6, 2H), 7.39 (td, J= 7.8, 1.9, 2H), 7.28-7.24 (m, 4H), 
7.21-7.13 (m, 8H), 6.94 (d, J= 8.3, 2H), 4.50-4.43 (m, 2H), 4.19 (t, J= 9.0, 2H), 3.99 (dd, J= 7.8, 7.8, 
2H), 3.11 (dd, J= 13.7, 5.1, 2H), 2.55 (dd, J= 13.7, 8.6, 2H); 13C NMR (CDCl3, 100 MHz): 162.7, 155.7, 
138.1, 132.2, 131.4, 129.3, 128.4, 126.4, 123.2, 120.2, 119.7, 71.8, 67.6, 41.7; Molecular Weight 
[MH]: 489.2 (expected), 489.3 (found); IR (cm-1): 3061, 3026, 3000, 2922, 2898, 2855, 1640, 
1602, 1581, 1485, 1474, 1464, 1448; []20D= 41.0o (c= 0.68, CHCl3).  
Synthesis of Ligand L18: 
 
To a solution of dimethyl 2,2'-azanediyldibenzoate11 (5.24 g, 1 equiv.) in DMF (154 mL) 
was added NaH (2.35 g, 60% in mineral oil, 3.2 equiv.) in portions. MeI (6.85 mL, 6 equiv.) was 
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added dropwise. The mixture was stirred at rt overnight. An additional NaH (0.73 gm 60% in 
mineral oil, 1 equiv.), followed by MeI (2.3 mL, 2 equiv.), was added. The mixture was stirred for 
2 h. The reaction was quenched with H2O. The mixture was extracted with EtOAc three times. 
The organic layer was washed with H2O several until no DMF remained in the organic layer. The 
organic layer was washed with brine twice, dried over Na2SO4 and filtered. The solvent was 
removed under vacco. The crude product was dissolved in EtOH (91.8 mL). A solution of KOH 
(4.12 g, 4 equiv.) was added. The mixture was refluxed overnight. The mixture was cooled to 0 oC 
and acidified with 2M HCl. EtOH was removed under vacco. The mixture was extracted with 
EtOAc five times. The organic layer was washed with H2O, dried over Na2SO4 and filtered. The 
solvent was removed under vacco to afford 2,2'-(methylazanediyl)dibenzoic acid (4.98 g, 100%) 
as a pale brown solid. It was used without further purification.  
 
General Procedure C2: 2,2'-(methylazanediyl)dibenzoic acid (1.0065 g) afforded 2,2'-
(methylazanediyl)bis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)benzamide) (0.8188 g) in 41% yield. 
Flash chromatography: EtOAc-2% MeOH/DCM. 1H NMR (DMSO, 400 MHz): 7.58 (br, 2H), 7.38 (d, 
J= 7.4, 2H), 7.30 (td, J= 7.8, 1.5, 2H), 7.24-7.16 (m, 10H), 7.03 (t, J= 7.5, 2H), 6.88 (d, J= 8.2, 2H), 
4.22-4.13 (m, 2H), 3.39 (s, 3H), 3.05-2.72 (m, 10H); 13C NMR (CDCl3, 100 MHz): 168.7, 147.9, 138.0, 
131.2, 130.01, 129.99, 129.2, 128.5, 126.4, 123.1, 122.0, 63.76, 53.2, 42.2, 36.7;; Molecular 
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Weight [MNa]: 560.3 (expected), 560.4 (found); IR (cm-1): 3399 (br), 3260 (br), 3064, 3028, 
2930, 2877, 1620, 1596, 1562, 1545, 1495; []20D= 37.6o (c= 1.00, CHCl3).  
 
To a solution of 2,2'-(methylazanediyl)bis(N-((S)-1-hydroxy-3-phenylpropan-2-yl) 
benzamide) (148.5 mg, 1 equiv.), NEt3 (0.175 mL, 4.4 equiv.) in DCM (3 mL) was added MsCl 
(0.048 mL, 2.2 equiv.) dropwise at 0 oC. The mixture was stirred at rt for 2 overnights. The mixture 
was quenched with sat. NH4Cl. The organic layer was washed with sat. NaHCO3 and brine, dried 
over Na2SO4 and filtered. The solvent was removed under vacco. Flash chromatography (1:30:70-
1:70:30 NEt3: EtOAc: hexane) afforded 2-((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-N-(2-((S)-4-benzyl-
4,5- dihydrooxazol -2-yl)phenyl)-N-methylaniline L18 (108.0 mg, 78%) as a pale yellow solid. 
1H NMR (CDCl3, 400 MHz): 7.59 (dd, J= 7.9, 1.6, 2H), 7.39 (td, J= 7.9, 1.6, 2H), 7.28-7.24 (m, 
4H), 7.20-7.17 (m, 2H), 7.16-7.11 (m, 6H), 7.02 (t, J= 7.7, 2H), 4.22-4.14 (m, 2H), 3.88 (t, J= 9.0, 
2H), 3.72 (t, J= 8.0, 2H), 3.31 (s, 3H), 2.99 (dd, J= 13.7, 4.7, 2H), 2.33 (dd, J= 13.7, 9.0, 2H); 13C 
NMR (CDCl3, 100 MHz): 164.3, 148.6, 138.2, 131.8, 131.3, 129.2, 128.4, 126.3, 123.1, 121.9, 121.7, 
71.3, 67.1, 42.7, 41.4; Molecular Weight [MH]: 502.3 (expected), 502.3 (found); IR (cm-1): 3060, 





Synthesis of Ligand L19 
 
A solution of 2-chlorobenzoic acid (4.04 g, 1 equiv.), methyl 2-aminobenzoate (4.3 mL, 
1.32 equiv.), Cu (190 mg, 12 mol %), Cu2O (140 mg, 4 mol %) and Cu(OAc)2 (360 mg, 8 mol %) in 
DMF (120 mL) was refluxed for 20 h. After cooling to rt, the mixture was filtered through a short 
pad of silica gel. The silica gel was washed with EtOAc. EtOAc in the filtrate was removed under 
vacco. 0.1M HCl (120 mL) was added. The mixture was diluted with H2O until no more solid was 
formed. The mixture was filtered. The solid was washed with H2O and dried under vacuum. The 
solid was re-dissolved in EtOAc. The organic layer was washed with 1M HCl, H2O and brine, dried 
over Na2SO4, and filtered. The solvent was removed under vacco. Flash chromatography (5% 
EtOAc/hex- 1% NEt3/EtOAc) afforded 2-((2-(methoxycarbonyl)phenyl)amino) benzoic acid12 (1.60 
g, 23%).  
 
To a solution of 2-((2-(methoxycarbonyl)phenyl)amino)benzoic acid (298.4 mg, 1 equiv.), 
EDCl.HCl (244 mg, 1.15 equiv.), DMAP (6.8 mg, 5 mol %) in DCM (19.4 mL) was added N-
methylmorpholine (0.2 mL, 1.65 equiv.). (S)- phenylalaninol (192 mg, 1.15 equiv.) was added. The 
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mixture was stirred at rt for 2 days. The mixture was quenched with sat. NH4Cl, washed with 1M 
HCl, sat. NaHCO3 and brine, dried over Na2SO4 and filtered. The solvent was removed under vacco. 
Flash chromatography (1:50:50-1:85:15 NEt3:EtOAc:hexane) afforded (S)-methyl 2-((2-((1-
hydroxy-3-phenylpropan-2-yl) arbamoyl)phenyl)amino)benzoate as a solid (282.5 mg, 63%). 1H 
NMR (CDCl3, 400 MHz): 10.15 (br, 1H), 7.98 (dd, J= 7.8, 1.5, 1H), 7.55 (dd, J= 7.4, 1.6, 1H), 7.41 (d, 
J= 7.8, 1H), 7.36-7.31 (m, 2H), 7.25-7.15 (m, 5H), 7.01 (t, J= 7.1, 1H), 6.86-6.80 (m, 2H), 4.41-4.34 
(m, 1H), 3.93 (s, 3H), 3.69 (d, J= 11.0, 1H), 3.58 (dd, J= 10.6, 2.7, 1H), 2.88 (dd, J= 7.4, 2.7, 2H), 
2.60 (br, 1H); 13C NMR (CDCl3, 100 MHz): 168.3, 168.1, 146.2, 140.2, 137.6, 133.8, 131.7, 131.6, 
129.2, 129.1, 128.6, 126.8, 126.6, 122.7, 121.6, 118.9, 116.0, 114.9, 64.0, 52.9, 52.1, 36.9; 
Molecular Weight [MNa]: 427.2 (expected), 427.2 (found); []20D= 325.6o (c= 1.00, CHCl3); IR 
(cm-1): 3303 (br), 3062, 3027, 3002, 2949, 2877, 1694, 1650, 1634, 1594, 1578, 1509, 1482, 1446.   
 
To a solution of (S)-methyl 2-((2-((1-hydroxy-3-phenylpropan-2-yl)carbamoyl)phenyl) 
amino)benzoate (208.6 mg, 1 equiv.), NEt3 (0.29 mL, 4 equiv.), DMAP (3.2 mg, 5 mol %) in DCM 
(7mL) was added a solution of TsCl (108.2 mg, 2 equiv.) in DCM (2 mL) at 0 oC. The reaction 
mixture was stirred at rt for two overnights. The reaction was quenched with sat. NH4Cl. The 
organic layer was washed with H2O and brine, and was dried over Na2SO4 and filtered. The solvent 
was removed under vacco. Flash chromatography (1:10:90 to 1:15:85 NEt3/EtOAc/Hexane) 
afforded (S)-methyl 2-((2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)amino)benzoate L19 as a solid 
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(167.8 mg, 84%). 1H NMR (CDCl3, 400 MHz): 11.04 (br, 1H), 8.00 (dd, J= 7.8, 1.5, 1H), 7.81 (dd, J= 
7.8, 1.5, 1H), 7.56 (d, J= 8.2, 1H), 7.47 (d, J= 8.2, 1H), 7.38 (td, J= 7.8, 1.6, 1H), 7.31-7.18 (m, 6H), 
6.94 (t, J=7.6, 1H), 6.87 (t, J= 7.7, 1H), 4.74-4.67 (m, 1H), 4.32 (t, I= 8.8, 1H), 4.08 (t, J= 7.8, 1H), 
3.82 (s, 3H), 3.22 (dd, J= 14.1, 5.8, 1H), 2.82 (dd, J= 13.6, 8.2, 1H); 13C NMR (CDCl3, 100 MHz): 
167.2, 163.1, 144.0, 143.3, 138.1, 133.0, 131.9, 131.4, 130.3, 129.3, 128.4, 126.4, 120.2, 119.3, 
119.1, 118.7, 116.8, 114.4, 70.5, 68.3, 51.8, 41.9; Molecular Weight [MH]: 387.2 (expected), 
387.2 (found); IR (cm-1): 3177 (br), 3061, 3026, 2949, 2898, 2842, 1709, 1637, 1604, 1580, 1518, 
1453; []20D= 51.6o (c= 0.55, CHCl3). 
Synthesis of Ligand L21: 
 
General Procedure C1: 6,6'-azanediylbis(3-bromobenzoic acid)9 (1.07 g) afforded 6,6'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-3-bromobenzamide) as a red solid (1.76 g) in 
100% yield. It was used without further purification.  
 
General Procedure D with DMAP: 6,6'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-3-bromobenzamide) (249.2 mg) afforded bis(2-((S)-4- benzyl-4,5-dihydrooxazol-2-yl)-3-
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bromophenyl)amine L21 (186.9 mg) in 79% yield. Flash chromatography: 1:20:80 NEt3: EtOAc: 
hexane. 1H NMR (CDCl3, 400 MHz): 11.01 (br, 1H), 7.95 (d, J= 2.4, 2H), 7.39 (d, J= 8.6, 2.4, 2H), 
7.31 (d, J= 9.0, 2H), 7.24-7.15 (m, 10H), 4.45-4.38 (m, 2H), 4.24 (t, J= 8.8, 2H), 3.98 (t, J= 7.9, 2H), 
3.10 (dd, J= 13.7, 5.9, 2H), 2.73 (d, J= 13.7, 7.9, 2H); 13C NMR (CDCl3, 100 MHz): 161.7, 141.8, 
137.8, 134.1, 132.9, 129.3, 128.4, 126.4, 119.6, 117.4, 111.8, 70.8, 68.3, 41.7; Molecular Weight 
[MH]: 646.05 (expected), 646.2 (found); IR (cm-1): 3132, 3083, 3061, 3026, 3000, 2959, 2896, 
1641, 1596, 1574, 1502, 1454, 1473; []20D= 42.8o (c= 1.00, CHCl3). 
Synthesis of Ligand L23: 
 
General Procedure B: 2-bromo-5-methoxybenzoic acid (2.01 g) afforded 6,6'-
azanediylbis(3-methoxybenzoic acid) (2.38 g) as a green solid in 86% yield. 1H NMR (DMSO, 400 
MHz): 13.00 (br, 2H), 10.27 (br, 1H), 7.36 (d, J= 2.7, 2H), 7.26 (d, J= 9, 2H); 7.05 (dd, J= 9.0, 2.7, 
2H), 3.73 (s, 6H); 13C NMR (DMSO, 100 MHz): 168.6, 152.5, 138.6, 121.0, 119.6, 118.6, 115.2, 55.9; 
Molecular Weight [MH]: 316.1 (expected), 316.1 (found); IR (cm-1): 3417, 3358, 1673, 1619, 
1597, 1566, 1525, 1461. 
 
General Procedure E: 6,6'-azanediylbis(3-methoxybenzoic acid) (0.3047 g) afforded 
dimethyl 6,6'-azanediylbis(3-methoxybenzoate) (0.3182 g) as a brown solid in 96% yield. 1H NMR 
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(CDCl3, 400 MHz): 10.48 (br, 1H), 7.46 (d, J= 2.8, 2H), 7.36 (d, J= 9.0, 2H), 6.98 (dd, J= 9.4, 2.8, 2H), 
3.93 (s, 6H), 3.80 (s, 6H); 13C NMR (CDCl3, 100 MHz):167.5, 152.5, 138.9, 121.2, 119.1, 117.2, 
114.5, 55.7, 52.1; Molecular Weight [MH]: 346.13 (expected), 346.2 (found); IR (cm-1):3329, 
2998, 2950, 2909, 2834, 1699, 1614, 1586, 1570, 1508.   
 
A solution of dimethyl 6,6'-azanediylbis(3-methoxybenzoate) (257.0 mg, 1 equiv.), (S)- 
phenylalaninol (318.4 mg, 2.6 equiv.), KCN (21.1 mg, 40 mol %) in PhMe (2.5 mL) was refluxed 
overnight. After cooling to rt, H2O was added. The mixture was extract with DCM three times. 
The organic layer was washed with H2O and brine. The organic layer was dried over Na2SO4 and 
filtered. The solvent was removed under vacco. The mixture was re-dissolved in DCM and washed 
with 1M HCl, sat. NaHCO3, H2O and brine. The organic layer was dried over Na2SO4 and filtered. 
The solvent was removed under vacco to afford 6,6'-azanediylbis(N-((S)-1-hydroxy-3-phenyl 
propan-2-yl)-3-methoxybenzamide) as a yellow solid (318.8 mg, 67%). It was used without 




General Procedure D with DMAP 6,6'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-3-methoxybenzamide) (291.0 mg) afforded bis(2-((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-4-
methoxyphenyl) amine L23 (242.7 mg) in 89% yield. Flash chromatography: 1:20:80- 1:70:30 NEt3: 
EtOAc: hexane. 1H NMR (CDCl3, 400 MHz): 10.34 (br, 1H), 7.33 (d, J= 3.2, 2H), 7.29 (d, J= 9.0, 2H), 
7.25-7.16 (m, 10 H), 6.92 (dd, J= 9.0, 2.8, 2H), 4.56-4.48 (m, 2H), 4.22 (t, J= 8.9, 2H), 3.99 (t, J= 8.0, 
2H), 3.81 (s, 6H), 3.18 (dd, J= 13.7, 5.5, 2H); 2.71 (dd, J= 14.1, 8.6, 2H); 13C NMR (CDCl3, 100 MHz): 
163.1, 152.7, 138.1, 137.9, 129.3, 128.4, 126.4, 119.9, 119.1, 116.1, 133.6, 70.7, 68.1, 55.8, 41.8; 
Molecular Weight [MH]: 548.3 (expected), 548.3 (found); IR (cm-1): 3300 (br), 3084, 3060, 3026, 
2998, 2931, 2899, 2834, 1642, 1606, 1512, 1463, 1455; []20D= 53.0o (c= 0.56, CHCl3).  
Synthesis of Ligand L25: 
 
General Procedure C1: 6,6'-azanediylbis(3-nitrobenzoic acid9 (504.0 mg) afforded 6,6'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-4-nitrobenzamide) as a red solid (435.9 mg) 




General Procedure D with DMAP: 6,6'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-3-nitrobenzamide) (228.9 mg) afforded bis(2-((S)-4- benzyl-4,5-dihydrooxazol-2-yl)-3-
nitrophenyl)amine L25 (169.1 mg) in 78% yield. Flash chromatography: 1:20:80- 1:60:40 NEt3: 
EtOAc: hexane. 1H NMR (CDCl3, 400 MHz): 12.45 (s, 1H), 8.80 (d, J= 2.7, 2H), 8.24 (dd, J= 9.4, 2.7, 
2H), 7.62 (d, J= 9.4, 2H), 7.19-7.15 (m, 6H), 7.12-7.10 (m, 4H), 4.31 (dd, J= 8.8, 8.8, 2H), 4.21-4.13 
(m, 2H), 4.00 (dd, J= 8.0, 8.0, 2H), 2.94 (dd, J= 13.7, 7.0, 2H), 2.75 (dd, J= 13.7, 6.7, 2H); 13C NMR 
(CDCl3, 100 MHz): 160.5, 146.7, 141.0, 137.8, 129.3, 128.2, 126.9, 126.7, 126.5, 117.8, 116.0, 71.1, 
68.8, 41.8; Molecular Weight [MH]: 578.20 (expected), 578.3 (found); IR (cm-1): 3086, 3061, 
3026, 2917, 1647, 1615, 1574, 1541, 1513, 1501, 1473, 1463, 1454; []20D= 319.2o (c= 1.00, 
CHCl3).  
Synthesis of Ligand L26: 
 
General Procedure B: 2-bromo-4-nitrobenzoic acid (1.42 g) afforded 6,6'-azanediylbis(4-
nitrobenzoic acid) (0.87 g) in 43% yield. 1H NMR (400 MHz, DMSO): 8.25 (d, J= 2.4, 2H), 8.14 (d, 
J= 8.8, 2H), 7.77 (dd, J= 8.8, 2.3, 2H); 13C NMR (100 MHz, DMSO): 167.6, 150.8, 143.8, 133.9, 
115.39, 115.38, 112.3; Molecular Weight [MH]: 346.0 (expected), 346.0 (found); IR (cm-1): 3250, 




General Procedure C1: 6,6'-azanediylbis(4-nitrobenzoic acid) (300.5 mg) afforded 6,6'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-4-nitrobenzamide) as an orange solid (487.6 
mg) in 92% yield. It was used without further purification.  
 
General Procedure D with DMAP: 6,6'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-4-nitrobenzamide) (265.2 mg) afforded bis(2-((S)-4- benzyl-4,5-dihydrooxazol-2-yl)-4-
nitrophenyl)amine L26 (168.8 mg) in 68% yield. Flash chromatography: 1:10:90- 1:80:20 NEt3: 
EtOAc: hexane. 1H NMR (CDCl3, 400 MHz): 11.72 (br, 1H), 8.32 (d, J= 2.3, 2H), 8.02 (d, J= 8.6, 2H), 
7.80 (dd, J= 8.6, 1.9, 2H), 7.20-7.17 (m, 6H), 7.15-7.12 (m, 4H), 4.38-4.28 (m, 4H), 4.02 (t, J= 6.9, 
2H), 3.02 (dd, J= 13.7, 5.8, 2H), 2.76 (dd, J= 13.7, 6.7, 2H); 13C NMR (CDCl3, 100 MHz): 161.1, 149.8, 
143.0, 137.7, 131.7, 129.3, 128.3, 126.5, 120.8, 114.9, 112.3, 71.0, 68.6, 41.7; Molecular Weight 
[MH]: 576.3 (expected), 576.3 (found); IR (cm-1): 3170, 3105, 3086, 3063, 3028, 2957, 2900, 




Synthesis of Ligand L27: 
 
General Procedure A: 2-amino-4-methoxybenzoic acid (1.5055 g) afforded 2-bromo-4-
methoxybenzoic acid13 (1.8755 g) in 90% yield.  
 
General Procedure B: 2-bromo-4-methoxybenzoic acid (1.00g) afforded 2,2'-
azanediylbis(4-methoxybenzoic acid) (1.24 g) as a black solid in 90% yield. 1H NMR (DMSO, 400 
MHz): 12.65 (br, 2H), 10.98 (br, 1H), 7.86 (d, J=9.0, 2H), 7.00 (d, J= 2.0, 2H), 6.53 (dd, J= 9.0, 2.4, 
2H), 3.74 (s, 6H); 13C NMR (DMSO, 100 MHz): 168.4, 163.6, 145.8, 134.2, 110.7, 107.5, 102.1, 55.8; 
Molecular Weight [MH]: 316.1 (expected), 316.1 (found); IR (cm-1): 3370, 3350, 1668, 1611, 
1563, 1525, 1446.  
 
General Procedure C2: 2,2'-azanediylbis(4-methoxybenzoic acid) (99.8 mg) afforded 2,2'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-4-methoxybenzamide) (109.6 mg) in 60% 
yield. Flash chromatography: 50% Hexane/EtOAc- 3.5% MeOH/EtOAc, florisil as stationary phase. 
185 
 
1H NMR (CDCl3, 400 MHz): 9.66 (br, 1H), 7.45 (d, J= 8.6, 2H), 7.24-7.15 (m, 10H), 6.83 (d, J= 7.8, 
2H), 6.69 (d, J= 2.8, 2H), 6.45 (dd, J= 8.6, 2.3, 2H), 4.36-4.28 (m, 2H), 3.71 (s, 6H), 3.66 (dd, J= 11.4, 
3.5, 2H), 3.55 (dd, J= 11.3, 4.7, 2H), 2.87 (d, J= 7.4, 4H), 13C NMR (CDCl3, 100 MHz): 168.3, 162.6, 
143.7, 137.8, 130.7, 129.3, 128.5, 126.5, 116.4, 107.6, 104.2, 63.5, 55.3, 52.8, 37.1; Molecular 
Weight [MNa]: 606.3 (expected), 606.3 (found); IR (cm-1): 3299 (br), 3085, 3060, 3026, 3002, 
2935, 2872, 1620, 1602, 1573, 1513, 1496, 1449; []20D= 99.8o (c= 0.95, CHCl3).  
 
General Procedure D with DMAP: 2,2'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-4-methoxybenzamide) (80.0 mg) afforded bis(2-((S)-4- benzyl-4,5-dihydrooxazol-2-yl)-5-
methoxyphenyl) amine L27 (42.8 mg) in 57% yield. Flash chromatography: 50% EtOAc/hexane, 
florisil (<200 mesh) as stationary phase. 1H NMR (CDCl3, 400 MHz): 10.98 (br, 1H), 7.77 (d, J= 8.6, 
2H), 7.24-7.16 (m, 10H), 7.04 (d, J= 2.3, 2H), 6.49 (dd, J= 9.0, 2.3, 2H), 4.47-4.39 (m, 2H), 4.19 (t, 
J= 8.7, 2H), 3.94 (t, J= 7.9, 2H), 3.78 (s, 6H), 3.14 (dd, J= 13.6, 5.4, 2H), 2.69 (dd, J= 13.6, 8.3, 2H); 
13C NMR (CDCl3, 100 MHz): 162.9, 162.2, 144.6, 138.3, 131.9, 129.3, 128.4, 126.3, 109.0, 106.7, 
102.9, 70.5, 68.0, 55.3, 41.9; Molecular Weight [MH]: 548.3 (expected), 548.3 (found); IR (cm-
1): 3060, 3025, 3000, 2957, 2917, 1639, 1612, 1576, 1503, 1464, 1452, 1442; []20D= 65.6o (c= 




Synthesis of Ligand L28: 
 
To a solution of 4-nitroisoindoline-1,3-dione (15.03 g, 1 equiv.) in H2O (180 mL) was added 
NaOH (21 mL, 30% w/w in H2O) at 0 oC dropwise. The mixture was stirred at 0 oC for 2 h. conc. 
HCl (13.5 mL) was added at 0 oC. The mixture was stirred at 0 oC for 30 mins. The mixture was 
filtered. The residue was washed with cold water and dried under vacuum. 2-carbamoyl-6-
nitrobenzoic acid was obtained as a pale yellow solid (11.9 g, 72%). 1H NMR (DMSO, 400 MHz): 
7.67 (br, 1H), 7.71 (t, J= 7.8, 1H), 7.91 (d, J= 7.8, 1H), 8.12 (d, J= 7.8, 1H), 8.13 (br, 1H), 13.57 (br, 
1H); 13C NMR (DMSO, 100 MHz): 125.8, 129.6, 130.7, 133.0, 137.2, 147.5, 166.4, 167.8; Molecular 
Weight [MH]: 209.0 (expected), 209.0 (found); IR (cm-1): 3481, 3431, 3269 (br), 1719, 1646, 
1614. 
 
At 0 oC, Br2 (2.9 mL, 2 equiv.) was dissolved in H2O (26 mL) and NaOH (22.5 mL, 30% w/w 
in H2O). A solution of 2-carbamoyl-6-nitrobenzoic acid (11.70 g, 1 equiv.) in H2O (40 mL) and 
NaOH (7.5 mL, 30% w/w in H2O) was added at 0 oC. The mixture was stirred at 45 oC for 45 mins. 
When mixture was cooled to 0 oC, conc. HCl (10 mL) was added dropwise. The mixture was stirred 
for 15 mins at 0 oC. The mixture was filtered. The residue was washed with cold water and dried 
under vacuum. 2-amino-6-nitrobenzoic acid was obtained as a yellow solid (8.49 g, 84%). 1H NMR 
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(DMSO, 400 MHz): 7.29 (t, J= 8.0, 1H), 7.00 (d, J=8.0, 1H), 6.88 (d, J=8.0, 1H); 13C NMR (DMSO, 
100 MHz): 106.1, 110.7, 120.6, 132.3, 150.4, 151.9, 166.9; Molecular Weight [MH]: 181.0 
(expected), 181.0 (found); IR (cm-1): 3462, 3361, 2967 (br), 1668, 1618.   
 
To a solution of 2-amino-6-nitrobenzoic acid (598.3 mg, 1 equiv.), K2CO3 (455.3 mg, 1 
equiv.) in DMF (9.2 mL) was added Me2SO4 dropwise. The mixture was stirred at 60 oC overnight. 
The mixture was diluted with Et2O and EtOAc. Water was added. The mixture was extracted with 
EtOAc three times, wash with H2O five times and brine once. The mixture was dried over Na2SO4 
and filtered. The solvent was removed under vacco. Flash chromatography (20% EtOAc/hexane- 
1:40:60 NEt3:EtOAc/hexane) afforded methyl 2-amino-6-nitrobenzoate14 (587.3 mg) in 91% yield.  
 
General Procedure A: 2-amino-6-nitrobenzoic acid (2.01 g) afforded 2-bromo-6-
nitrobenzoic acid15 (2.25 g) in 83% yield.  
 
To a solution of 2-bromo-6-nitrobenzoic acid (0.6500 g, 1 equiv.), K2CO3 (0.4496 g, 1.2 
equiv.) in acetone (9.8 mL was added MeI (0.15 mL, 3.6 equiv.) dropwise. The mixture was 
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refluxed overnight. H2O was added. The mixture was extracted with DCM three times. The 
organic layer was washed with H2O and brine, dried over Na2SO4 and filtered. The solvent was 
removed under vacco. Flash chromatography (15% EtOAc/hexane) afforded methyl 2-bromo-6-
nitrobenzoate15 (0.6102 g) in 89% yield.  
 
In a glove box, Pd2dba3 (22.9 mg, 2.5 mol %), rac-BINAP (46.7 mg, 7.5 mol %) and Cs2CO3 
(0.6513 g, 2 equiv.) were added to a 20 mL flask. The flask was removed from the glove box. 
methyl 2-bromo-6-nitrobenzoate (259.9 mg, 1 equiv.) and methyl 2-amino-6-nitrobenzoate 
(235.4 mg, 1.2 equiv.) were added. PhMe (4 mL) was added. The reaction mixture was stirred at 
100 oC overnight. After cooling to rt, the solvent was removed under vacco. The sample was 
dissolved in EtOAc and filtered through silica gel. The solvent was removed under vacco. Flash 
chromatography (30-40% EtOAc/hexane) afforded dimethyl 6,6'-azanediylbis(2-nitrobenzoate) 
as a brown solid (203.0 mg) in 54% yield. 1H NMR (CDCl3, 400 MHz): 9.14 (br, 1H), 7.54-7.45 (m, 
6H), 3.95 (s, 6H); 13C NMR (CDCl3, 100 MHz): 165.3, 150.2, 142.1, 131.7, 122.3, 117.2, 116.7, 53.5; 
Molecular Weight [MH]: 376.1 (expected), 376.1 (found); IR (cm-1): 3342 (br), 3099, 3008, 2955, 




A solution of dimethyl 6,6'-azanediylbis(2-nitrobenzoate) (167.7 mg, 1 equiv.), (S)- 
phenylalaninol (175.7 mg, 2.6 equiv.), KCN (11.6 mg, 40 mol %) in PhMe (2.7 mL) was refluxed for 
two overnights. After cooling to rt, H2O was added. The mixture was extract with DCM three 
times. The organic layer was washed with H2O, 1M HCl, H2O and brine. The organic layer was 
dried over Na2SO4 and filtered. The solvent was removed under vacco. Flash chromatography 
(30% EtOAc/hex- EtOAc) afforded 6,6'-azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2-
nitrobenzamide) (43.5 mg) contaminated with a trace amount of impurities in 16% yield.  
 
To a solution of 6,6'-azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2- 
nitrobenzamide) (43.5 mg, 1 equiv.) in DCM (0.285 mL) was added SOCl2 (0.37 mL, 7.2 equiv.) at 
0 oC dropwise. The mixture was stirred at rt overnight. The excess SOCl2 and DCM were removed 
under vacco. A solution of KOH (8.0 mg, 2 equiv.) in MeOH (0.435 mL) was added. The mixture 
was stirred at rt overnight. H2O was added. The mixture was extracted with DCM three times. 
The organic layer was washed with brine, dried over Na2SO4 and filtered. The solvent was 
removed under vacco. Flash chromatography (1:30:70-1:60:40 NEt3:EtOAc:hexane) afforded 
bis(2-((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-3-nitrophenyl)amine L28 (17.1 mg) as a yellow solid in 
42% yield. 1H NMR (CDCl3, 400 MHz): 7.70 (dd, J= 6.3, 3.1, 2H), 7.44-7.40 (m, 4H), 7.26-7.24 (2H, 
m), 7.20-7.16 (m, 4H), 7.11-7.07 (m, 2H), 6.03 (d, J= 9.0, 2H), 4.75-4.69 (m, 2H), 3.85 (dd, J= 11.3, 
3.9, 2H), 3.60 (dd, J= 11.3, 2.8, 2H), 3.10 (dd, J= 13.7, 6.2, 2H), 2.96 (13.7, 8.6, 2H); 13C NMR (CDCl3, 
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100 MHz): 164.1, 147.8, 141.2, 136.6, 130.6, 129.3, 128.6, 126.7, 123.1, 122.4, 117.7, 51.1, 46.3, 
36.8; Molecular Weight [MH]: 576.2 (expected), 576.0 (found); IR (cm-1): 3365 (br), 3274 (br), 
3061, 3028, 2925, 2854, 1652, 1609, 1577, 1532, 1452; []20D= 79.7o (c= 0.63, CHCl3).  
Synthesis of Ligand L29: 
 
General Procedure A: 2-amino-6-fluorobenzoic acid (4.53 g) afforded 2-bromo-6-
fluorobenzoic acid16 (5.55 g) in 87% yield.  
 
General Procedure B: 2-bromo-6-fluorobenzoic acid (1.50 g) afforded 6,6'-azanediylbis(2-
fluorobenzoic acid) (1.40 g) as a pale brown solid in 70% yield. 1H NMR (DMSO, 400 MHz): 13.67 
(br, 2H), 9.79 (br, 2H), 7.42-7.36 (m), 7.15 (d, J=8.2, 2H), 6.82 (dd, J= 10.2, 8.7, 2H);13C NMR (DMSO, 
100 MHz): 166.6 (s), 161.6 (d, J= 250), 143.77 (d, J=4), 133.36 (d, J= 12), 114.46 (d, J= 3), 110.88 
(d, J= 16), 108.77 (d, J= 23); Molecular Weight [MH]: Expected: 292.0, Found: 292.0; IR (cm-1): 




General Procedure C1: 6,6'-azanediylbis(2-fluorobenzoic acid) (0.5000 g) afforded 6,6'-
azanediylbis(2-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)benzamide) (0.9000 g) as a yellow 
solid in 94% yield. It was used without further purification.  
 
General Procedure D with DMAP: 6,6'-azanediylbis(2-chloro-N-((S)-1-hydroxy-3- 
phenylpropan-2-yl)benzamide) (0.5600 g) afforded bis(2-((S)-4-benzyl-4,5- dihydrooxazol-2-yl)-3-
fluorophenyl) amine L29 (0.3699 g) in 71% yield. Flash Chromatography: 1:10:90-1:55:45 
NEt3:EtOAc:hexane. 1H NMR (CDCl3, 400 MHz): 10.49 (br, 1H), 7.28-7.13 (m, 14H), 6.69 (dd, J= 
10.1, 8.3, 2H), 4.64-4.56 (m, 2H), 4.31 (t, J= 9.0, 2H), 4.10 (t, J= 7.9, 2H), 3.22 (dd, J= 13.7, 5.1, 2H), 
2.75 (dd, J= 13.6, 8.6, 2H), 13C NMR (CDCl3, 100 MHz): 163.4 (s), 160.9 (s), 160.3 (d, J= 1.5), 144.3 
(d, J= 4.6), 137.6 (s), 131.7 (d, J= 11.4), 128.9 (d, J= 68.7), 126.5 (s), 114.1 (d, J= 3.1), 108.0 (d, J= 
22.9), 106.6 (d, J= 15.3); 71.3 (s), 67.4 (s), 41.7 (s); Molecular Weight [MH]: 524.22 (expected), 
524.3 (found); IR (cm-1): 3250 (br), 3083, 3062, 3026, 2922, 2899, 2852, 1632, 1608, 1578, 1519, 
1495, 1458; []20D= 39.0o (c= 1.00, CHCl3).  




To a solution of 2-bromo-6-chlorobenzoic acid (2.002 g, 1 equiv.), K2CO3 (1.41 g, 1.2 equiv.) 
in acetone (30.8 mL) was added MeI (1.90 mL, 3.6 equiv.) dropwise. The mixture was refluxed 
overnight. H2O was added. The mixture was extracted with DCM three times. The organic layer 
was washed with H2O and brine, dried over Na2SO4 and filtered. The solvent was removed under 
vacco. Flash chromatography (8-12% EtOAc/hexane) afforded methyl 2-bromo-6-
chlorobenzoate17 (1.7988 g) as a solid in 85% yield.  
 
To a solution of 2-amino-6-chlorobenzoic acid (2.98 g, 1 equiv.), K2CO3 (2.41 g, 1 equiv.) 
in DMF (48 mL) was added Me2SO4 (1.655 mL, 1 equiv.) dropwise. The mixture was stirred at rt 
overnight. H2O was added. The mixture was extracted with EtOAc three times. The organic layer 
was washed with H2O several times until no more DMF remained, washed with brine, dried over 
Na2SO4 and filtered. The solvent was removed under vacco. Flash chromatography (12% 
EtOAc/hexane-1:40:60 NEt3/EtOAc/hexane) afforded methyl 2-amino-6-chlorobenzoate (2.79 g) 
as a brown oil in 86% yield. 1H NMR (DMSO, 400 MHz): 3.92 (s, 3H), 4.87 (br, 2H), 6.57 (d, J= 8.2, 
1H), 6.74 (d, J=7.8, 1H); 7.07 (t, J= 8.0, 1H); 13C NMR (DMSO, 100 MHz); Molecular Weight [MH]: 




In a glove box, Pd2dba3 (68.7 mg, 2.5 mol %), rac-BINAP (140.1 mg, 7.5 mol %) and Cs2CO3 
(1.368 g, 1.4 equiv.) were added to a 50 mL flask. The flask was removed from the glove box. 
Methyl 2-bromo-6-chlorobenzoate (0.7508 g, 1 equiv.) and methyl 2-amino-6-chlorobenzoate 
(0.6682 g, 1.2 equiv.) were added. PhMe (12 mL) was added. The reaction mixture was stirred at 
100 oC overnight. After cooling to rt, the solvent was removed under vacco. The sample was 
dissolved in EtOAc and filtered through silica gel. The solvent was removed under vacco. Flash 
chromatography (10-12% EtOAc/hexane) afforded dimethyl 6,6'-azanediylbis(2- chlorobenzoate) 
as a pale yellow solid (0.6200 g) in 58% yield. 1H NMR (CDCl3, 400 MHz): 8.21 (br, 1H), 7.32 (t, J= 
8.0, 2H), 7.18 (d, J= 8.0, 2H), 7.09 (d, J=8.0, 2H); 13C NMR (CDCl3, 100 MHz): 166.7, 142.7, 133.5, 
131.5, 123.1, 122.0, 116.7, 52.6; Molecular Weight [MH]: 354.03, 356.03 (expected), 354.1, 
356.1 (found); IR (cm-1): 2800 (br), 1737, 1705, 1597.   
 
A mixture of dimethyl 6,6'-azanediylbis(2-chlorobenzoate) (0.3539 g, 1 equiv.), KOH 
(0.2244 g, 4 equiv.) in EtOH (5 mL) and H2O (5 mL) was refluxed with stirring for 26 h. Additional 
KOH (0.1122 g, 2 equiv.) was added. The mixture was reflux with stirring for overnight. After 
cooling to rt, the mixture was diluted with H2O (20 mL) and acidified with 1M HCl until pH < 3. 
Filtration afforded analytically pure 6,6'-azanediylbis(2-chlorobenzoic acid) (0.3026 g) as a pale 
yellow solid in 93% yield. 1H NMR (DMSO, 400 MHz): 8.49 (br, 1H), 7.21-7.15 (m, 4H), 6.99 (dd, 
J= 6.5, 2.7, 2H), 3.98 (s, 6H); 13C NMR (DMSO, 100 MHz): 167.5, 142.02, 131.9, 131.7, 124.3, 123.1, 
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117.6; Molecular Weight [MH]: 324.0 (expected), 324.0 (found); IR (cm-1): 3309, 2970, 2853, 
2750 (br), 1665, 1564. 
 
General Procedure C: 6,6'-azanediylbis(2-chlorobenzoic acid) (0.1483 g) afforded 6,6'-
azanediylbis(2-chloro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)benzamide) (0.0950 g) as a yellow 
solid in 35% yield. Flash Chromatography: 50-80% EtOAc/hexane. 1H NMR (CD3OD, 400 MHz): 
7.27-7.24 (m, 4H), 7.21 (d, J= 7.8, 2H), 7.14 (d, J= 7.5, 4H), 7.08-7.05 (m, 4H), 7.00 (d, J= 8.3, 2H), 
4.35-4.28 (m, 2H), 3.59 (d, J= 5.5, 4H), 2.97 (dd, J= 13.7, 6.3, 2H), 2.83 (dd, J= 13.7, 5.9, 2H);13C 
NMR (CD3OD, 100 MHz): 166.6, 141.5, 138.3, 131.4, 130.2, 129.0, 127.9, 127.5, 125.8, 122.1, 
117.0, 62.4, 53.3, 36.2; Molecular Weight [MNa]: 614.2 (expected), 614.3 (found); IR (cm-1): 
3377 (br), 3085, 3061, 3027, 2926, 2874, 1627, 1596, 1586, 1560, 1469; []20D= 35.1o (c= 0.65, 
MeOH).  
 
General Procedure D with 4-pyrrolidinopyridine: 6,6'-azanediylbis(2-chloro-N-((S)-1- 
hydroxy-3-phenylpropan-2-yl)benzamide) (0.0629 g) afforded bis(2-((S)-4-benzyl- 4,5-
dihydrooxazol-2-yl)-3-chlorophenyl) amine L30 (0.0292 g) in 49% yield. Flash Chromatography: 
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1:20:80-1:50:50 NEt3:EtOAc:hexane. 1H NMR (CDCl3, 400 MHz): 9.03 (br, 1H), 7.28-7.17 (m, 14H), 
7.00 (dd, J= 7.0, 1.8, 2H), 4.65-4.57 (m, 2H), 4.34 (t, J= 8.8, 2H), 4.13 (t, J= 8.0, 2H), 3.23 (dd, J= 
13.7, 5.5, 2H), 2.78 (dd, J= 13.7, 8.6, 2H); 13C NMR (CDCl3, 100 MHz): 161.2, 143.3, 137.7, 134.5, 
131.0, 129.3, 128.6, 126.5, 122.4, 118.0, 116.1, 71.7, 67.8, 41.8; Molecular Weight [MH]: 556.2 
(expected), 556.2 (found); IR (cm-1): 3350 (br), 3061, 3027, 2922, 2898, 2850, 1662, 1573, 1496, 
1444; []20D= 23.2o (c= 0.48, CHCl3).  
Synthesis of Ligand L31: 
 
General Procedure A: 2-amino-6-methoxybenzoic acid (2.01 g) afforded 2-bromo-6-
methoxybenzoic acid18 (1.83 g) in 66% yield.  
 
General Procedure B: 2-bromo-6-methoxybenzoic acid (0.8002 g) afforded 6,6'-
azanediylbis(2-methoxybenzoic acid) (0.4889 g) as a brown solid in 45% yield. 1H NMR (DMSO, 
400 MHz): 13.05 (br, 2H), 8.52 (br, 1H), 7.26 (t, J= 8.5, 2H), 6.82 (d, J= 8.3, 2H), 6.63 (d, J= 8.2, 2H), 
3.77 (s, 6H); 13C NMR (DMSO, 100 MHz): 168.5, 158.4, 142.2, 131.8, 113.5, 111.0, 104.7, 56.3; 
Molecular Weight [MH]: 316.1 (expected), 316.1 (found); IR (cm-1): 3400, 3195, 1710, 1691, 




General Procedure C2: 6,6'-azanediylbis(2-methoxybenzoic acid) (0.2023 g) afforded 6,6'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2-methoxybenzamide) as (0.3143 g) as a 
yellow solid in 84% yield. Flash chromatography: EtOAc-3% MeOH/EtOAc, florisil (<200 mesh) as 
stationary phase. 1H NMR (CDCl3, 400 MHz): 10.35 (br, 1H), 7.28-7.23 (m, 8H), 7.19-7.14 (m, 4H), 
6.97 (d, J= 8.2, 2H), 6.95 (br, 2H), 6.42 (d, J= 8.3, 2H), 4.42-4.34 (m, 2H), 3.85-3.80 (m, 2H), 3.73 
(s, 6H), 3.64-3.56 (m, 4H), 3.01-2.97 (m, 4H);13C NMR (CDCl3, 100 MHz): 167.4, 158.2, 143.9, 137.8, 
130.9, 129.4, 128.4, 126.4, 113.2, 111.5, 103.1, 63.7, 55.9, 52.9, 37.2; Molecular Weight [MNa]: 
606.3 (expected), 606.3 (found); IR (cm-1): 3376 (br), 3084, 3061, 3027, 2928, 2880, 2839, 1630, 
1580, 1509, 1460, 1435; []20D= 152.8o (c= 1.00, CHCl3).  
 
General Procedure D with DMAP: 6,6'-azanediylbis(N-((S)-1-hydroxy-3- phenylpropan-2-
yl)-2-methoxybenzamide) (0.1504 g) afforded bis(2-((S)-4- benzyl-4,5-dihydrooxazol-2-yl)-3-
methoxyphenyl) amine L31 (0.0737 g) in 52% yield. Flash chromatography: 50% EtOAc/hexane, 
florisil (<200 mesh) as stationary phase. 1NMR (CDCl3, 400 MHz): 9.41 (br, 1H), 7.26-7.16 (m, 12H), 
6.98 (d, J= 8.2, 2H), 6.49 (d, J= 8.2, 2H), 4.63-4.56 (m, 2H), 4.30 (t, J= 9.0, 2H), 4.09 (d, J= 8.1, 2H), 
3.84 s, 6H), 3.27 (dd, J= 14.1, 5.1, 2H), 2.76 (dd, J= 13.7, 9.0, 2H), 13C NMR (CDCl3, 100 MHz): 161.9, 
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159.4, 143.8, 138.1, 131.1, 129.2, 128.5, 126.3, 111.1, 107.6, 103.4, 71.3, 67.5, 56.1, 41.8; 
Molecular Weight [MH]: 548.3 (expected), 548.3 (found); IR (cm-1): 3320 (br), 3083, 3061, 3025, 
3002, 2958, 2935, 2897, 2837, 1660, 1637, 1581, 1516, 1495, 1465, 1436; []20D= 36.9o (c= 0.58, 
CHCl3). 
Synthesis of Ligand L32: 
 
General Procedure A: 2-amino-6-methylbenzoic acid (2.00 g) afforded 2-bromo-6-
methylbenzoic acid as a pale brown solid (2.03 g) in 71% yield. 1H NMR (CD3OD, 400 MHz): 7.42 
(d, J=8.2, 1H), 7.23-7.15 (m, 2H); 2.34 (s, 3H); 13C NMR (CD3OD, 100 MHz): 170.0; 137.1; 136.1; 
129.9; 128.7, 117.7, 18.3; Molecular Weight [MH]: 212.96, 215.0 (expected), 213.1, 215.0 
(found); IR (cm-1): 3061 (br), 3022, 2928, 1720, 1594, 1565.  
 
General Procedure B: 2-bromo-6-methylbenzoic acid (1.00 g) afforded 6,6'-
azanediylbis(2-methylbenzoic acid) as a dark brown solid (1.09 g) in 82% yield. 1H NMR (DMSO, 
400 MHz): 13.39 (br, 2H), 8.77 (br, 1H), 7.18 (dd, J= 7.8, 7.8, 2H), 7.05 (d, J= 8.2, 2H), 6.79 (d, J= 
7.8, 2H), 2.34 (s, 6H); 13C NMR (DMSO, 100 MHz): 170.1, 142.0, 138.0, 130.8, 123.49, 123.47, 
116.2, 21.4; Molecular Weight [MH]: 284.1 (expected), 284.1 (found); IR (cm-1): 3420, 1674, 




General Procedure C2: 6,6'-azanediylbis(2-methylbenzoic acid) (467.8 mg) afforded 6,6'-
azanediylbis(N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2-methylbenzamide) (477.9 mg) as a light 
brown solid in 53% yield. Flash chromatography: 40-100% Hexane/EtOAc. 1H NMR (CDCl3, 400 
MHz): 7.21-7.06 (m, 12H), 6.98 (d, J=8.2, 2H), 6.71 (d, J= 7.4, 2H), 6.06 (d, J=9.0, 2H), 4.44-4.35 
(m, 2H), 3.79 (dd, J= 11.3, 3.5, 2H), 3.63 (br, 2H), 3.52 (dd, J= 11.3, 4.7, 2H), 2.86 (dd, J= 13.4, 6.1, 
2H), 2.77 (dd, J= 14.1, 9, 2H), 2.06 (s, 6H), 13C NMR (CDCl3, 100 MHz): 169.0, 140.1, 137.9, 136.1, 
129.6, 129.2, 128.5, 127.7, 126.3, 123.2, 115.9, 63.8, 52.6, 37.2, 19.3; Molecular Weight [MNa]: 
574.27 (expected), 574.4 (found); IR (cm-1): 3371 (br), 3277 (br), 3062, 3028, 2924, 2871, 1620, 
1598, 1579, 1510, 1463; []20D= 144.9o (c= 0.88, CHCl3).  
 
General Procedure D with DMAP: 6,6'-azanediylbis(N-((S)-1-hydroxy-3-phenyl propan-2-
yl)-2-methylbenzamide) (293.6 mg) afforded bis(2-((S)-4-benzyl -4,5-dihydrooxazol-2-yl)-3-
methylphenyl)amine L32 (188.7 mg) in 69% yield. Flash Chromatography: 1:10:90-1:30:70 NEt3: 
EtOAc:hexane. 1H NMR (CDCl3, 400 MHz): 9.25 (br, 1H), 7.28-7.12 (m, 14H), 6.74 (d, J= 7.0, 2H), 
4.65-4.58 (m, 2H), 4.29 (t, J= 8.8, 2H), 4.08 (t, J= 7.8), 3.22 (dd, J= 14.1, 5.5, 2H), 2.77 (dd, J= 14.0, 
8.6, 2H); 2.34 (s, 6H); 13C NMR (CDCl3, 100 MHz): 163.5, 142.8, 139.0, 137.9, 130.1, 129.3, 128.5, 
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126.5, 122.6, 117.8, 115.7, 70.9, 67.6, 41.9, 20.9; Molecular Weight [MH]: 516.3 (expected), 
516.3 (found); IR (cm-1): 3061, 3027, 2963, 2925, 2898, 1655, 1598, 1575, 1516, 1496, 1460; 
[]20D= 79.6o (c= 0.66, CHCl3). 
A.1.9 Relative Stereochemistry of Cycloadduct from -substituted nitroalkenes 
 
A solution of Zn(OTf)2 (3.6 mg, 0.01 mmol, 10 mol %), rac-L14 (4.8 mg, 0.005 mmol, 10 
mol %), and MS 4Å in PhMe (0.5 mL) in a vial was stirred at rt for 15 mins. A solution of nitro-
alkene 17 (15.2 mg, 0.15 mmol, 1.5 equiv.) in PhMe (0.25 mL) in a vial was added to the zinc 
complex. The vial containing nitro-alkene 17 was rinsed with PhMe (0.25 mL) to ensure complete 
transfer of the nitro-alkene 17. (1E,2E)-3-(4- chlorophenyl)-N-(4-methoxyphenyl)prop-2-en-1-
imine (27.5 mg, 0.10 mmol, 1 equiv.) was added. The vial was sealed with a cap. The mixture was 
stirred at rt for 22 h. The mixture was filtered through florisil. Flash column chromatography (8-
10% EtOAc/hex, florisil as stationary phase) afforded (2S, 3R, 4S)-2-ethyl-1-(4- methoxyphenyl)-
3-nitro-4-phenylpiperidine (24.1 mg, 64%) as a yellow solid. The relative stereochemistry is 




1H NMR (CDCl3, 400 MHz): 7.31-7.26 (m, 5H), 6.96 (d, J= 9.0, 2H), 6.84 (d, J= 9.0, 2H), 6.62 
(d, J= 7.9, 1H), 5.05-5.02 (m, 1H), 4.82 (d, J= 7.9, 1H), 4.12 (td, J= 7.1 2.0, 1H), 4.00-3.97 (m,1H), 
3.78 (s, 3H), 2.02-1.91 (m, 1H), 1.83-1.72 (m, 1H), 1.14 (t, J= 7.4, 3H); 13C NMR (CDCl3, 100 MHz): 
155.1, 140.4, 136.8, 133.4, 130.6, 129.8, 128.7, 119.8, 114.7, 97.1, 84.6, 60.6, 55.6, 37.5, 25.6, 
10.4; Molecular Weight [MH]: 373.1 (expected), 373.1 (found); IR (cm-1): 3044, 2965, 2934, 
2877, 2834m, 1644, 1578, 1547, 1509, 1492, 1463, 1440. 
Table 1.  Crystal data and structure refinement for R173MP. 
Identification code  r173mp 
Empirical formula  C20 H21 Cl N2 O3 
Formula weight  372.84 
Temperature  120 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 10.6192(7) Å a= 90°. 
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 b = 12.5451(7) Å b= 110.242(3)°. 
 c = 14.4977(10) Å g = 90°. 
Volume 1812.1(2) Å3 
Z 4 
Density (calculated) 1.367 Mg/m3 
Absorption coefficient 0.233 mm-1 
F(000) 784 
Crystal size Not Determined 
Theta range for data collection 2.04 to 26.37°. 
Index ranges -13<=h<=13, -15<=k<=15, -18<=l<=18 
Reflections collected 29653 
Independent reflections 3703 [R(int) = 0.0514] 
Completeness to theta = 26.37° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3703 / 0 / 237 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0368, wR2 = 0.0768 
202 
 
R indices (all data) R1 = 0.0577, wR2 = 0.0858 
Largest diff. peak and hole 0.260 and -0.254 e.Å-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for R173MP. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________ 
 x y z U(eq) 
_____________________________________________________________________ 
C(1) 4373(2) -367(2) 2716(1) 25(1) 
C(2) 6536(2) 429(1) 3489(1) 16(1) 
C(3) 7921(2) 299(1) 3788(1) 17(1) 
C(4) 8770(2) 1015(1) 4433(1) 15(1) 
C(5) 8265(2) 1892(1) 4784(1) 13(1) 
C(6) 6876(2) 2017(1) 4462(1) 18(1) 
C(7) 6018(2) 1290(1) 3831(1) 19(1) 
C(8) 10491(2) 2658(1) 5565(1) 15(1) 
C(9) 11437(2) 2974(1) 6390(1) 16(1) 
C(10) 11150(2) 3308(1) 7291(1) 15(1) 
C(11) 9703(2) 3023(1) 7202(1) 15(1) 
C(12) 8718(2) 3220(1) 6149(1) 14(1) 
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C(13) 8637(2) 4421(1) 5929(1) 20(1) 
C(14) 7705(2) 4686(1) 4897(1) 23(1) 
C(15) 12181(2) 2925(1) 8252(1) 15(1) 
C(16) 12885(2) 1981(1) 8299(1) 17(1) 
C(17) 13794(2) 1615(1) 9177(1) 18(1) 
C(18) 13999(2) 2208(1) 10022(1) 17(1) 
C(19) 13343(2) 3160(1) 10001(1) 19(1) 
C(20) 12433(2) 3518(1) 9111(1) 16(1) 
Cl(1) 15114(1) 1739(1) 11142(1) 26(1) 
N(1) 9564(1) 1879(1) 7471(1) 17(1) 
N(2) 9136(1) 2624(1) 5437(1) 14(1) 
O(1) 5776(1) -351(1) 2872(1) 21(1) 
O(2) 9937(1) 1168(1) 7050(1) 24(1) 
O(3) 9054(2) 1713(1) 8090(1) 47(1) 
_____________________________________________________________________ 
Table 3.   Bond lengths [Å] and angles [°] for R173MP: 
_____________________________________________________________________ 
C(1)-O(1) 1.427(2) C(15)-C(16) 1.389(2) 
C(2)-C(7) 1.380(2) C(15)-C(20) 1.394(2) 
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C(2)-O(1) 1.382(2) C(16)-C(17) 1.384(2) 
C(2)-C(3) 1.391(2) C(17)-C(18) 1.384(2) 
C(3)-C(4) 1.382(2) C(18)-C(19) 1.378(3) 
C(4)-C(5) 1.395(2) C(18)-Cl(1) 1.7480(17) 
C(5)-C(6) 1.393(2) C(19)-C(20) 1.391(2) 
C(5)-N(2) 1.410(2) N(1)-O(3) 1.2162(19) 
C(6)-C(7) 1.387(2) N(1)-O(2) 1.2217(18) 
C(8)-C(9) 1.329(2) C(7)-C(2)-O(1) 124.80(16) 
C(8)-N(2) 1.387(2) C(7)-C(2)-C(3) 119.28(15) 
C(9)-C(10) 1.499(2) O(1)-C(2)-C(3) 115.90(14) 
C(10)-C(15) 1.522(2) C(4)-C(3)-C(2) 120.49(15) 
C(10)-C(11) 1.539(2) C(3)-C(4)-C(5) 121.03(16) 
C(11)-N(1) 1.507(2) C(6)-C(5)-C(4) 117.54(15) 
C(11)-C(12) 1.543(2) C(6)-C(5)-N(2) 121.59(14) 
C(12)-N(2) 1.462(2) C(4)-C(5)-N(2) 120.87(15) 
C(12)-C(13) 1.536(2) C(7)-C(6)-C(5) 121.68(16) 
C(13)-C(14) 1.518(2) C(2)-C(7)-C(6) 119.95(16) 
C(9)-C(8)-N(2) 123.73(16) C(17)-C(16)-C(15) 121.35(16) 
C(8)-C(9)-C(10) 123.33(15) C(16)-C(17)-C(18) 118.79(16) 
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C(9)-C(10)-C(15) 114.32(14) C(19)-C(18)-C(17) 121.53(16) 
C(9)-C(10)-C(11) 111.08(13) C(19)-C(18)-Cl(1) 119.16(13) 
C(15)-C(10)-C(11) 112.59(13) C(17)-C(18)-Cl(1) 119.31(14) 
N(1)-C(11)-C(10) 112.59(13) C(18)-C(19)-C(20) 118.92(16) 
N(1)-C(11)-C(12) 108.36(13) C(19)-C(20)-C(15) 120.88(16) 
C(10)-C(11)-C(12) 111.19(13) O(3)-N(1)-O(2) 123.23(15) 
N(2)-C(12)-C(13) 111.37(14) O(3)-N(1)-C(11) 117.57(14) 
N(2)-C(12)-C(11) 110.37(13) O(2)-N(1)-C(11) 119.19(13) 
C(13)-C(12)-C(11) 109.44(13) C(8)-N(2)-C(5) 121.22(13) 
C(14)-C(13)-C(12) 112.95(14) C(8)-N(2)-C(12) 116.42(13) 
C(16)-C(15)-C(20) 118.49(15) C(5)-N(2)-C(12) 121.22(13) 
C(16)-C(15)-C(10) 121.17(15) C(2)-O(1)-C(1) 117.14(13) 
C(20)-C(15)-C(10) 120.34(15)   
_____________________________________________________________________  
Table 4. Anisotropic displacement parameters (Å2x 103) for R173MP. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ]. 
_____________________________________________________________________ 




C(1) 17(1)  26(1) 25(1)  -4(1) 0(1)  -4(1) 
C(2) 16(1)  17(1) 12(1)  -1(1) 2(1)  -1(1) 
C(3) 20(1)  14(1) 18(1)  -2(1) 8(1)  3(1) 
C(4) 12(1)  17(1) 15(1)  2(1) 5(1)  2(1) 
C(5) 14(1)  14(1) 10(1)  2(1) 3(1)  1(1) 
C(6) 16(1)  17(1) 19(1)  -5(1) 4(1)  3(1) 
C(7) 12(1)  23(1) 20(1)  -2(1) 2(1)  2(1) 
C(8) 13(1)  17(1) 16(1)  1(1) 7(1)  -1(1) 
C(9) 12(1)  20(1) 17(1)  2(1) 6(1)  -1(1) 
C(10) 13(1)  14(1) 15(1)  -1(1) 2(1)  -2(1) 
C(11) 16(1)  15(1) 15(1)  -2(1) 6(1)  1(1) 
C(12) 12(1)  17(1) 14(1)  -3(1) 4(1)  1(1) 
C(13) 21(1)  15(1) 21(1)  -2(1) 3(1)  3(1) 
C(14) 23(1)  19(1) 24(1)  2(1) 5(1)  4(1) 
C(15) 10(1)  19(1) 15(1)  -1(1) 4(1)  -4(1) 
C(16) 14(1)  20(1) 15(1)  -4(1) 4(1)  -3(1) 
C(17) 14(1)  18(1) 24(1)  0(1) 7(1)  -1(1) 
C(18) 10(1)  27(1) 14(1)  4(1) 2(1)  -4(1) 
C(19) 15(1)  26(1) 16(1)  -5(1) 6(1)  -6(1) 
C(20) 15(1)  18(1) 18(1)  -3(1) 7(1)  -2(1) 
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Cl(1) 17(1)  40(1) 17(1)  8(1) 1(1)  -1(1) 
N(1) 14(1)  21(1) 16(1)  1(1) 5(1)  1(1) 
N(2) 12(1)  17(1) 12(1)  -3(1) 3(1)  1(1) 
O(1) 17(1)  21(1) 21(1)  -8(1) 2(1)  -1(1) 
O(2) 31(1)  17(1) 27(1)  0(1) 15(1)  2(1) 
O(3) 78(1) 36(1) 53(1) 8(1) 55(1) 3(1) 
_____________________________________________________________________ 
Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
R173MP: 
_____________________________________________________________________ 
 x  y  z  U(eq) 
_____________________________________________________________________ 
H(1A) 4243 -376 3339 37 
H(1B) 3976 -993 2349 37 
H(1C) 3957 257 2355 37 
H(3) 8277 -273 3552 20 
H(4) 9693 910 4636 18 
H(6) 6516 2603 4675 21 
H(7) 5094 1382 3639 23 
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H(8) 10753 2447 5043 18 
H(9) 12321 2990 6410 19 
H(10) 11199 4088 7308 18 
H(11) 9442 3483 7651 18 
H(12) 7826 2970 6109 17 
H(13A) 8326 4787 6400 24 
H(13B) 9529 4684 6013 24 
H(14A) 7978 4298 4428 34 
H(14B) 7743 5437 4782 34 
H(14C) 6803 4491 4829 34 
H(16) 12743 1588 7728 20 
H(17) 14258 981 9200 22 
H(19) 13506 3557 10572 23 
H(20) 11988 4161 9089 20 
_____________________________________________________________________ 
A.1.10 Relative Stereochemistry of Cycloadduct from -methyl nitroethylene 
A solution of Zn(OTf)2 (10.9 mg, 0.03 mmol, 10 mol %), rac-L14 (14.8 mg, 0.03 mmol, 10 
mol %), and MS 4Å in PhMe (2.5 mL) in a vial was stirred at rt for 15 mins. A solution of methyl 
nitro-ethylene 97 (31.3 mg, 0.356 mmol, 1.2 equiv.) in PhMe (0.25 mL) in a vial was added to the 
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zinc complex. The vial containing nitro-alkene 97 was rinsed with PhMe (0.25 mL) to ensure 
complete transfer of the nitro-alkene 97. (E)-4-phenoxy-N-((E)-3-phenylallylidene)aniline 78 
(91.0 mg, 0.304 mmol, 1 equiv.) was added. The vial was sealed with a cap. The mixture was 
stirred at rt for 12 h. MeOH (2 mL) was added. NaCNBH3 (42 mg, 0.67 mmol, 2.2 equiv.)and ZnCl2 
(82.9 mg, 0.61 mmol, 2 equiv.) were added. The mixture was stirred for 3 h. The reaction was 
quenched with sat. NaHCO3. The aqueous layer was extracted with Et2O twice. The combined 
organic layer was washed with brine, drived over Na2SO4 and filtered. Solvent was removed 
under vacco. The crude 3-nitropiperidine was dissolved in MeOH (7.2 mL). At 0 oC, NiCl2 
hexahydrate (180.6 mg, 0.760 mmol, 2.5 equiv.) was added. NaBH4 (189.8 mg, 5.02 mmol, 16.5 
equiv.) was added slowly. The mixture was stirred at 0 oC for 1.5 h and then at rt overnight. H2O 
was added. 10% HCl was added. 15% NaOH was added. The aqueous layer was extracted with 
EtOAc five times. The combined organic layer was dried over Na2SO4 and filtered. Solvent was 
removed under vacco. Flash column chromatography (1:15:85 NEt3:EtOAc:hex to 1:60:40 
NEt3:EtOAc:hex) afforded (3R,4S)-3-methyl-3-nitro-1-(4-phenoxyphenyl)-4- phenylpiperidine 
(43.7 mg, 37% over 3 steps) as a brown oil. 
 
1H NMR (CDCl3, 400 MHz): 7.35-7.23 (m, 7H), 7.05-6.95 (m, 7H), 3.64 (dt, J= 11.4, 2.0, HF), 
3.42 (dd, J= 11.3, 1.6, HA), 2.73 (td, J= 12.0, 2.8, HG), 2.71 (d, J= 11.8, HB), 2.60 (dd, J= 12.9, 3.5, 
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HC), 2.30 (qd, J= 12.8, 1.0, HE), 1.76 (dq, J= 13.6, 3.0, HD), 1.52 (br, 2H), 0.92 (s, CH3); 13C NMR 
(CDCl3, 400 MHz): 158.5, 150.1, 148.8, 141.3, 129.6, 129.1, 128.0, 126.7, 122.4, 120.4, 119.0, 
117.7, 65.8, 51.4, 51.1, 50.8, 27.8, 26.9; Molecular Weight [MH]: 359.2 (expected), 359.3 
(found); IR (cm-1): 3377, 3083, 3058, 3038, 2960, 2924, 2869, 2802, 1588, 1504, 1487, 1460, 1451. 
The relative stereochemistry was determined by 2D-NOESY NMR.  
JC-1899-product_PROTON_01

























































A.1.11 Absolute Stereochemistry of Cycloadducts 
 
A solution of Zn(OTf)2 (32.7 mg, 0.09 mmol, 30 mol %), and L29 (46.4 mg, 0.09 mmol, 30 mol %) 
in PhMe (0.5 mL) in a vial was stirred at rt for 15 mins. A solution of the nitro-alkene 59 (151.7 
mg, 1.50 mmol, 5 equiv.) in PhMe (0.5 mL) in a vial was added to the zinc complex. The vial 
containing nitro-alkene 59 was rinsed with 0.5 mL and then 0.2 mL PhMe to ensure complete 
transfer of the nitro-alkene 59. 1-azadiene 103 (73.7 mg, 0.293 mmol, 1 equiv.) was added. After 
stirring at rt for overnight, the mixture was filtered through florisil. The yield was determined to 
be 82% by 1H NMR of the crude mixture using 1,3,5-trimethoxybenzene as an internal standard. 
Pure [4+2] cycloadduct was obtained by flash chromatography (florisil as stationary phase). Its 
spectral properties are identical to those previously reported. Its optical rotation ([] = 198.6o, 
CHCl3, c=1.04) is consistent with that of reported for the absolute structure drawn above19 ([]= 
381.7o, CHCl3, c=1.0, 99% ee). The absolute stereochemistry is also consistent from that 
obtained from previously reported asymmetric Michael addition of other nucleophiles to nitro-




A.1.12 NMR Spectra 
JC-1662e_PROTON_01
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APPENDIX 2: CHAPTER 3 EXPERIMENTAL 
A.2.1 General Procedure 
All reactions were carried out under an atmosphere of argon in over-dried glassware. For 
substrate synthesis, dichloromethane, diethyl ether and toluene were degassed with argon and 
passed through a column of neutral alumina and a column of Q5 reactant while all other solvents 
were freshly distilled. Non-distilled solvents were used in the photoredox catalyzed reactions. 
Unless otherwise stated, flash column chromatography was performed on Silicycle Inc. silica gel 
60 (230-400 mesh). Thin layer chromatography was performed on Silicycle Inc. 0.25 mm silica gel 
60-F plates. Visualization was accomplished with UV light  , See a h’s Magi  or 
potassium permanganate. 1H NMR and 13C NMR spectra were obtained in CDCl3 at ambient 
temperature and chemical shifts are expressed in parts per illio  δ, pp . Mass spe tra ere 
obtained on an Agilent Technologies 6130 Quadropole Mass Spec (LRMS, ESI + APCI). Infrared 
spectra were collected on a Nicolet iS-50 FT-IR spectrometer. All alkenes are commercially 
available and were distilled prior to use although control experiments show that non-distilled 
alkenes give the same results in the photoredox catalyzed reactions. [Ir(dF-CF3ppy)2dtbbpy]PF6 
were purchased from Aspira Scientific, Inc. (Milpitas, CA) or Strem Chemicals, Inc. (Newburyport, 
MA). A Kessil blue LED (34W maximum, 24 VDC) was used as the light source for the photoredox 





A.2.2 Synthesis of Substrate 
General Procedure A: Synthesis of Amides from Carboxylic Acids 
To a solution of the carboxylic acid (1 equiv.) in DCM (0.3 M) was added oxalyl chloride 
(1.1 equiv.) dropwise. DMF (3 drops) was added. The mixture was stirred at rt until no more gas 
bubbles were observed (within 3-4h). The solvent was removed under reduced pressure. The 
crude acid chloride was dissolved in THF (2 mL per mmol of acid chloride). This mixture was added 
to commercial aq. NH3 (14.8M, 2 mL per mmol of acid chloride) dropwise at 0 oC. The mixture 
was allowed to warm to rt and stir overnight. The mixture was diluted with EtOAc. The organic 
and aqueous layers were separated. The aqueous layer was extracted with EtOAc twice. The 
combined organic layer was washed with brine, dried over Na2SO4 and filtered. The solvent was 
removed under reduced pressure to afford the crude amide, which was used without further 
purification. 
General Procedure B: Synthesis of Amines from Amides 
To a solution of the crude amide (1 equiv.) in THF (0.3 M) was added LAH (1.9 equiv.) in 
portions at 0 oC. The mixture was allowed to warm to rt and stir overnight. The mixture was 
cooled to 0 oC. Water (1 mL per 1 g LAH) was added slowly. 15% NaOH (1 mL per 1 g LAH) was 
added slowly. Water (3 mL per 1 g) was added. The mixture was allowed to rt and stirred for 15 
mins. The mixture was filtered. The solvent in the filtrate was removed under reduced pressure 




General Procedure C: Trifluoroacetylation of Amines 
To a solution of the amine (1 equiv.) and NEt3 (2 equiv.) in DCM (0.25 M) was added 
trifluoroacetic anhydride (1.02 equiv. or 0.95 equiv. if the amine was not purified in the previous 
step) at 0 oC. The mixture was slowly allowed to warm to rt and stir overnight. The reaction was 
quenched with sat. NH4Cl. The aqueous layer was extracted with DCM two time. The combined 
organic layer was washed with sat. NaHCO3, brine, dried over Na2SO4 and filtered. The solvent 
was removed under reduced pressure. Flash column chromatography afforded the 
trifluoroacetamide. 
 
To a solution of acetone (3.20 mL, 43.6 mmol, 1.05 equiv.) in Et2O (30 mL) was added 
Grignard reagent in Et2O (30 mL) freshly prepared from 1-bromo-3-methylbutane(5.0 mL, 41.7 
mmol, 1.00 equiv.) and Mg (1.0653 g, 43.8 mmol, 1.05 equiv.) at 0 oC. The reaction was allowed 
to warm to rt and stirred overnight. The reaction was quenched with sat. NH4Cl solution. The 
organic and aqueous layer was separated. The organic layer was extracted with Et2O twice. The 
combined organic layer was washed with brine, dried over Na2SO4 and filtered. The solvent was 
removed under reduced pressure to afford 2,5-dimethylhexan-2-ol (3.48 g, 72%). The product 
was used without further purification.  
2,5-dimethylhexan-2-ol (3.44 g, 29.6 mmol, 1 equiv.) and chloroacetonitrile (9.62 mL, 
177.6 mmol, 6 equiv.) were dissolved in AcOH (11.3 mL). At 0 oC, concentrated sulfuric acid (12.9 
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mL, 266.4 mmol, 9 equiv.) was added dropwise. The mixture was stirred at rt for 5 h. The mixture 
was poured into ice-water. The mixture was extracted with DCM three times. The combined 
organic layer was washed with sat. Na2CO3 twice and brine, dried over Na2SO4 and filtered. The 
solvent was removed under vacuum. Flash column chromatography (15-20% EtOAc/hexane) 
afforded 2-chloro-N-(2,5-dimethylhexan-2-yl)acetamide as a colorless oil (3.97 g, 73%). A 
solution of 2-chloro-N-(2,5-dimethylhexan-2-yl)acetamide (3.96 g, 19.2 mmol, 1 equiv.), thiourea 
(1.76 g, 23.1 mmol, 1.20 equiv.) in EtOH/AcOH (39 mL/ 8 mL) was refluxed overnight. The mixture 
was cooled to rt. Solid NaOH was added until pH is larger than 5. The mixture was extracted with 
DCM three times. The combined organic layer was extracted with 2M HCl three times. The 
aqueous layer was basified with NaOH solid and extracted with DCM three times. The combined 
organic layer was dried over Na2SO4 and filtered. The solvent was removed under vacuum to 
afford crude 2,4-dimethylpentan-2-amine (2.51 g, 100%). It was used without further purification.   
 
To a solution of 2,4-dimethylpentan-2-amine (1.00 g, 7.74 mmol, 1.0 equiv.) and NEt3 
(1.13 mL, 8.11 mmol, 1.05 equiv.) in DCM (15.5 mL) was added Tf2O (1.30 mL, 7.74 mmol, 1.0 
equiv.) dropwise at –78 oC. The mixture was stirred at this temperature for 3 h before quenching 
with sat. NH4Cl. The organic layer was washed with sat. NaHCO3 and brine, dried over Na2SO4 and 
filtered. Flash column chromatography (3-10% EtOAc/hexane) afforded N-(2,5-dimethylhexan-2-
yl)-1,1,1-trifluoromethane-sulfonamide 38 (1.36 g, 67% as a colorless oil). The spectral data is 




By General Procedure C, N-(2,5-dimethylhexan-2-yl)-2,2,2-trifluoroacetamide 59 (361.9 
mg, 69%) was synthesized from 2,4-dimethylpentan-2-amine (303.0 mg). 
1H NMR (CDCl3, 400 MHz): 6.03 (br, 1H), 1.72-1.68 (m, 2H), 1.49 (septet, J= 6.7, 1H), 1.15-
1.09 (m, 2H), 0.88-0.86 (d, J= 6.7, 6H); 13C NMR (CDCl3, 100 MHz): 156.0 (q, J= 35.9), 115.6 (q, J= 
289.4), 55.3, 37.6, 32.8, 28.3, 26.2, 22.5; 19F NMR (CDCl3, 376 MHz): 76.3; Molecular weight 
[MH]: 224.1 (expected), 224.1 (found); IR (cm-1): 3440, 3314 (br), 3091, 2957, 2934, 2873, 1704, 
1652. 
 
By General Procedure A, 4-methylpentan-1-amine (7.00 g, 90%) was synthesized from 4-
methylpentanamide (7.50 g). By General Procedure B, 4-methylpentan-1-amine (4.85 g, 79%) 
was synthesized from 4-methylpentanamide (7.00 g). By General Procedure C, 2,2,2-trifluoro-N-
(4-methylpentyl)acetamide (2.10 g, 45%) was synthesized from 4-methylpentan-1-amine 61 
(2.40 g). Flash column chromatography conditions: 10-15% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.77 (br, 1H), 3.31 (q, J= 6.9, 2H), 1.60-1.52 (m, 3H), 1.22-1.16 
(m, 2H), 0.87 (d, J= 6.3, 6H); 13C NMR (CDCl3, 100 MHz): 157.3 (q, J= 36.9), 115.9 (q, J= 287.6), 40.2, 
35.7, 27.6, 26.7, 22.3; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular weight [MH]: 196.1 




By General Procedure A, 4-ethyloctanamide (1.90 g, 96%) was synthesized from 4-
ethyloctanoic acid (2.00 g). By General Procedure B, 4-ethyloctan-1-amine (1.36 g, 92%) was 
synthesized from 4-ethyloctanamide (1.61 g). By General Procedure C, N-(4-ethyloctyl)-2,2,2-
trifluoroacetamide (0.946 g, 74%) was synthesized from 4-ethyloctan-1-amine (0.795 g). Flash 
column chromatography conditions: 7.5-12.5% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.71 (br, 1H), 3.32 (q, J= 6.8, 2H), 1.56-1.54 (m, 2H), 1.27-1.21 
(m, 11H), 0.87 (t, J= 6.9, 3H), 0.82 (t, J= 7.2, 3H); 13C NMR (CDCl3, 100 MHz): 157.3 (q, J= 36.6), 
115.9 (q, J= 287.9), 40.4, 38.4, 32.6, 30.0, 28.8, 26.1, 25.7, 23.0, 14.0, 10.7; 19F NMR (CDCl3, 376 
MHz): 76.1; Molecular weight [MH]: 252.2 (expected), 252.2 (found); IR (cm-1):3309 (br), 3105, 
2959, 2929, 2873, 2860, 1702, 1650. 
 
By General Procedure A, 3-cyclopentylpropanamide (2.28 g, 97%) was synthesized from 
3-cyclopentylpropanoic acid (2.37 g). By General Procedure B, 3-cyclopentylpropan-1-amine 
(1.52 g, 74%) was synthesized from 3-cyclopentylpropanamide (2.28 g). By General Procedure C, 
N-(3-cyclopentylpropyl)-2,2,2-trifluoroacetamide (380 mg, 43%) was synthesized from 3-




1H NMR (CDCl3, 400 MHz): 6.83 (br, 1H), 3.32 (q, J= 6.9, 2H), 1.77-1.69 (m, 3H), 1.61-1.46 
(m, 6H), 1.34-1.28 (m, 2H), 1.07-1.02 (m, 2H); 13C NMR (CDCl3, 100 MHz): 157.3 (q, J= 36.9), 115.9, 
(q, J= 287.6), 40.2, 39.6, 33.0, 32.5, 28.1, 25.1; 19F NMR (CDCl3, 376 MHz): 76.1; ; Molecular 
weight [MH]: 222.1 (expected), 222.1 (found); IR (cm-1): 3300 (br), 3105, 2947, 2868, 1701, 
1649. 
 
To a solution of 4-methylhexanoic acid (3.04 g, 23.4 mmol, 1 equiv.) and NEt3 (3.32 mL, 
23.8 mmol, 1.02 equiv.) in THF (230 mL) was added ethyl chloroformate (2.27 mL, 23.8 mmol, 
1.02 equiv.) dropwise at 0 oC. The mixture was stirred at 0 oC for 1 h. aq. NH3 (21.5 mL) was added 
dropwise. The mixture was allowed to warm to rt and stirred overnight. The mixture was 
extracted with EtOAc three times. The combined organic layer was washed with brine, dried over 
Na2SO4 and filtered. Solvent was removed under vacuum to afford 4-methylhexanamide (2.30 g, 
76%) as a white solid. It was used without further purification.  
 
By General Procedure B, 4-methylhexan-1-amine (1.38 g, 76%) was synthesized from 4-
methylhexanamide (2.04 g). By General Procedure C, 2,2,2-trifluoro-N-(4-methylhexyl)acetamide 
(0.576 g, 31%) was synthesized from 4-methylhexan-1-amine (1.03 g). Flash column 
chromatography conditions: 7.5-15% Et2O/hexane. 
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1H NMR (CDCl3, 400 MHz): 6.72 (br, 1H), 3.32 (q, J= 6.8, 2H), 1.62-1.54 (m, 2H), 1.35-1.28 
(m, 3H), 1.17-1.08 (m, 2H), 0.86-0.82 (m, 6H); 13C NMR (CDCl3, 100 MHz): 157.3 (q, J=36.6), 115.9 
(q, J= 287.6), 40.3, 34.0, 33.4, 29.2, 26.4, 18.9, 11.2; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular 
weight [MH]: 210.1 (expected), 210.1 (found); IR (cm-1): 3318 (br), 3109, 2961, 2933, 2876, 
1702.  
 
To a solution of commercially available optically active (S)-4-methylhexan-1-ol (655.3 mg, 
5.64 mmol, 1 equiv.), PPh3 (1.761 g, 6.77 mmol, 1.2 equiv.) and phthalimide (1.317 g, 6.77 mmol, 
1.2 equiv.) in THF (28 mL) was added DEAD (1.05 mL, 6.77 mmol, 1.2 equiv.) at 0 oC dropwise. 
The mixture was warmed to rt and stirred overnight. Solvent was removed under vacuum. The 
mixture was filtered through Si gel (50% Et2O/hex for elution). Flash column chromatography 
afforded (S)-2-(4-methylhexyl)isoindoline-1,3-dione (1.31 g, 95%). 
1H NMR (CDCl3, 400 MHz): 7.81-7.79 (m, 2H), 7.69-7,66 (m, 2H), 3.63 (t, J= 7.5, 2H), 1.72-
1.61 (m, 2H), 1.35-1.28 (m, 3H), 1.14-1.08 (m, 2H), 0.83-0.80 (m, 6H); 13C NMR (CDCl3, 100 MHz): 
168.4, 133.8, 132.2, 123.1, 38.3, 34.0, 33.5, 29.3, 26.2, 19.0, 11.3; Molecular weight [MH]: 




To a solution of (S)-2-(4-methylhexyl)isoindoline-1,3-dione (1.20 g, 4.89 mmol, 1 equiv.) 
in EtOH (58 mL) was added hydrazine monohydrate (0.835 mL, 17.1 mmol, 3.5 equiv.). The 
mixture was refluxed overnight. The mixture was cooled to rt. H2O and 1M NaOH was added to 
dissolve the solid formed. The mixture was extracted with DCM three times. The combined 
organic layer was washed with brine, dried over Na2SO4 and filtered. Solvent was removed under 
vacuum to afford a 1: 0.63 mixture of (S)-4-methylhexan-1-amine and EtOH (347.4 mg in total). 
The mixture was dissolved in MeOH (7.2 mL). Ethyl trifluoroacetate (0.190 mL, 1.60 mmol, 1.1 
equiv.) was added at 0 oC. The mixture was allowed to warm to rt and stirred overnight. Solvent 
was removed under vacuum. Flash column chromatography afforded (S)-2,2,2-trifluoro-N-(4-
methylhexyl)acetamide (325.5 mg, 32% over 2 steps). 
1H NMR (CDCl3, 400 MHz): 6.72 (br, 1H), 3.32 (q, J= 6.8, 2H), 1.62-1.54 (m, 2H), 1.35-1.28 
(m, 3H), 1.17-1.08 (m, 2H), 0.86-0.82 (m, 6H); 13C NMR (CDCl3, 100 MHz): 157.3 (q, J=36.6), 115.9 
(q, J= 287.6), 40.3, 34.0, 33.4, 29.2, 26.4, 18.9, 11.2; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular 
weight [MH]: 210.1 (expected), 210.1 (found); IR (cm-1): 3318 (br), 3109, 2961, 2933, 2876, 
1702.  
 
By General Procedure C, 2,2,2-trifluoro-N-(5-methylhexan-2-yl)acetamide (3.14 g, 86%) 




1H NMR (CDCl3, 400 MHz): 6.54 (br, 1H), 4.00-3.90 (m, 1H), 1.54-1.46 (m, 3H), 1.19-1.14 
(m, 5H), 0.86 (d, J= 6.7, 6H); 13C NMR (CDCl3, 100 MHz): 156.6 (q, J= 36.6), 115.9 (q, J= 287.9), 46.8, 
34.9, 34.0, 27.8, 22.3, 20.1; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular Weight [MH]: 210.1 
(expected), 210.1 (found); IR (cm-1): 3233 (br), 257, 2875, 1738, 1714, 1556, 1460, 1436, 1391, 
1363, 1275, 1227, 1185, 1144. 
 
To a solution of the (S)-2-hydroxy-4-methylpentanamide2 (2.54 g, 19.4 mmol, 1 equiv.) in 
THF (129 mL, 0.15 M) was added LAH (2.20 g, 58.0 mmol, 3 equiv.) in portions at 0 oC. The mixture 
was refluxed overnight. The mixture was cooled to 0 oC. Water (2.2 mL) was added slowly. 15% 
NaOH (2.2 mL) was added slowly. Water (6.6 mL) was added. The mixture was allowed to rt and 
stirred for 15 mins. The mixture was filtered. The solvent in the filtrate was removed under 
reduced pressure to afford crude (S)-1-amino-4-methylpentan-2-ol (2.13 g, 94%), which was used 
without further purification. 
To the crude (S)-1-amino-4-methylpentan-2-ol (299.0 mg, 2.55 mmol, 1 equiv.) in DCM 
(10.2 mL, 0.25 M) was added NEt3 (0.375 mL, 2.68 mmol, 1.05 equiv.) and TFAA (0.34 mL, 2.42 
mmol, 0.95 equiv.) at 0 oC. The mixture was stirred for 30 mins and allowed to warm to rt. The 
solvent was removed under reduced pressure. The crude product was filtered through Si gel. 
Flash column chromatography (10-25% EtOAc/hexane) afforded (S)-2,2,2-trifluoro-N-(2-hydroxy-
4-methylpentyl)acetamide (310.0 mg, 57%) as a white solid. 
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1H NMR (CDCl3, 400 MHz): 7.36 (br, 1H), 3.84-3.78 (m, 1H), 3.50 (ddd, J= 13.7, 6.3, 2.7, 
1H), 3.15-3.09 (m, 1H), 2.98 (br, 1H), 1.71 (septet, J= 6.7, 1H), 1.42-1.35 (m, 1H), 1.25-1.18 (m, 
1H), 0.90 (d, J= 6.7, 3H), 0.88 (d, J= 6.7, 3H); 13C NMR (CDCl3, 100 MHz): 157.5 (q, J= 37.1), 115.5 
(q, J= 287.4), 67.9, 45.6, 43.4, 24.0, 22.7, 21.5; 19F NMR (CDCl3, 376 MHz): 76.4; Molecular 
weight [MH]: 212.1 (expected), 212.1 (found); IR (cm-1): 3420, 3311 (br), 3104, 2959, 2937, 
2874, 1703.  
To (S)-2,2,2-trifluoro-N-(2-hydroxy-4-methylpentyl)acetamide (200.5 mg, 0.94 mmol, 1 
equiv.) in DCM (19 mL, 0.05 M) was added lutidine (0.326 mL, 2.82 mmol, 3 equiv.) At 0 oC, TBSOTf 
(0.431 mL, 0.188 mmol, 2 equiv.) was added. The mixture was slowly warmed to rt. The mixture 
was stirred at rt for 3.5 h. The reaction was quenched with sat. NH4Cl. The organic and aqueous 
layers were separated. The aqueous layer was extracted with DCM twice. The combined organic 
layer was washed with sat. NaHCO3 and brine, dried over Na2SO4 and filtered. The solvent was 
removed under reduced pressure. Flash column chromatography (5% EtOAc/hex) afforded (S)-
N-(2-((tert-butyldimethylsilyl)oxy)-4-methylpentyl)-2,2,2-trifluoroacetamide (285.9 mg, 93%). 
1H NMR (CDCl3, 400 MHz): 6.58 (br, 1H), 3.93-3.93 (m, 1H), 3.51-3.46 (m, 1H), 3.28-3.22(m, 
1H), 1.68-1.55 (m, 1H), 1.42-1.25 (m, 2H), 0.87-0.89 (m, 15H), 0.08 (s, 6H); 13C NMR (CDCl3, 100 
MHz): 157.1 (q, J= 36.4), 115.9 (q, J= 288.1), 68.6, 45.0, 44.4, 25.7, 24.3, 23.0, 22.6, 17.9, 4.5, 
4.8; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular weight [MH]: 326.2 (expected), 326.2 




Anhydrous N2H4 (100 µL, 3.29 mmol, 2.0 equiv.) was added to a solution of tert-butyl (1-
(1,3-dioxoisoindolin-2-yl)-4-methylpentan-2-yl)carbamate3 (570 mg, 1.65 mmol, 1.0 equiv.) in 
anhydrous EtOH (17 mL) and anhydrous CH2Cl2 (3 mL). The reaction mixture was heated at 60 °C 
for 12 h. The reaction mixture was cooled to room temperature and filtered. The solid was 
washed with Et2O. The filtrate was concentrated under reduced pressure. The crude amine was 
used in the subsequent step without further purification. 
TFAA (0.26 mL, 1.82 mmol, 1.1 equiv.) was added dropwise to a solution of crude and 
Et3N (0.46 mL, 3.30 mmol, 2.0 equiv.) in anhydrous CH2Cl2 (5.5 mL) at 0 °C. The reaction mixture 
was raised to room temperature. The reaction mixture was stirred at this temperature for 5 h 
and then diluted with H2O (5 mL). The phases were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic phase was washed with H2O (10 mL) and 
brine (10 mL), dried (Na2SO4), filtered and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography (55-65% Et2O/hexane) to give tert-butyl 
(4-methyl-1-(2,2,2-trifluoroacetamido)pentan-2-yl)carbamate as a white solid (369 mg, 72%). 
1H NMR (400 MHz, CDCl3): 8.01 (br, 1H), 7.36 (br, 0.5H, rotamer), 5.30 (br, 0.5H, rotamer), 
4.75 (d, J= 7.4, 1H), 3.85-3.82 (m, 1H),  3.37-3.23 (m, 2H), 1.67 (septet, J= 6.7, 1H), 1.43-1.23 (m, 
11H), 0.90-0.87 (m, 6H); 13C NMR (100 MHz, CDCl3): 157.7 (q, J= 37.1), 157.2, 115.9 (q, J= 287.7), 
80.2, 48.2, 46.5, 41.4, 28.1, 24.7, 22.8, 21.8; Molecular weight [MNa]: 335.1558 (expected), 




To a solution of 2-(4-hydroxypentyl)isoindoline-1,3-dione4 (450.0 mg, 1.93 mmol, 1 equiv.) 
and lutidine (0.70 mL, 6.01, 3.1 equiv.) in DCM (9.5 mL) was added TBSOTf (0.56 mL, 2.44 mmol, 
1.26 equiv.) at 0 oC. The mixture was stirred at rt for 3h. The reaction was quenched with 1 M 
HCl. The organic and aqueous layer were separated. The organic layer was washed with brine, 
dried over Na2SO4 and filtered. The solvent was removed under vacuum. Flash column 
chromatography (10-30% Et2O/hexane) afforded 2-(4-((tert-butyldimethylsilyl)oxy)pentyl)-
isoindoline-1,3-dione (605 mg, 100%). 
1H NMR (CDCl3, 400 MHz): 7.82-7.80 (m, 2H), 7.68-7.66 (m, 2H), 3.79 (sextet, J=6.0, 1H), 
3.65 (t, J= 7.3, 2H), 1.80-1.71 (m, 2H), 1.46-1.38 (m, 2H), 1.08 (d, J=5.9, 3H), 0.83 (s, 9H), 0.00 (6H); 
13C NMR (CDCl3, 100 MHz): 168.4, 133.8, 132.2, 123.1, 67.8, 38.1, 36.7, 25.9, 24.8, 23.8, 18.1, 
4.41, 4.76; Molecular weight [MH]: 348.2 (expected), 348.2 (found); IR (cm-1): 3044, 2954, 
2929, 2884, 2856, 1775, 1712. 
 
To a solution of 2-(4-((tert-butyldimethylsilyl)oxy)pentyl)isoindoline-1,3-dione (589.2 mg, 
1.88 mmol., 1 equiv.) in EtOH (23 mL) was added hydrazine monohydrate (0.32 mL, 6.58 mmol, 
3.5 equiv.). The mixture was refluxed overnight. The mixture was cooled to rt. Water and 1 M 
NaOH were added. The mixture was extracted with DCM three times. The combined organic layer 
was washed with brine, dried over Na2SO4 and filtered. The solvent was removed under vacuum 
to afford crude 4-((tert-butyldimethylsilyl)oxy)pentan-1-amine (343.4 mg, 84%). 
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To a solution of the crude 4-((tert-butyldimethylsilyl)oxy)pentan-1-amine (300.8 mg, 1.38 
mmol, 1 equiv.), NEt3 (0.196 mL, 1.41 mmol, 1.02 equiv.) in DCM (7 mL) was added TFAA (0.182 
mL, 1.31 mmol, 0.95 equiv.) at 0 oC dropwise. The mixture was allowed to warm to rt. The mixture 
was stirred for 3 h. Solvent was removed under vacuum. The mixture was filtered through Si gel. 
Flash column chromatography (12-22% Et2O/hexane) afforded N-(4-((tert-butyldimethylsilyl)-
oxy)pentyl)-2,2,2-trifluoroacetamide (396.5 mg, 92%). 
1H NMR (CDCl3, 400 MHz): 6.94 (br, 1H), 3.89-3.82 (m, 1H), 3.46-3.38 (m, 1H), 3.31-3.25 
(m, 1H), 1.72-1.54 (m, 2H), 1.48-1.43 (m, 2H), 1.12 (d, J=6.3, 3H), 0.86 (s, 9H), 0.04 (s, 3H), 0.03 
(s, 3H); 13C NMR (CDCl3, 100 MHz): 157.2 (q, J= 36.6), 115.9 (q, J= 287.6), 67.9, 39.9, 36.3, 25.8, 
24.7, 23.3, 18.0, 4.564.90; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 312.2 
(expected), 312.2 (found); IR (cm-1): 3313 (br), 2957, 2931, 2860, 1708, 1558, 1463, 1433, 1371, 
1255, 1229, 1184, 1148, 1066, 1005. 
 
To a solution of 2-isopropoxyethan-1-aminium chloride (2.50 g, 17.9 mmol, 1.0 equiv.) in 
MeOH (90 mL) was added NEt3 (2.75 mL, 19.7 mmol, 1.1 equiv.) and then ethyl trifluoroacetate 
(2.35 mL, 19.7 mmol, 1.1 equiv.). The mixture was stirred at rt overnight. Solvent was removed 
under reduced pressure. The crude product was filtered through Si gel. Flash column 
chromatography (25-35% Et2O/hexane) afforded 2,2,2-trifluoro-N-(2-isopropoxyethyl)acetamide 
(2.90 g, 81%) as a colorless oil. 
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1H NMR (CDCl3, 400 MHz): 6.94 (br, 1H), 3.55 (septet, J= 6.1, 1H), 3.51-3.44 (m, 4H), 1.10 
(d, J= 6.3, 6H); 13C NMR (CDCl3, 100 MHz): 157.2 (q, J= 37.1), 115.8 (q, J= 287.6), 72.0, 65.2, 39.9, 
21.8; 19F NMR (CDCl3, 376 MHz): 76.3; Molecular weight [MH]: 198.1 (expected), 198.1 
(found); IR (cm-1): 3317 (br), 3103, 2976, 2937, 2874, 1706, 1553, 1455, 1382, 1371, 1337, 1209, 
1151, 1094.  
 
To a solution of 2-methylhexan-2-ol (3.00 g, 25.8 mmol, 1 equiv.) and chloroacetonitrile 
(9.8 mL, 0.155 mmol, 6.0 equiv.) in AcOH (11.5 mL) was added conc. H2SO4 (13.15 mL, 232.2 mmol, 
9 equiv.) at 0 oC dropwise. The mixture was allowed to warm to rt and stir for 5 h. The mixture 
was poured into ice/water mixture. The mixture was extracted with DCM three times. The 
combined organic layer was washed with sat. Na2CO3 twice and brine, dried over Na2SO4 and 
filtered. Solvent was removed under vacuum. Flash column chromatography (20% EtOAc/hexane) 
afforded 2-chloro-N-(2-methylhexan-2-yl)acetamide (3,81 g, 77%).  
1H NMR (CDCl3, 400 MHz): 6.27 (br, 1H), 3.89 (s, 2H), 1.66-1.62 (m, 2H), 1.30 (s, 6H), 1.27-
1.17 (m, 4H), 0.86 (t, J= 7.0, 3H); 13C NMR (CDCl3, 100 MHz): 164.7, 54.2, 32.9, 40.0, 26.5, 26.1, 
22.9, 14.0; Molecular weight [MH]: 190.1 (expected), 190.1 (found); IR (cm-1): 3413, 3296, 3084, 




A solution of 2-chloro-N-(2-methylhexan-2-yl)acetamide (3.50 g, 18.3 mmol) and thiourea 
(1.67 g, 21.9 mmol, 1.2 equiv.) in EtOH/AcOH (44 mL, 4.9:1) was refluxed overnight. The mixture 
was diluted with water. Solid NaOH was added until pH of the solution is less than 5. The mixture 
was extracted with DCM three times. The combined organic layer was extracted with 2M HCl 
twice. The combined acidic layer was basified with solid NaOH until pH is higher than 10 and was 
extracted with DCM three times. The combined organic layer was dried over Na2SO4 and filtered. 
Solvent was removed under vacuum to afford 2-methylhexan-2-amine (705 mg, 34%). It was used 
without further purification. 
 
By General Procedure C: 2,2,2-trifluoro-N-(2-methylhexan-2-yl)acetamide (218.7 mg, 48%) 
was synthesized from 2-methylhexan-2-amine (248.0 mg). 
1H NMR (CDCl3, 400 MHz): 6.05 (br, 1H), 1.72-1.68 (m, 2H), 1.35 (s, 6H), 1.31-1.22 (m, 4H), 
0.89 (t, J= 7.2); 13C NMR (CDCl3, 100 MHz): 156.0 (q, J=35.8), 115.6 (q, J= 289.3.), 53.5, 39.6, 26.2, 
26.0, 22.8, 13.4 ; 19F NMR (CDCl3, 376 MHz): 76.3; Molecular weight [MH]: 210.1 (expected), 
210.1 (found); IR (cm-1): 3441, 3320, 3095, 2959, 2932, 2865, 1704. 
 
To a solution of LAH (0.226 g, 5.96 mmol, 1 equiv.) in Et2O (6 mL) was added anhydrous 
AlCl3 (0.793 g, 5.95 mmol, 1 equiv.) at 0 oC in portions. The mixture was stirred at 10 mins at 0 oC. 
Homogernanonitrile5 (0.9711 g, 5.95 mmol, 1 equiv.) in Et2O (1 mL) was added via cannula. The 
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mixture was stirred at 0 oC for 1 h and was warmed to rt. The mixture was stirred overnight. The 
reaction was quenched by 1M NaOH. The mixture was extracted with EtOAc three times. The 
combined organic layer was washed with brine, dried over Na2SO4 and filtered. The solvent was 
removed under vacuum. Crude (E)-4,8-dimethylnona-3,7-dien-1-amine (0.900 g, 90%) was used 
without further purification. 
 
To a solution of (E)-4,8-dimethylnona-3,7-dien-1-amine (0.755 g, 4.51 mmol, 1 equiv.) and 
NEt3 (0.642 mL, 4.61 mmol, 1.02 equiv.) in DCM (18 mL) was added TFAA (0.595 mL, 4.28 mmol, 
0.95 equiv.) dropwise at 0 oC. The mixture was slowly warmed to rt and stirred overnight. The 
solvent was removed under vacuum. The mixture was filtered through silica gel. Flash column 
chromatography (4-12% Et2O/hex) afforded (E)-N-(4,8-dimethylnona-3,7-dien-1-yl)-2,2,2-
trifluoroacetamide  (0.87 g, 73%). To a solution of (E)-N-(4,8-dimethylnona-3,7-dien-1-yl)-2,2,2-
trifluoroacetamide (509.4 mg, 1.935 mmol, 1 equiv.) in EtOH (17 mL) was added 10% Pd/C (600 
mg). The mixture was stirred under a H2 atmosphere (H2 balloon) overnight. The mixture was 
filtered through celite. Flash column chromatography (10-15% Et2O/hex) afforded N-(4,8-
dimethylnonyl)-2,2,2-trifluoroacetamide 84 (473.3 mg, 92%). 
1H NMR (CDCl3, 400 MHz): 6.62 (br, 1H), 3.32 (q, J= 6.9, 2H), 1.66-1.47 (m, 3H), 1.39-1.06 
(m, 9H), 0.86-0.84 (m, 9H); 13C NMR (CDCl3, 100 MHz): 157.2 (q, J= 36.9), 115.9 (q, J= 287.9), 40.3, 
39.2, 37.0, 33.8, 32.4, 27.9, 26.5, 24.7, 22.6, 22.5, 19.4; 19F NMR (CDCl3, 376 MHz): 76.1; 
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Molecular weight [MH]: 266.2 (expected), 266.2 (found); IR (cm-1): 3306 (br), 3107, 2954, 2927, 
2870, 1701.  
 
BH3 (1.0 M in THF, 8.6 mL, 8.61 mmol, 1.0 equiv.) was added dropwise to a solution of 
tert-butyldimethyl((2-methylpent-4-en-1-yl)oxy)silane6 (1845 mg, 8.61 mmol, 1.0 equiv.) in 
anhydrous THF (22 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. A premixed 
solution of NaOH (2.0 M, 20 mL) and H2O2 (30%, 10 mL) was added dropwise to the reaction 
mixture at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. The reaction was diluted with 
H2O (20 mL) and Et2O (10 mL). The phases were separated and the aqueous layer was extracted 
with Et2O (3 x 20mL). The combined organic layer was washed with H2O (20 mL) and brine (20 
mL), dried (MgSO4), filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (20-30% EtOAc/hexane) to give 5-((tert-
butyldimethylsilyl)oxy)-4-methylpentan-1-ol as a colorless oil (1067 mg, 53%). The Spectral data 
are in accordance with the published values.7 
 
DEAD (0.83 mL, 5.29 mmol, 1.2 equiv.) was added dropwise to a solution of 5-((tert-
butyldimethylsilyl)oxy)-4-methylpentan-1-ol (1024 mg, 4.41 mmol, 1.0 equiv.), phthalimide (778 
mg, 5.29 mmol, 1.2 equiv.) and Ph3P (1472 mg, 5.29 mmol, 1.2 equiv.) in anhydrous THF (22 mL) 
at 0 °C. The reaction mixture was allowed to warm to room temperature and was stirred for 12 
h. The reaction solvent was removed under reduced pressure. The crude reaction mixture was 
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suspended in hexane, filtered and concentrated. The crude product was purified by flash column 
chromatography (3-6% EtOAc/hexane) to give 2-(5-((tert-butyldimethylsilyl)oxy)-4-
methylpentyl)isoindoline-1,3-dione as a colorless oil (1504 mg, 94%). 
1H NMR (400 MHz, CDCl3): 7.86 - 7.78 (m, 2H), 7.73 - 7.67 (m, 2H), 3.67 (t, J= 7.3, 2H), 3.41 (dd, 
J= 9.8, 5.8, 1H), 3.36 (dd, J=9.8, 6.2, 1H), 1.79 - 1.54 (m, 3H), 1.17 - 1.06 (m, 1H), 0.86 (d, J= 6.7, 
3H), 0.85 (s, 9H), 0.00 (s, 6H); 13C NMR (100 MHz, CDCl3): 168.4, 133.8, 132.2, 123.1, 68.0, 38.3, 
35.4, 30.2, 26.1, 25.9, 18.3, 16.6, 5.4; Molecular weight [MH]: 362.2152 (expected), 362.2143 
(found); IR (cm-1): 2961, 2930, 2857, 1711, 1427, 1110, 700. 
 
Anhydrous N2H4 (90 µL, 2.76 mmol, 2.0 equiv.) was added to a solution of 2-(5-((tert-
butyldimethylsilyl)oxy)-4-methylpentyl)isoindoline-1,3-dione (500 mg, 1.38 mmol, 1.0 equiv.) in 
anhydrous EtOH (13 mL). The reaction mixture was heated at 60 °C for 2 h. The reaction mixture 
was cooled to room temperature and filtered. The solid was washed with Et2O. The filtrate was 
concentrated under reduced pressure. The crude product was suspended in Et2O and filtered. 
The crude amine was used in the subsequent step without further purification. 
TFAA (0.21 mL, 1.52 mmol, 1.1 equiv.) was added dropwise to a solution of crude amine 
and Et3N (0.38 mL, 2.76 mmol, 2.0 equiv.) in anhydrous CH2Cl2 (4.5 mL) at 0 °C. The reaction 
mixture was allowed to warm to room temperature. The reaction mixture was stirred at this 
temperature for 5 h and then diluted with H2O (5 mL). The phases were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 5 mL). The combined organic phase was washed 
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with H2O (10 mL) and brine (10 mL), dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (10% EtOAc/hexane) 
to give N-(5-((tert-butyldimethylsilyl)oxy)-4-methylpentyl)-2,2,2-trifluoroacetamide 87 as a 
colorless oil (405 mg, 90%). 
1H NMR (400 MHz, CDCl3): 6.66 (br, 1H), 3.42-3.38 (m, 2H), 3.36-3.31 (m, 2H), 1.67-1.53 
(m, 3H), 1.50-1.43 (m, 1H), 1.13-1.09 (m, 1H), 0.87-0.85 (m, 12H), 0.86 (d, J = 6.9, 3H), 0.02 (s, 
6H); 13C NMR (100 MHz, CDCl3): 157.2 (q, J = 36.7), 115.8 (q, J = 287.3), 68.0, 40.3, 35.3, 30.2, 
26.4, 25.9, 18.3, 16.5, 5.5, 5.5; ; Molecular weight [MH] : 328.1920 (expected), 328.1901 
(found); IR (cm-1): 3304, 2955, 2930, 2858, 1701, 1560, 1161, 1093, 834. 
 
iPrMgCl (2.0 M in Et2O, 12.4 mL, 24.7 mmol, 2.0 equiv.) was added dropwise to a solution 
of 4-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylbutanamide8 in anhydrous THF (25 mL) at 
78 °C. The reaction mixture was stirred at 78 °C for 5 min before being warmed to room 
temperature. The reaction mixture was stirred at rt for 4 h before being diluted with NH4Cl (sat. 
aq., 10 mL) and H2O (10 ml). The phases were separated and the aqueous layer was extracted 
with Et2O (3 x 10 ml). The combined organic layer was washed with H2O (20 mL) and brine (20 
mL), dried (MgSO4), filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (5-10% EtOAc/hexane) to give 6-((tert-
butyldiphenylsilyl)oxy)-2-methylhexan-3-one as a colorless oil (2323 mg, 51%). 
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1H NMR (400 MHz, CDCl3): 7.69-7.61 (m, 4H), 7.47-7.34 (m, 6H), 3.68 (t, J= 6.1, 2H), 2.59 
(septet, J= 6.1, 1H), 2.58 (t, J= 7.2, 2H), 1.87-1.78 (m, 2H), 1.09 (d, J= 6H), 1.06 (s, 9H); 13C NMR 
(100 MHz, CDCl3): 214.6, 135.5, 133.8, 129.6, 127.6, 63.0, 40.9, 36.5, 26.9, 19.2, 18.3; Molecular 
weight [MH]: 369.2250(expected), 369.2238 (found); IR (cm-1): 2961, 2930, 2857, 1711, 1428, 
1111, 581. 
 
nBuLi (1.6 M in hexanes, 12.0 mL, 19.2 mmol, 4.0 equiv.) was added dropwise to a solution 
of Ph3MePBr (7186 mg, 20.1 mmol, 4.2 equiv.) in anhydrous THF (40 mL) at 0 °C. The reaction 
mixture was warmed to room temperature and stirred at this temperature for 1 h. 6-((tert-
butyldiphenylsilyl)oxy)-2-methylhexan-3-onein anhydrous THF (8 mL) was added dropwise to the 
reaction mixture. The reaction mixture was heated to 70 °C and stirred at this temperature for 
12 h. The reaction mixture was cooled to room temperature and diluted with H2O (40 mL). The 
phases were separated and the aqueous layer was extracted with Et2O (3 x 20 ml). The combined 
organic layer was washed with H2O (20 mL) and brine (20 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (2% Et2O/hexane) to give tert-butyl((5-methyl-4-methylenehexyl)oxy)diphenyl-
silane as a colorless oil (1764 mg, 100%). 
1H NMR (400 MHz, CDCl3): 7.74-7.64 (m, 4H), 7.47-7.33 (m, 6H), 4.74 (s, 1H), 4.66 (s, 1H),  
3.69 (t, J= 6.4, 2H), 2.22 (septet, J= 6.8, 1H), 2.11 (t, J= 7.8, 2H), 1.77-1.66 (m, 2H), 1.07 (s, 9H), 
1.02 (d, J= 6.0, 6H); 13C NMR (100 MHz, CDCl3): 155.7, 135.6, 134.1, 129.5, 127.6, 106.2, 63.7, 
303 
 
33.8, 31.2, 30.5, 26.9, 21.8, 19.2; Molecular weight [MH]: 367.2457 (expected), 367.2457 
(found); IR (cm-1): 2959, 2931, 2858, 1428, 1107, 690. 
 
Pd/C (10%, 250 mg) was added to a solution of give tert-butyl((5-methyl-4-
methylenehexyl)oxy)diphenylsilane (1620 mg, 4.40 mmol, 1.0 equiv.) in EtOH (22 mL). The 
atmosphere was removed under reduced pressure and replaced with an atmosphere of H2 
(balloon of H2 with needle running into the reaction mixture); this process was repeated three 
times. A balloon of H2 was connected to the reaction flask and the reaction mixture was stirred 
at room temperature for 12 h. The reaction mixture was filtered through a plug of Celite. The 
Celite was washed with Et2O (100 mL) and the filtrate was concentrated under reduced pressure 
to give the crude TBDPS protected alcohol which was used in the following step without 
purification. 
TBAF (1.0 M in THF, 8.8 mL, 8.80 mmol, 2.0 equiv.) was added dropwise to a solution of 
crude TBDPS protected alcohol in anhydrous THF (20 mL) at room temperature. The reaction 
mixture was stirred at this temperature for 3 h before being diluted with NH4Cl (sat. aq., 10 mL) 
and H20 (10 mL). The phases were separated and the aqueous layer was extracted with Et2O (3 x 
10 ml). The combined organic layer was washed with H2O (20 mL) and brine (20 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (20-50% Et2O/hexane) to give 4,5-dimethylhexan-1-ol as a 
colorless oil (559 mg, 98%). 
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1H NMR (400 MHz, CDCl3): 3.62 (t, J= 6.8, 2H), 1.67-1.27 (m, 6H),  1.18-1.07 (m, 1H), 0.86 
(d, J= 6.9, 3H), 0.81 (d, J= 6.8, 3H), 0.80 (d, J= 6.9, 3H); 13C NMR (100 MHz, CDCl3): 63.4, 38.4, 32.0, 
30.8, 30.1, 20.2, 17.9, 15.3; IR (cm-1): 3317, 2956, 2933, 2871, 1462, 1377, 1058. The molecular 
weight cannot be observed with MS (EI).  
 
DEAD (0.81 mL, 5.15 mmol, 1.2 equiv.) was added dropwise to a solution of 4,5-
dimethylhexan-1-ol (559 mg, 4.29 mmol, 1.0 equiv.), phthalimide (758 mg, 5.15 mmol, 1.2 equiv.) 
and Ph3P (1433 mg, 5.15 mmol, 1.2 equiv.) in anhydrous THF (14 mL) at 0 °C. The reaction mixture 
was allowed to warm to room temperature and was stirred at this temperature for 12 h. The 
reaction solvent was removed under reduced pressure. The crude reaction mixture was 
suspended in hexane, filtered and concentrated. The crude product was purified by flash column 
chromatography (2-10% EtOAc/hexane) to give 2-(4,5-dimethylhexyl)isoindoline-1,3-dione as a 
colorless oil (1100 mg, 99%). 
1H NMR (400 MHz, CDCl3): 7.88-7.76 (m, 2H), 7.74-7.65 (m, 2H), 3.65 (t, J= 7.4, 2H), 1.74-
1.51 (m, 3H), 1.40-1.28 (m, 2H), 1.19-1.08 (m, 1H), 0.84 (d, J= 6.8, 3H), 0.79 (d, J= 6.7, 3H), 0.78 
(d, J= 6.7, 3H); 13C NMR (100 MHz, CDCl3): 168.4, 133.8, 132.2, 123.1, 38.4, 38.2, 31.9, 31.2, 26.6, 
20.2, 17.9, 15.2; Molecular weight [MH]: 260.1651 (expected), 260.1630 (found); IR (cm-1): 




Anhydrous N2H4 (0.26 mL, 8.33 mmol, 2.0 equiv.) was added to a solution of 2-(4,5-
dimethylhexyl)isoindoline-1,3-dione (1080 mg, 4.17 mmol, 1.0 equiv.) in anhydrous EtOH (20 
mL). The reaction mixture was heated at 60 °C for 2 h. The reaction mixture was cooled to room 
temperature, filtered. The solid was washed with Et2O. The filtrate was concentrated under 
reduced pressure. The crude amine was used in the subsequent step without further purification. 
TFAA (0.65 mL, 4.59 mmol, 1.1 equiv.) was added dropwise to a solution of crude amine and Et3N 
(1.10 mL, 8.34 mmol, 2.0 equiv.) in anhydrous CH2Cl2 (13 mL) at 0 °C. The reaction mixture was 
raised to room temperature. The reaction mixture was stirred at this temperature for 5 h and 
then diluted with H2O (5 mL). The phases were separated and the aqueous layer was extracted 
with CH2Cl2 (3 x 5 mL). The combined organic phase was washed with H2O (10 mL) and brine (10 
mL), dried (Na2SO4), filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (10-15% Et2O/hexane) to give N-(4,5-dimethylhexyl)-
2,2,2-trifluoroacetamide 89 as a colorless oil (412.5 mg, 44%). 
1H NMR (CDCl3, 400 MHz): 6.93 (br, 1H), 3.31 (q, J= 6.9, 2H), 1.63-1.46 (m, 3H), 1.38-1.23 
(m, 2H), 1.14-1.05 (m, 1H), 0.83 (d, J= 7.0, 3H), 0.79 (d, J= 2.4, 3H), 0.77 (d, J= 2.3, 3H); 13C NMR 
(CDCl3, 100 MHz): 157.3 (q, J= 36.4), 115.9 (q, J= 287.6), 40.3, 38.1, 31.8, 31.0, 26.8, 20.0, 17.8, 
15.1; 19F NMR (CDCl3, 376 MHz): 76.2 ; Molecular weight [MH]: 224.1 (expected), 224.1 




To a solution of ethyl 6-methyl-4-(nitromethyl)heptanoate9 (1.60 g, 7.3 mmol, 1 equiv.) in 
MeOH (38.5 mL) was added NiCl2 hexahydrate (1.7282 g,7.3 mmol, 1 equiv. ) at 0 oC. NaBH4 
(3.0256 g, 80.3 mmol, 11 equiv.) was added in portions and VERY SLOWLY. The mixture was kept 
at 0 oC for 1 h. 6 M NaOH (9 mL) was added. The mixture was warmed to rt and stirred for 2 h. 
The mixture was acidified with 2 M HCl. The mixture was extracted with DCM four times. The 
combined organic layer was dried over Na2SO4 and filtered. The solvent was removed under 
vacuum to afford 4-isobutylpyrrolidin-2-one. The crude lactam was dissolved in 6 M HCl (35 mL). 
The mixture was refluxed overnight. The solvent was removed under vacuum to afford 2-(2-
carboxyethyl)-4-methylpentan-1-aminium chloride. The crude hydrochloride salt was dissolved 
in MeOH (28 mL). NEt3 (2.44 mL, 17.5 mmol, 2.4 equiv.) and ethyl trifluoroacetate (1.06 mL, 10.5 
mmol, 1.44 equiv.) was added. The mixture was stirred at rt overnight. Solvent was removed 
under vacuum. The mixture was dissolved in EtOAc. The mixture was washed with 1 M HCl, dried 
over Na2SO4 and filtered. Solvent was removed under vacuum to afford  6-methyl-4-((2,2,2-
trifluoroacetamido)methyl)heptanoic acid. The crude carboxylic acid was dissolved in DMF (23 
mL). K2CO3 (4.837 g, 35.0 mmol, 4.8 equiv.). MeI (2.18 mL, 35.0 mmol, 4.8 equiv.) was added 
dropwise. The mixture was stirred for 7 h. The mixture was diluted with Et2O, washed with H2O 
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four times and brine twice. It was dried over Na2SO4 and filtered. Solvent was removed under 
vacuum. Flash column chromatography afforded methyl 6-methyl-4-((2,2,2-
trifluoroacetamido)methyl)heptanoate 92 (572.9 mg, 30% over 5 steps) as a slightly yellow oil.  
1H NMR (CDCl3, 400 MHz): 7.38 (br, 1H), 3.62 (s, 3H), 3.42-3.36 (m, 1H), 3.25-3.18 (m, 1H), 
2.37 (dd, J= 15.7, 4.7, 1H), 2.26 (dd, J= 15.7, 7.8, 1H), 1.64-1.56 (m, 1H), 1.20-1.08 (m, 2H), 0.87 
(d, J= 6.6, 3H), 0.85 (d, J= 6.7, 3H); 13C NMR (CDCl3, 100 MHz): 173.9, 157.5 (q, J= 36.6), 115.9 (q, 
J= 287.6), 51.77, 44.0, 41.6, 37.4, 32.5, 25.1, 22.5, 22.3; 19F NMR (CDCl3, 376 MHz): 76.1; 
Molecular weight [MH]: 268.1 (expected), 268.1 (found); IR (cm-1): 3318 (br), 3104, 2957, 2873, 
2851, 1705. 
 
To a solution of TBS-protected lithocholic acid10 (1.20 g, 2.44 mmol, 1 equiv.) in THF (0.1 
M) was added NEt3 (0.347 mL, 2.49 mmol, 1.02 equiv.) at 0 oC. Ethyl chloroformate (0.238 mL, 
2.49 mmol, 1.02 equiv.) was added dropwise. The mixture was stirred at 0 oC for 1 h. aq. NH3 
(2.25 mL, 14.8 M) was added. The mixture was allowed to warm to rt and stir overnight. H2O was 
added. The organic and aqueous layers were separated. The aqueous layer was extracted with 
EtOAc twice. The combined organic layer was washed with brine, dried over Na2SO4 and filtered. 
The Solvent was removed under reduced pressure to yield the amide (1.20 g, 100%) as a white 
solid. It was used without further purification. 
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To a solution of the crude amide (1.20 g, 2.44 mmol, 1 equiv.) in THF (16 mL, 0.15 M) was 
added LAH (0.186 g, 4.88 mmol, 2 equiv.)in portions at 0 oC. The mixture was allowed to warm to 
rt and stir overnight. The mixture was cooled to 0 oC. Water (0.185 mL) was added slowly. 15% 
NaOH (0.185 mL) was added slowly. Water (0.555 mL) was added. The mixture was allowed to rt 
and stirred for 15 mins. The mixture was filtered. The solvent in the filtrate was removed under 
reduced pressure to afford the crude amine (1.14 g, 98%), which was used without further 
purification. 
 
By General Procedure C, trifluoroacetamide 94 (304.4 mg, 50%) was synthesized from the 
crude amine (502.4 mg). Conditions for flash column chromatography: 10-15% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.42 (br, 1H), 3.60-3.54 (m, 1H), 3.35-3.27 (m, 2H), 1.94-0.88 
(m, 43H), 0.62 (s, 3H), 0.05 (s, 6H); 13C NMR (CDCl3, 100 MHz): 157.1 (q, J=36.9), 115.1 (q, J= 288.0.), 
72.8, 56.4, 56.0, 42.7, 42.3, 40.4, 40.2, 40.1, 36.9, 35.8, 35.6, 35.4, 34.6, 32.8, 31.0, 28.2, 27.3, 
26.4, 26.0, 25.6, 24.2, 23.4, 20.8, 18.5, 18.3, 12.0, 4.6; 19F NMR (CDCl3, 376 MHz): 76.0; 
Molecular weight [MH]: 570.4 (expected), 570.4 (found); IR (cm-1): 3299, 3103, 2935, 2916, 





A.2.3 Reaction Discovery 
To a mixture of the amine (0.1 mmol, 1 equiv.), alkene (0.15 mmol, 1.5 equiv.) and K3PO4 
(0.2 mmol, 2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed by DMF 
(1.0 mL). Argon was bubbled through the solution for 5 mins. [Ir(dF-CF3pp)2dtbbp]PF6 (0.9 or 1.8 
mg, 1 or 2 mol %) was added. Argon was bubbled through the solution for another 10 mins. The 
vial was then capped and illuminated with a Blue LED for 16h (The distance between the Blue 
LED and the vial is around 1.5 cm). The mixture was filtered through silica gel. The yield was 





1H NMR (CDCl3, 400 MHz): 5.21 (br, 1H), 3.68 (s, 3H), 2.54-2.46 (m, 1H), 1.90 (dd, J= 14.5, 
9.4), 1.68-1.58 (m, 1H), 1.52-1.46 (m, 1H), 1.40 (s, 3H), 1.37 (s, 3H), 1.25-1.18 (m, 2H), 1.16 (d, J= 
7.1, 3H), 1.11 (dd, J= 14.0, 9.8), 0.86 (s, 3H), 0.85 (s, 3H); 13C NMR (CDCl3, 100 MHz): 178.8, 119.3 
(q, J= 321.2), 60.3, 51.9, 44.5, 37.8, 35.5, 34.9, 32.8, 28.9, 27.5, 27.2, 26.6, 20.4; 19F NMR (CDCl3, 
376 MHz): 77.8; Molecular weight [MH]: 360.2 (expected), 360.1 (found); IR (cm-1): 3232, 
2956, 2876, 1738, 1715, 1460, 1435, 1391, 1362, 1275, 1227, 1185, 1143. 
 
1H NMR (CDCl3, 400 MHz): 6.05 (br, 1H), 3.65 (s, 3H), 2.52-2.45 (m, 1H), 1.85 (dd, J= 14.1, 
9.4, 1H), 1.68-1.64 (m, 2H), 1.37 (s, 3H), 1.36 (s,3H), 1.18-1.10 (m, 6H), 0.83 (s, 3H), 0.82 (s, 3H); 
13C NMR (CDCl3, 100 MHz): ; 178.3, 156.0 (q, J= 35.9), 115.6 (q, J= 289.4), 55.2, 51.6, 45.4, 35.6, 
35.6, 34.1, 32.8, 27.0, 26.7, 26.5, 26.1, 20.4; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular weight 
[MH]: 324.2 (expected), 324.2 (found); IR (cm-1): 3332 (br), 3086, 2955, 2875, 1712. 
 
1H NMR (CDCl3, 400 MHz): 6.49 (br, 1H), 3.63 (s, 3H), 3.34-3.24 (m,2H), 2.50-2.43 (m,1H), 
1.85 (dd, J= 14.4, 9.4), 1.18-1.09 (m, 6H), 0.82 (s, 3H), 0.81 (s, 3H); 13C NMR (CDCl3, 100 MHz):178.3, 
157.2 (q, J= 36.6), 115.9 (q, J= 287.9), 51.7, 45.2, 40.6, 38.8, 35.6, 33.0, 27.1, 26.9, 23.6, 20.4; 19F 
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NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 296.2 (expected), 296.2 (found); IR (cm-
1): 3317 (br), 3099, 2955, 2876, 1706. 
A.2.4 Optimization of Reaction Conditions 
 
To a mixture of the amine (0.1 mmol, 1 equiv.), alkene (0.15 mmol, 1.5 equiv.) and Base 
(0.2 mmol, 2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed by the 
solvent. Argon was bubbled through the solution for 5 mins. [Ir(dF-CF3pp)2dtbbp]PF6 (0.9 mg, 2 
mol %) was added. Argon was bubbled through the solution for another 10 mins. The vial was 
then capped and illuminated with a Blue LED for 16h (The distance between the Blue LED and the 
vial is around 1.5 cm). The mixture was filtered through silica gel. The yield was determined by 
NMR with 1,3,5-trimethoxybenzene as the standard. Yields in brackets refer to isolated yield after 





A.2.5 Alkene and Amide Scopes 
General Procedure D: Photocatalytic C-C Bond Formation  
To a mixture of the amine (0.1 mmol, 1 equiv.), alkene and finely ground K3PO4 (0.2 mmol, 
2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed by the solvent. Argon 
was bubbled through the solution for 5 mins. [Ir(dF-CF3pp)2dtbbp]PF6 (2-5 mol %) was added. 
Argon was bubbled through the solution for another 10 mins. The vial was then capped and 
illuminated with a Blue LED for 16-20 h (The distance between the Blue LED and the vial is around 




By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
methyl 2,4,4-trimethyl-7-(2,2,2-trifluoroacetamido)heptanoate 62 (21.5 mg, 75%) was obtained 
from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (18.9 mg). Flash column chromatography 
conditions: 15-35% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.49 (br, 1H), 3.63 (s, 3H), 3.34-3.24 (m,2H), 2.50-2.43 (m,1H), 
1.85 (dd, J= 14.4, 9.4), 1.18-1.09 (m, 6H), 0.82 (s, 3H), 0.81 (s, 3H); 13C NMR (CDCl3, 100 MHz):178.3, 
157.2 (q, J= 36.6), 115.9 (q, J= 287.9), 51.7, 45.2, 40.6, 38.8, 35.6, 33.0, 27.1, 26.9, 23.6, 20.4; 19F 
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NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 296.2 (expected), 296.2 (found); IR (cm-
1): 3317 (br), 3099, 2955, 2876, 1706. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
ethyl 4,4-dimethyl-7-(2,2,2-trifluoroacetamido)heptanoate 66 (19.9 mg, 68%) was obtained from 
2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.4 mg). Flash column chromatography 
conditions: 5-50% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.34 (br, 1H), 4.12 (q, J= 7.2, 2H), 3.34 (q, J= 6.8, 2H), 2.26-2.22 
(m, 2H), 1.57-1.53 (m,4H), 1.25 (t, J= 7.2, 3H), 1.23-1.19 (m, 2H), 0.87 (s, 6H); 13C NMR (CDCl3, 100 
MHz): 174.2, 157.2 (q, J= 37.4), 115.9 (q, J= 287.7), 60.4, 40.6, 38.5, 36.1, 32.2, 29.5, 26.6, 23.8, 
14.2; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 296.2 (expected), 296.2 
(found); IR (cm-1): 3327 (br), 3104, 2959, 2873, 1706. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
tert-butyl 4,4-dimethyl-7-(2,2,2-trifluoroacetamido)heptanoate 67 (21.4 mg, 67%) was obtained 
from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.3 mg). Flash column chromatography 
conditions: 20-30% Et2O/hexane. 
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1H NMR (CDCl3, 400 MHz): 6.35 (br, 1H), 3.33 (q, J= 6.8, 2H), 2.27-2.13 (m, 2H), 1.58-1.48 
(m,4H), 1.44 (s, 9H), 1.22-1.18 (m, 2H), 0.86 (s, 6H); 13C NMR (CDCl3, 100 MHz): 173.6, 157.1 (q, 
J= 36.6), 115.8 (q, J= 288.0), 80.2, 40.6, 38.6, 36.2, 32.3, 30.7, 28.1, 26.6, 23.8; 19F NMR (CDCl3, 
376 MHz): 76.1; Molecular weight [MH]: 324.2 (expected), 324.2 (found); IR (cm-1): 3319 (br), 
3105, 2960, 2936, 2872, 1727, 1704, 1648, 1557, 1504, 1472, 1457. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
benzyl 4,4-dimethyl-7-(2,2,2-trifluoroacetamido)heptanoate 68 (21.4 mg, 67%) was obtained 
from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.3 mg). Flash column chromatography 
conditions: 20-30% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz):7.39-7.32 (m, 5H), 6.36 (br, 1H), 5.11 (s, 2H), 3.31 (q, J= 6.8, 2H), 
2.32-2.28 (m, 2H), 1.59-1.49 (m, 2H), 1.22-1.19 (m, 2H), 0.86 (s, 6H); 13C NMR (CDCl3, 100 MHz): 
174.0, 157.1 (q, J= 36.6), 135.9, 128.6, 128.3, 128.3, 115.8 (q, J= 287.7), 66.3, 40.6, 28.5, 36.1, 
32.3, 29.5, 26.6, 23.8; 19F NMR (CDCl3, 376 MHz): 75.9; Molecular weight [MH]: 358.2 
(expected), 358.1 (found); IR (cm-1): 3321 (br), 3091, 3035, 2957, 2871, 1704. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
N-(7-((dimethylamino)oxy)-4,4-dimethyl-7-oxoheptyl)-2,2,2-trifluoroacetamide 69 (14.8 mg, 
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52%) was obtained from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.0 mg). Flash column 
chromatography conditions: 50% Et2O/hexane – Pure EtOAc. 
1H NMR (CDCl3, 400 MHz): 6.79 (br, 1H), 3.33 (q, J= 6.6 Hz, 2H), 3.01 (s, 3H), 2.94 (s, 3H), 
2.27 (m, 2H), 1.61-1.52 (m, 4H), 1.25-1.20 (m, 2H), 0.88 (s, 6H); 13C NMR (CDCl3, 100 MHz): 173.6, 
157.3 (q, J= 33.6), 115.9 (q, J= 288.2), 40.6, 38.2, 36.0, 32.4, 28.2, 27.0, 23.5; 19F NMR (CDCl3, 376 
MHz): 75.8; Molecular weight [MH]: 311.2 (expected), 311.2 (found); IR (cm-1): 3254 (br), 
3086, 2955, 2871, 1718, 1634. 
 
By General Procedure D (1.2 equiv. of alkene, 5 mol % Ir photocatalyst, 0.5 mL PhCF3), N-
(4,4-dimethyl-7-oxooctyl)-2,2,2-trifluoroacetamide 70 (16.3 mg, 63%) was obtained from 2,2,2-
trifluoro-N-(4-methylpentyl)acetamide (19.1 mg). Flash column chromatography conditions: 40-
60% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.44 (br, 1H), 3.33 (q, J= 6.6, 2H), 2.38-2.34 (m, 2H), 2.15 (s, 
3H), 1.58-1.45 (m, 4H), 1.20-1.16 (m, 2H), 0.85 (s, 6H); 13C NMR (CDCl3, 100 MHz): 209.3, 157.2 (q, 
J= 36.6), 115.9 (q, J= 288.1), 40.6, 38.7, 28.6, 34.8, 32.1, 30.0, 26.7, 23.8; 19F NMR (CDCl3, 376 
MHz): 76.0; Molecular weight [MH]: 266.1 (expected), 266.2 (found); IR (cm-1): 3313 (br), 
3097, 2958, 2872, 1706. 
When the reaction was carried out with 1.5 equiv. of alkene, 2 mol % Ir photocatalyst,0.25 
mL PhCF3, the desired product was only isolated in low yield (27%). A significant of aza-Michael 
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addition product (44%) was also obtained. The aza-Michael addition product exists as two 
rotamers (~1:2), as observed in NMR. Some of the peaks of the two rotamers cannot be 
distinguished in 13C NMR. 
 
1H NMR (CDCl3, 400 MHz): 3.67 (t, J= 7.6, 1H, minor rotamer), 3.59 (t, J= 6.9, 2H, major 
rotamer), 3.36 (t, J= 8.0, 2H, major rotamer), 3.30 (t, J= 7.9, 1H, minor rotamer), 2.82 (t, J= 6.9, 
2H, major rotamer), 2.77 (t, J= 7.5, 1H, minor rotamer), 2.19 (s, 1.5 H, minor rotamer), 2.17 (s, 
3H, major rotamer), 1.64-1.50 (m, 4.5H, both rotamers), 1.19-1.13 (m, 3H, both rotamers), 0.90-
0.87 (m, 9H, both rotamers); 13C NMR (CDCl3, 100 MHz): 206.5 (major rotamer), 205.4 (minor 
rotamer), 156.9 (q, J= 35.9), 116.4 (q, J= 287.4), 49.0 (q, J= 3.0, major rotamer)), 47.6, 42.7, 42.6, 
41.8 (q, J=3.3, minor rotamer), 40.8, 35.7, 35.5, 30.2, 30.2, 27.8, 27.6, 26,7, 24.7, 22.4, 22.4 ; 19F 
NMR (CDCl3, 376 MHz): 69.21 (major rotamer), 60.29 (minor rotamer); IR (cm-1): 2955, 2933, 
2872, 1718, 1685, 1464, 1436; Molecular weight [MH]: 268.2 (expected); 268.2 (found). 
 
By General Procedure D (3 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL PhCF3), 
2,2,2-trifluoro-N-(4-methyl-4-(3-oxocyclopentyl)pentyl)acetamide 71 (13.5 mg, 51%) was 
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obtained from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (18.7 mg). Flash column 
chromatography conditions: 30-70% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.30 (br, 1H), 3.33 (q, J= 6.9, 2H), 2.32 (dd, J= 18.4, 8.2, 1H), 
2.18-1.91 (m, 5H), 1.63-1.52 (m, 3H), 1.26-1.22 (m, 2H), 0.87 (s, 3H), 0.85 (s, 3H); 13C NMR (CDCl3, 
100 MHz): 219.1, 157.2 (q, J= 36.6), 115.8 (q, J= 287.9), 46.6, 40.1, 40.0, 39.1, 37.8, 34.0, 24.0, 
23.9, 23.7, 23.6; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 278.1 (expected), 
278.1 (found); IR (cm-1): 3313 (br), 3097, 2961, 2874, 1706. 
 
By General Procedure D (3 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL PhCF3), 
2,2,2-trifluoro-N-(4,4,5-trimethyl-7-oxononyl)acetamide  72 (17.4 mg, 59%) was obtained from 
2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.7 mg). Flash column chromatography 
conditions: 30-45% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.34 (br, 1H), 3.33 (q, J= 6.8, 2H), 2.49-2.32 (m, 3H), 2.14 (dd, 
J= 16.0, 10.2, 1H), 1.97-1,91 (m, 1H), 1.61-1.51 (m, 2H), 1.30-1.17 (m, 2H), 1.05 (t, J= 7.3, 3H), 
0.82 (s, 6H), 0.79 (d, J= 6.6, 3H); 13C NMR (CDCl3, 100 MHz): 212.0, 157.2 (q, J= 33.8), 115.8 (q, J= 
287.9),44.9, 40.7, 37.1, 36.7, 36.1, 34.7, 24.2, 23.5, 14.9, 7.8; 19F NMR (CDCl3, 376 MHz): 76.0; 
Molecular weight [MH]: 294.2 (expected), 294.2 (found); IR (cm-1): 3326 (br), 3104, 2965, 2942, 




By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
methyl 3-acetoxy-4,4-dimethyl-7-(2,2,2-trifluoroacetamido)heptanoate 73 (13.7 mg, 40%) was 
obtained from 2,2,2-trifluoro-N-(4-methylpentyl)acetamide (19.8 mg). Flash column 
chromatography conditions: 45-60% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.53 (br, 1H), 3.69 (s, 3H), 3.66 (s, 3H), 3.40-3.27 (m, 2H), 2.84-
2.74 (m, 2H), 2.43 (m, 1H), 1.74-1.66 (m, 1H), 1.69-1.54 (m, 1H), 1.36-1.21 (m, 2H), 0.94 (s, 3H), 
0.92 (s, 3H); 13C NMR (CDCl3, 100 MHz): 174.3, 172.9, 157.3 (q, J= 36.9), 115.8 (q, J= 287.9), 51.8, 
51.6, 49.1, 40.4, 37.8, 34.9, 32.1, 25.1, 25.0, 23.2; 19F NMR (CDCl3, 376 MHz): 75.9; Molecular 




By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
methyl 2-methyl-3-(1-(3-(2,2,2-trifluoroacetamido)propyl)cyclopentyl)propanoate 74 (19.1 mg, 
61%) was obtained from N-(3-cyclopentylpropyl)-2,2,2-trifluoroacetamide (21.7 mg). Flash 
column chromatography conditions: 30-35% Et2O/hexane. 
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1H NMR (CDCl3, 400 MHz): 6.58 (br, 1H), 3.66 (s, 3H), 3.39-3.23 (m, 2H), 2.50-2.42 (m, 1H), 
1.93 (dd, J= 14.5, 9.0, 1H), 1.58-1.23 (m, 13H), 1.16 (d, J= 7.0, 3H); 13C NMR (CDCl3, 100 MHz): 
178.4, 157.3 (q, J= 36.6), 115.9 (q, J= 287.6), 51.7, 45.0, 41.7, 40.6, 37.7, 37.6, 36.3, 34.7, 24.1, 
24.0, 23.9, 20.2; 19F NMR (CDCl3, 376 MHz): 75.8; Molecular weight [MH]: 322.2 (expected), 
322.2 (found); IR (cm-1): 3326 (br), 3105, 2951, 2873, 1705. 
 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL 
PhCF3methyl 4-ethyl-2-methyl-4-(3-(2,2,2-trifluoroacetamido)propyl)octanoate 75 (28.3 mg, 
81%) was obtained from N-(4-ethyloctyl)-2,2,2-trifluoroacetamidetrifluoroacetamide (25.2 mg). 
Flash column chromatography conditions: 15-30% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.56 (br, 1H), 3.65 (s, 3H), 3.35-3.21 (m, 2H), 2.48-2.41 (m,1H), 
1.82 (dd, J= 14.9, 9.4, 1H), 1.53-1.37 (m, 2H), 1.27-1.08 (m, 13H), 0.89 (t, J= 7.3, 3H), 0.72 (two 
overlapped triplet from each diastereomer, J= 7.4, 3H); ); 13C NMR (CDCl3, 100 MHz): 178.5, 157.2 
(q, J= 36.6), 115.9 (q, J= 287.9), 51.7, 40.7, 39.8, 39.7, 37.7, 35.5, 34.9, 34.9, 33.1, 32.9, 28.3, 28.3, 
25.1, 25.0, 23.5, 22.5, 22.4, 20.4, 14.1, 7.4, 7.4; 19F NMR (CDCl3, 376 MHz): 75.9; Molecular 





By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
benzyl 4-ethyl-4-methyl-7-(2,2,2-trifluoroacetamido)heptanoate 76 (25.6 mg, 68%) was obtained 
from enantiomerically enriched (S)-2,2,2-trifluoro-N-(4-methylhexyl)acetamide (21.3 mg). Flash 
column chromatography conditions: 25-35% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 7.39-7.31 (m, 5H), 6.31 (br, 1H), 5.11 (s, 2H), 3.31 (q, J=6.8, 2H), 
2.29-2.24 (m, 2H), 1.58-1.46 (m, 4H), 1.23-1.16 (m,4H), 0.81-0.76 (m, 6H); 13C NMR (CDCl3, 100 
MHz): 174.1, 157.1, 135.9, 128.6, 128.2, 115.8, 66.3, 40.6, 35.4, 34.6, 33.3, 31.0, 29.1, 23.9, 23.3, 
7.8; 19F NMR (CDCl3, 376 MHz): 75.6; Molecular weight [MH]: 372.2 (expected), 372.1 (found); 
IR (cm-1): 3335 (br), 3091, 3035, 2961, 2877, 1704.  
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL DMF), 
tert-butyl 4,4-dimethyl-7-(2,2,2-trifluoroacetamido)octanoate (25.6 mg, 77%) 77 was obtained 
from 2,2,2-trifluoro-N-(5-methylhexan-2-yl)acetamide (20.8 mg). Flash column chromatography 
conditions: 13-25% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.03 (br, 1H), 3.93 (quintet, J= 7.0, 1H), 2.14-2.10 (m, 2H), 1.49-
1.42 (m,12H), 1.20-1.15 (m, 6H), 0.82 (s, 6H); 13C NMR (CDCl3, 100 MHz): 173.6, 156.5 (q, J= 36.6), 
115.9 (q, J= 288.2), 80.2, 47.1, 37.6, 36.1, 32.2, 30.8, 30.7, 28.1, 26.7, 20.5; 19F NMR (CDCl3, 376 
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MHz): 75.8; Molecular weight [MH]: 338.2 (expected), 338.2 (found); IR (cm-1): 3311 (br), 
3095, 2960, 2935, 2871, 1726, 1699, 1554, 1456, 1391, 1367, 1207, 1157. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL DMF), 
methyl 2,4,4,7-tetramethyl-7-(2,2,2-trifluoroacetamido)octanoate 60 (26.2 mg, 83%) was 
obtained from N-(2,5-dimethylhexan-2-yl)-2,2,2-trifluoroacetamide (21.8 mg). Flash column 
chromatography conditions: 10-25% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.05 (br, 1H), 3.65 (s, 3H), 2.52-2.45 (m, 1H), 1.85 (dd, J= 14.1, 
9.4, 1H), 1.68-1.64 (m, 2H), 1.37 (s, 3H), 1.36 (s,3H), 1.18-1.10 (m, 6H), 0.83 (s, 3H), 0.82 (s, 3H); 
13C NMR (CDCl3, 100 MHz): ; 178.3, 156.0 (q, J= 35.9), 115.6 (q, J= 289.4), 55.2, 51.6, 45.4, 35.6, 
35.6, 34.1, 32.8, 27.0, 26.7, 26.5, 26.1, 20.4; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular weight 
[MH]: 324.2 (expected), 324.2 (found); IR (cm-1): 3332 (br), 3086, 2955, 2875, 1712. 
 
By General Procedure D (3 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL 1:1 PhCF3/t-
amyl alcohol), tert-butyl 6-((tert-butyldimethylsilyl)oxy)-4,4-dimethyl-7-(2,2,2-trifluoro- 
acetamido)-heptanoate 78 (25.5 mg, 60%) was obtained from N-(2-((tert-butyldimethylsilyl)oxy)-




1H NMR (CDCl3, 400 MHz): 6.59 (br, 1H), 3.97 (quintet, J= 5.0, 1H), 3.50 (dt, J= 13.3, 4.6, 
1H), 3.32-3.26 (m, 1H), 2.23-2..11 (m, 2H), 1.59-1.52 (m, 2H), 1.50-1.36 (m, 11H), 0.92-0.89 (m, 
15H), 0.11 (s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 100 MHz): 173.3, 157.2 (q, J= 36.6), 115.6 (q, J= 
287.6), 80.2, 67.6, 47.2, 46.8, 37.6, 32.0, 30.7, 28.1, 27.2, 26.9, 25.7, 17.8, 4.2, 4.5; 19F NMR 
(CDCl3, 376 MHz): 75.9; Molecular weight [MH]: 454.3 (expected), 454.3 (found); IR (cm-1): 
3323 (br), 3096, 2956, 2930, 2858, 1728, 1705. 
 
By General Procedure D (3 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL 1:1 PhCF3/t-
amyl alcohol), tert-butyl 6-((tert-butoxycarbonyl)amino)-4,4-dimethyl-7-(2,2,2-trifluoro- 
acetamido)heptanoate (28.7 mg, 67%) 79 was obtained from tert-butyl (4-methyl-1-(2,2,2-
trifluoroacetamido)pentan-2-yl)carbamate (30.2 mg). Flash column chromatography conditions: 
30-50% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 7.61 (br, 1H), 4.61 (d, J= 8.2, 1H), 3.95-3.94 (m, 1H), 3.40-3.22 
(m, 2H), 2.17 (t, J= 8.3, 2H), 1.63-1.50 (m, 2H), 1.44 (s, 9H), 1.42 (s, 9H), 1.33 (d, J= 5.8, 2H), 0.91 
(s, 6H); 13C NMR (CDCl3, 100 MHz): 173.3, 157.7 (q, J= 40), 156.9, 115.8 (q, J= 286), 80.5, 80.3, 
47.9, 46.6, 44.1, 36.9, 32.7, 30.6, 28.2, 26.8; 19F NMR (CDCl3, 376 MHz): 76.1; Molecular weight 
[MH]: 285.1 (expected for MW-2BOC+2H), 285.1 (found); IR (cm-1): 3676, 3330 (br), 3109, 2977, 




By General Procedure D (3 equiv. of alkene, 5 mol % Ir photocatalyst, 0.25 mL PhCF3), tert-
butyl 4-((tert-butyldimethylsilyl)oxy)-4-methyl-7-(2,2,2-trifluoroacetamido)heptanoate 80 (33.4 
mg, 76%) was obtained from N-(4-((tert-butyldimethylsilyl)oxy)pentyl)-2,2,2-trifluoroacetamide 
(31.0 mg). Flash column chromatography conditions: 7-20% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.35 (br, 1H), 3.37-3.32 (m, 2H), 2.25 (t, J= 8.0, 2H), 1.74-1.70 
(m,2H), 1.66-1.59 (m, 2H), 1.44-1.42 (m, 11H), 1.19 (s, 3H), 0.86 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 
13C NMR (CDCl3, 100 MHz): 173.4, 157.2 (q, J= 36.6), 115.8 (q, J= 287.9), 80.2, 74.5, 40.3, 39.1, 
36.9, 30.6, 28.1, 27.3, 25.8, 23.8, 18.2, 2.01; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular Weight 
[MH]: 440.2 (expected), 440.3 (found); IR (cm-1): 3330 (br), 3096, 2955, 2930, 2886, 2857, 1727, 
1703, 1555, 1473, 1463, 1392, 1367, 1311, 1253, 1207, 1152, 1122, 1039. 
 
By General Procedure D (3.0 equiv. of alkene, 5 mol% Ir photocatalst, 0.25 mL PhCF3), 
methyl 2,4-dimethyl-4-(2-(2,2,2-trifluoroacetamido)ethoxy)-pentanoate 81 (25.3 mg, 79%) was 
obtained from 2,2,2-trifluoro-N-(2-isopropoxyethyl)acetamide (19.5 mg). First Chromatography: 
25-35% Et2O/hexane, Si gel; Second chromatography: 25-40% Et2O/hexane, florisil (200 mesh, 
fine powder, activated magnesium silicate). 
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1H NMR (CDCl3, 400 MHz): 7.30 (br, 1H), 3.64-3.58 (m, 4H), 3.44-3.34 (m, 2H), 3.30-3.24 
(m, 1H), 2.68-2.59 (m, 1H), 2.12 (dd, J= 14.1, 11.0, 1H), 1.41 (dd, J= 14.0, 2.3, 1H), 1.17-1.14 (m, 
9H);  13C NMR (CDCl3, 100 MHz): 178.6, 156.9 (q, J= 36.9), 116.0 (q, J= 287.6), 74.6, 59.5, 51.5, 
46.5, 40.1, 36.0, 26.0, 23.5, 19.2; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 
298.1 (expected), 298.1 (found); IR (cm-1): 3321 (br), 3094, 2975, 2953, 2937, 2879, 1713, 1552, 
1462, 1437, 1378, 1367, 1276, 1206, 1148, 1092. 
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL DMF), 
tert-butyl 4,7-dimethyl-7-(2,2,2-trifluoroacetamido)octanoate 82a (12.5 mg, 38%) was obtained 
from 2,2,2-trifluoro-N-(2-methylhexan-2-yl)acetamide (20.4 mg). Flash column chromatography 
conditions: 10-20% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 5.91 (br, 1H), 2.28-2.13 (m, 2H), 1.81-1.60 (m, 3H), 1.44 (s, 9H), 
1.41-1.39 (m, 1H), 1.37 (s, 6H), 1.31-1.21 (m,2H), 1.13-1.04 (m,1H), 0.88 (d, J=6.3); 13C NMR (CDCl3, 
100 MHz): 173.2, 156.0 (q, J= 35.9), 115.6 (q, J= 289.4), 80.1, 55.3, 37.1, 33.2, 32.6, 31.8, 30.7, 
28.1, 26.3, 19.2  ; 19F NMR (CDCl3, 376 MHz): 76.2; Molecular weight [MH]: 338.2 (expected), 




By General Procedure D (3.0 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 DMF), 2,2,2-
trifluoro-N-(2,5,6-trimethyl-8-oxodecan-2-yl)acetamide 82b (15.8 mg, 53%) was obtained as a 
1:1 inseperable mixture of diastereomers from 2,2,2-trifluoro-N-(2-methylhexan-2-yl)acetamide 
(20.4 mg). Flash column chromatography conditions: 15-25% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.01 (br, 1H), 5.94 (br, 1H), 2.44-2.32 (m, 6H), 2.27-2.04 (m, 
5H), 1.80-1.63 (m, 5H), 1.37 (s, 12H), 1.35-1.20 (m, 4H), 1.04 (t, J= 7.5, 6H), 0.85-0.82 (m, 6H), 
0.80-0.76 (m, 6H); 13C NMR (CDCl3, 100 MHz): 211.9, 211.6, 156.03 (q, J= 35.9), 155.98 (q, J= 35.8), 
115.6 (q, J= 289.4), 55.4, 47.7, 45.7, 37.8, 37.71, 37.66, 37.3, 36.53, 36.51, 33.2, 32.5, 28.6, 27.5, 
26.6, 26.40, 26.37, 26.3, 17.3, 16.1, 14.7, 14.4, 7.8; 19F NMR (CDCl3, 376 MHz): 76.13, 76.16; 
Molecular weight [MH]: 308.2 (expected), 308.2 (found); IR (cm-1): 3326 (br), 3086, 2968, 2938, 
2878, 1707. 
A.2.6 Photoredox-Catalyzed Reactions with Substrates Bearing Multiple Reactive 
C-H Bonds 
General Procedure D: Photocatalytic C-C Bond Formation  
To a mixture of the amine (0.1 mmol, 1 equiv.), alkene and finely ground K3PO4 (0.2 mmol, 
2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed by the solvent. Argon 
was bubbled through the solution for 5 mins. [Ir(dF-CF3pp)2dtbbp]PF6 2-5 mol %) was added. 
Argon was bubbled through the solution for another 10 mins. The vial was then capped and 
illuminated with a Blue LED for 16-20 h (The distance between the Blue LED and the vial is around 
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1.5 cm). The mixture was filtered through silica gel. The product was purified by column 
chromatography.  
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3), 
tert-butyl 4,8-dimethyl-4-(3-(2,2,2-trifluoroacetamido)propyl)nonanoate 86 (22.9 mg, 64%) was 
obtained from N-(4,8-dimethylnonyl)-2,2,2-trifluoroacetamide (24.3 mg). Flash column 
chromatography conditions: 15-25% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.35 (br, 1H), 3.33 (q, J= 6.8 Hz, 2H),2.13-2.09 (m, 2H), 1.54-
1.48 (m, 5H), 1.44(s, 9H), 1.21=1.11 (m, 7H), 0.86 (d, J= 6.6, 6H), 0.82 (s, 3H); 13C NMR (CDCl3, 100 
MHz): 173.7, 157.1 (q, J= 37.1), 115.8 (q, J= 287.6), 80.2, 40.6, 39.8, 39.3, 36.0, 34.6, 33.9, 30.3, 
28.1, 27.9, 24.5, 23.4, 22.6, 21.1; 19F NMR (CDCl3, 376 MHz): 75.8; Molecular weight [MH]: 
394.3 (expected), 394.2 (found); IR (cm-1): 3324 (br), 3100, 2956, 2933, 2870, 1728, 1703. 
 
By General Procedure D (3.0 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL PhCF3) 
tert-butyl 4-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-7-(2,2,2-trifluoroacetamido)hep- 
tanoate (22.8 mg, 54%) 88 was obtained from N-(5-((tert-butyldimethylsilyl)oxy)-4-
methylpentyl)-2,2,2-trifluoroacetamide (30.2 mg). Some starting material (7.8 mg, 26%) was also 
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covered. First chromatography: 10-25% Et2O/hexane. Second chromatography: 10-45% 
Et2O/hexane, florisil (200 mesh, fine powder, activated magnesium silicate) 
1H NMR (CDCl3, 400 MHz): 6.29 (br, 1H), 3.34 (q, J= 6.5, 2H), 3.25 (s, 2H), 2.17-2.13 (m, 
2H), 1.55-1.52 (m, 4H), 1.44 (s, 9H), 1.27-1.24 (m, 2H), 0.88 (s, 9H), 0.79 (s, 3H), 0.02 (s, 6H); 13C 
NMR (CDCl3, 100 MHz): 173.6, 80.1, 68.9, 40.7, 37.0, 33.4, 31.5, 30.3, 28.1, 25.8, 23.3, 21.5, 18.2, 
5.6; 19F NMR (CDCl3, 376 MHz): 75.8; Molecular weight [MH]: 454.3 (expected), 454.3 
(found); IR (cm-1): 3312 (br), 2955, 2931, 2858, 1728, 1704. The carbons in the trifluoroacetyl 
group cannot be observed in 13C NMR even after extended NMR time but their presence is 
supported by 19F NMR.  
 
By General Procedure D (1.5 equiv. of alkene, 2 mol % Ir photocatalyst, 0.25 mL PhCF3) 
tert-butyl 4-isopropyl-4-methyl-7-(2,2,2-trifluoroacetamido)heptanoate 90 (15.2 mg, 46%) was 
obtained from N-(4,5-dimethylhexyl)-2,2,2-trifluoroacetamide (21.1 mg). Some starting material 
(9.1 mg, 43%) was also covered. Flash column chromatography conditions: 20-30% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 6.46 (br, 1H), 3.32 (q, J= 6.8, 2H), 2.10 (t, J= 8.4, 2H), 1.61-1.51 
(m, 5H), 1.44 (s, 9H), 1.29-1.18 (m, 2H), 0.83-0.81 (m, 6H), 0.74 (s, 3H); 13C NMR (CDCl3, 100 MHz): 
173.8, 157.1 (q, J= 36.6), 115.9 (q, J= 287.9), 80.2, 40.7, 36.6, 33.5, 33.3, 31.3, 30.2, 28.1, 23.2, 
20.6, 17.0; 19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 352.2 (expected), 352.2 




By General Procedure D (3.0 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL PhCF3) 1-
benzyl 8-(tert-butyl) 4,4,5-trimethyl-5-(3-(2,2,2-trifluoroacetamido)propyl)octanedioate 91 (19.3 
mg, 39%) was obtained from tert-butyl 4-isopropyl-4-methyl-7-(2,2,2-
trifluoroacetamido)heptanoate (33.9 mg). Flash column chromatography conditions: 25-45% 
Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 7.37-7.29 (m, 5H), 6.40 (br, 1H), 5.11 (s, 2H), 3.31 (q, J= 6.8, 
2H), 2.34-2.30 (m, 2H), 2.19-2.15 (m, 2H), 1.67-1.55 (m, 6H), 1.44 (s, 9H), 1.35-1.29 (m, 2H), 0.80 
(s, 6H), 0.78 (s, 3H); 13C NMR (CDCl3, 100 MHz): 174.3, 173.6, 157.2 (q, J= 36.9), 136.0, 128.6, 128.3, 
128.2, 115.8 (q, J= 287.9), 80.4, 66.3, 40.9, 40.1, 38.9, 32.3, 32.0, 31.5, 30.0, 29.8, 28.1, 25.3, 21.7, 
21.6, 19.4; 19F NMR (CDCl3, 376 MHz): 75.9; Molecular Weight [MH]: 514.3 (expected), 514.3 
(found); IR (cm-1): 3313 (br), 3095, 3074, 2035, 2974, 2881, 1727. 
A.2.7 Application to Biologically Interesting Molecules 
General Procedure D: Photocatalytic C-C Bond Formation  
To a mixture of the amine (0.1 mmol, 1 equiv.), alkene and finely ground K3PO4 (0.2 mmol, 
2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed by the solvent. Argon 
was bubbled through the solution for 5 mins. [Ir(dF-CF3pp)2dtbbp]PF6 (2-5 mol %) was added. 
Argon was bubbled through the solution for another 10 mins. The vial was then capped and 
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illuminated with a Blue LED for 16-20 h (The distance between the Blue LED and the vial is around 
1.5 cm). The mixture was filtered through silica gel. The product was purified by column 
chromatography.  
 
By General Procedure D (3.0 equiv. of alkene, 4 mol % Ir photocatalyst, 0.25 mL 1:1 
PhCF3/t-amyl alcohol) 8-(tert-butyl) 1-methyl 5,5-dimethyl-3-((2,2,2-trifluoroacetamido)methyl)-
octanedioate 93 (27.2 mg, 70%) was obtained from methyl 5-methyl-3-((2,2,2-
trifluoroacetamido)methyl)hexanoate (26.6 mg). The product was purified by flash column 
chromatography twice. First Chromatography: 30-40% Et2O/hexane, Si gel; Second 
chromatography: 25-100% Et2O/hexane, florisil (200 mesh, fine powder, activated magnesium 
silicate). 
1H NMR (CDCl3, 400 MHz): 7.09 (br, 1H), 3.69 (s, 3H), 3.44-3.38 (m, 1H), 3.30-3.23 (m, 1H), 
2.46 (dd, J= 16.0, 4.3, 1H), 2.35 (dd, J= 16.0, 7.8, 1H), 2.23-2.14 (m, 3H), 1.55-1.51 (m, 2H), 1.44 
(s, 9H), 1.22 (d, J= 5.1, 2H), 0.91-0.87 (m, 6H); 13C NMR (CDCl3, 100 MHz): 173.7, 173.3, 157.5 (q, 
J= 37.4), 115.9 (q, J= 287.6), 80.3, 51.9, 45.5, 44.0, 39.5, 37.0, 33.2, 30.7, 30.6, 28.1, 26.5, 26.4; 
19F NMR (CDCl3, 376 MHz): 76.0; Molecular weight [MH]: 396.2 (expected), 396.2 (found); IR 




By General Procedure D (1.5 equiv. of alkene, 6 mol % Ir photocatalyst, 0.30 mL 1:1 
PhCF3/t-amyl alcohol) benzyl 4-((3R,5R,8R,9S,10S,13S,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-
10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-4-methyl-7-(2,2,2-
trifluoro-acetamido)heptanoate 95 (30.9 mg, 44%) was obtained as a pair of diastereomeric 
mixture (~2:1) from N-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-
10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentyl)-2,2,2-
trifluoroacetamide (21.1 mg). Some starting material (25.0 mg, 47%) was also covered. Flash 
column chromatography conditions: 5-25% Et2O/hexane. 
1H NMR (CDCl3, 400 MHz): 7.39-7.30 (m, 5H), 6.31 (br, 1H), 5.11 (s, 2H), 3.61-3.53 (m, 1H), 
3.37-3.24 (m, 2H), 2.29-2.25 (m, 2H), 1.81-1.59 (m, 5), 1.53-0.89 (m, 39H), 0.73 (s, 3H), 0.05 (s, 
6H); 13C NMR (CDCl3, 100 MHz): 174.1, 157.1 (q, J=36.6), 136.0, 135.9, 128.55, 128.54, 128.23, 
128.21, 128.19, 72.7, 66.3, 66.3, 56.7, 56.6, 56.5, 43.8, 43.8, 42.2, 40.1, 40.9, 40.6, 40.6, 40.2, 
43.8, 43.8, 42.2, 41.0, 40.9, 40.6, 40.6, 40.2, 38.5, 38.5, 36.9, 35.7, 35.6, 35.5, 35.3, 35.3, 34.5, 
33.5, 33.2, 31.0, 29.3, 29.0, 27.2, 26.2, 26.0, 23.6, 23.5, 23.3, 23.1, 22.9, 22.8, 22.8, 22.7, 20.6, 
18.3, 15.0, 14.9, 4.6; 19F NMR (CDCl3, 376 MHz): 75.9; Molecular weight [MH]: 732.5 
(expected), 732.5 (found); IR (cm-1): 3326 (br), 3091, 3067, 3034, 2927, 2884, 2857, 1705.  
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A.2.8 Mechanistic Studies 
Quantum Yield 
 
The above reaction was set up in a glove box (44.1 mg of 96, 2 mol % [Ir] photocatalyst, 
1.5 equiv. methyl methacrylate 39, 2 equiv. K3PO4, 0.5 mL PhCF3, 6 drops of H2O). It was then 
taken from the glove box and irradiated ( =419nm) for 2 h (t=7200 s). After irradiation, the 
sample was filtered through silica gel. After flash column chromatography (20-40% Et2O/hexane), 
1.2 mg of the alkylated product 74 (1.9%) was isolated. 
The above experiment was repeated with 44.3 mg starting material. 1.3 mg of the 
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By UV-Vis, all incident light is absorbed by the [Ir] photocatalyst under the reaction 
conditions (Absorbance > 3 in PhCF3). Therefore, fraction of light absorbed is ~ 1 (f =1). 
The photon flux of the spectrophotometer was measured by literature procedures 
(ferrioxalate actinometry).11 At 419 nm, it was determined to be 5.2 x 10-9 einstein s-1.  
 
On/Off Studies 
The above reaction was set up (43.8 mg of 96, 2 mol % [Ir] photocatalyst, 1.5 equiv. benzyl 
acrylate 50, 2 equiv. K3PO4, 0.5 mL PhCF3, 6 drops of H2O) according to General Procedure D. 
Mesitylene was added as an internal standard. The reaction mixture was irradiated with a Blue 
LED for an hour. An aliquot (20 L) was taken from the reaction mixture and filtered through a 
short plug of silica gel. The amount of product was determined by HPLC. The reaction mixture 
was degassed by bubbling argon through for 10 mins. The reaction mixture was covered by 
aluminum foil and re-subject to the Blue LED. The amount of the product was determined in the 
same way as before. After degassing, the reaction mixture was unwrapped and irradiated with 
the Blue LED. The reaction was monitored for 6 hours in total. It was observed that the  
photoredox-catalyzed reaction demonstrates an On/Off behavior.  T. he quantum yield (<1) and 
the On/Off behavior are consistent with a closed catalytic cycle.  
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In addition, we believe that chain propagation mechanism is very unlikely by considering 









































Potential Pathways for the Generation of Nitrogen Radical 
a. Possibility of Oxidation/Deprotonation Stepwise Mechanism 
Stern-Volmer studies were carried out with Horiba Fluorolog 3 (model number: FL3-11). 
The standard solutions were prepared in DMF, a competent solvent for the reaction. The 
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solutions (0.01 mM Ir photocatalyst and varying concentrations of trifluoroacetamide) were 
irradiated at 380 nm and luminescence was measured at 470 nm. 
[trifluroacetamide] 
( mM) 
0 0.2 0.4 0.6 1.0 
I0/I 1 0.99879 0.99963 1.00021 0.99988 
 
 
The result shows that the Ir photocatalyst is not quenched by the neutral amide in the 
absence of a base. This is consistent with CV studies which were obtained with a CH instrument 
(electrochemical analyzer, CHI1232B, serial number: A3268). A glassy electrode, a Pt mesh 
counter electron and an Ag/AgCl reference electrode were used and measurement was taken in 
a 2 mM solution of the amide in MeCN containing 0.1 M NBu4PF6. No oxidation was observed 
even at voltage >2V vs Ag/AgCl (or >1.955 V vs SCE). This suggests that the excited Ir photocatalyst 
(1.2V vs SCE) cannot oxidize the neutral form of trifluoroacetamide and is consistent with the 
quenching studies. Thus oxidation/deprotonation stepwise event is unlikely to be responsible for 














b. Discussion about Deprotonation/Oxidation Stepwise and PCET Mechanism 
Stern-Volmer studies were also conducted with the potassium salt of trifluoroacetamide. 
Standard solutions of potassium propyl(2,2,2-trifluoroacetyl)amide and [Ir(dF-CF3pp)2dtbbp]PF6 
in anhydrous DMF were prepared by mixing equal amount of potassium hydride and 2,2,2-
trifluoro-N-propylacetamide in the glove box to make sure there was no water present. The 
solutions (0.01 mM Ir photocatalyst and varying concentrations of potassium propyl(2,2,2-
trifluoroacetyl)amide) were irradiated at 380 nm and luminescence was measured at 470 nm. 
The plot was obtained by two independent runs (i.e. new standard solutions were prepared for 
each run): 
Run 1 
[potassium salt of 
trifluroacetamide] 
( mM) 
0 0.2 0.4 0.6 1.0 
I0/I 1 1.04686 1.11111 1.19689 1.31199 
 
Run 2 
[potassium salt of 
trifluroacetamide] 
( mM) 
0 0.2 0.4 0.6 1.0 





[potassium salt of 
trifluroacetamide] 
( mM) 
0 0.2 0.4 0.6 1.0 
I0/I 1 1.108434 1.083081 1.163444 1.33707 
 
 
The result shows that the Ir photocatalyst is quenched by the potassium salt of the 
trifluoroacetamide. This is consistent with CV studies which indicate that the redox potential of 
the potassium salt of the trifluoroacetamide is 0.80V vs Ag/AgCl (or 0.77 V vs SCE). The potential 
suggests that the excited state of the photocatalyst (1.2 V vs SCE) can oxidize the potassium salt 
of trifluoroacetamide. 
In addition, the presence of negatively charged nitrogen is evidenced by the formation of 
aza-Michael addition product with K3PO4 in PhCF3 (>50% conversion, see below). No aza-Michael 
adduct is formed, as determined by 1H NMR, in the absence of K3PO4. Substrates bearing weaker 















electron-withdrawing groups on nitrogen, pentafluorobenzoyl and difluoroacetyl groups (pKa of 
trifluoroacetic acid16 =0.2, difluoroacetic acid17 =1.1, pentafluorobenzoic acid18 =1.7) do not yield 
the C-H functionalized product under the photocatalyzed conditions nor do they form the aza-
Michael addition product with K3PO4 in wet PhCF3 (see below). There appears a correlation 
between the presence of negatively charged nitrogen and the generation of nitrogen radical. Also, 
the reaction is biphasic and a three-component (Amide, [Ir] photocatalyst and K3PO4) transition 
state is unlikely. This leads us to believe that deprotonation then oxidation stepwise event is 
responsible for the generation of nitrogen radical.  
 
To a mixture of the amine (0.1 mmol, 1 equiv.), methyl vinyl ketone (0.15 mmol, 1.5 equiv.) 
and K3PO4 (0.2 mmol, 2 equiv.) in a vial was added 3 drops of deionized water (~40 mg), followed 
by PhCF3 (0.25 mL). The vial was then capped and illuminated with a Blue LED for 20 h (The 
distance between the Blue LED and the vial is around 1.5 cm). The mixture was filtered through 
silica gel. The conversion was determined by 1H NMR spectroscopy. The product can be purified 
by column chromatography (35-60% Et2O/hexane). The product exists as two rotamers (~1:2), as 





 1H NMR (CDCl3, 400 MHz): 3.67 (t, J= 7.6, 1H, minor rotamer), 3.59 (t, J= 6.9, 2H, major 
rotamer), 3.36 (t, J= 8.0, 2H, major rotamer), 3.30 (t, J= 7.9, 1H, minor rotamer), 2.82 (t, J= 6.9, 
2H, major rotamer), 2.77 (t, J= 7.5, 1H, minor rotamer), 2.19 (s, 1.5 H, minor rotamer), 2.17 (s, 
3H, major rotamer), 1.64-1.50 (m, 4.5H, both rotamers), 1.19-1.13 (m, 3H, both rotamers), 0.90-
0.87 (m, 9H, both rotamers); 13C NMR (CDCl3, 100 MHz): 206.5 (major rotamer), 205.4 (minor 
340 
 
rotamer), 156.9 (q, J= 35.9), 116.4 (q, J= 287.4), 49.0 (q, J= 3.0, major rotamer)), 47.6, 42.7, 
42.6, 41.8 (q, J=3.3, minor rotamer), 40.8, 35.7, 35.5, 30.2, 30.2, 27.8, 27.6, 26,7, 24.7, 22.4, 
22.4 ; 19F NMR (CDCl3, 376 MHz): 69.21 (major rotamer), 60.29 (minor rotamer); IR (cm-1): 







A.2.9 NMR Spectra 
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